ERN RARE-LIVER

Rare liver diseases can cause progressive liver injury leading to fibrosis and cirrhosis. The complications of cirrhosis can lead to death and, in many cases, the only effective treatment is liver transplantation. Fatigue, pruritus in cholestatic conditions, and pain and abdominal swelling in cystic conditions significantly affect quality of life.

In paediatric patients, delay in diagnosis, and failure to thrive and attain developmental milestones are additional key factors, along with the challenge of transition in care through adolescence.

ERN RARE-LIVER addresses three disease themes: autoimmune liver disease, metabolic biliary atresia and related liver disease, and structural liver disease. The network will, for the first time in liver disease, fully integrate adult and paediatric care with a focus on the needs of transitional populations and the implications for families with a genetic diagnosis.

The development of up-to-date guidelines is a priority. Care guidelines will be implemented in collaboration with the European Association for the Study of the Liver (EASL) and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). This will be supported by the standardisation of key diagnostic and prognostic tests.

Clinician awareness of rare liver disorders and equitable access to rapidly evolving treatment options are major challenges to be addressed.

Registry

Contact information

Publications

Filter list publications

TitleAuthorsDateKeywordsIssue name
Predictive role of hepatic venous pressure gradient in bleeding events among patients with cirrhosis undergoing orthotopic liver transplantation.Giabicani M, Joly P, Sigaut S, Timsit C, Devauchelle P, Dondero F, Durand F, Froissant PA, Lamamri M, Payancé A, Restoux A, Roux O, Thibault-Sogorb T, Valainathan SR, Lesurtel M, Rautou PE, Weiss E2024-06-01bleeding, cirrhosis, hepatic venous pressure gradient, liver transplantation, portal hypertension, pre-transplant assessmentJHEP reports : innovation in hepatology
French guidelines on TIPS: Indications and modalities.Larrue H, Allaire M, Weil-Verhoeven D, Barge S, Thabut D, Payance A, Moga L, Jézéquel C, Artru F, Archambeaud I, Elkrief L, Oberti F, Roux C, Laleman W, Rudler M, Dharancy S, Laborde N, Minello A, Mouillot T, Desjonquères E, Wandji LCN, Bourlière M, Ganne-Carrié N, Bureau C2024-05-17TIPS, cirrhosis, guidelines, portal hypertensionLiver international : official journal of the International Association for the Study of the Liver
Impact of cholecystectomy on the gut-liver axis and metabolic disorders.Raposo MA, Oliveira ES, Santos AD, Guadagnini D, Mourabit HE, Housset C, Lemoinne S, Saad MJA2024-05-08Bile Acids, Cholecystectomy, Gut microbiota, Metabolic DiseasesClinics and research in hepatology and gastroenterology
Validation of NIAAAm-CRP criteria to predict alcohol-associated steatohepatitis on liver histology.Stauber RE, Rautou PE, Stefanescu H, Horhat A, Thiele M, Lackner C2024-05-01Alcohol-associated liver disease, histology, noninvasiveJHEP reports : innovation in hepatology
Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply.Hofer BS, Burghart L, Halilbasic E, Simbrunner B, Petrenko O, Mandorfer M, Stättermayer AF, Trauner M, Reiberger T2024-05-01Alimentary pharmacology & therapeutics
Reply: Improving access to transient elastography data for real-world prognostic applications in primary biliary cholangitis.Corpechot C, Lemoinne S, Soret PA, Chazouillères O, de Lédinghen V2024-05-01Hepatology (Baltimore, Md.)
Abdominal surgery in patients with chronic noncirrhotic extra hepatic portal vein obstruction: A multicenter retrospective study.Elkrief L, Denecheau-Girard C, Magaz M, Praktiknjo M, Colucci N, Ollivier-Hourmand I, Dumortier J, Simon Talero M, Tellez L, Artru F, Meszaros M, Verhelst X, Tabchouri N, Beires F, Andaluz I, Leo M, Diekhöner M, Dokmak S, Fundora Y, Vidal-Gonzalez J, Toso C, Plessier A, Carlos Garcia Pagan J, Rautou PE2024-04-29Hepatology (Baltimore, Md.)
Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors.Ollivier-Hourmand I, Lebedel L, Bartroli Alabau B, Goria O, Bureau C, Dumortier J, Heurgué A, Silvain C, De-Ledinghen V, Rautou PE, Payancé A, García Ballester T, Alvarado-Tapias E, Hernández-Gea V, Valla D, Zekrini K, Nguyen TTN, Dao T, Garcia Pagan JC, Morello R, Plessier A2024-04-26Acute portal thrombus, abdominal inflammation, recurrence, thrombophiliaJournal of hepatology
PPAR agonists in PBC: Where do we go from here? Or how to choose between the new and the old.Tanaka A, Corpechot C2024-04-25Clinics and research in hepatology and gastroenterology
Artificial intelligence supported ultrasonography: Can it be the solution for early and accurate diagnosis of steatotic liver disease?Gabeta S, Rigopoulou EI, Dalekos GN2024-04-24Artificial intelligence, Metabolic dysfunction-associated steatotic liver disease, Steatotic liver disease, UltrasonographyEuropean journal of internal medicine
Blockade of neutrophil extracellular trap components ameliorates cholestatic liver disease in Mdr2 (Abcb4) knockout mice.Hintermann E, Tondello C, Fuchs S, Bayer M, Pfeilschifter JM, Taubert R, Mollenhauer M, Elferink RPJO, Manns MP, Christen U2024-04-22Autoimmune liver disease, Hepatobiliary disease, Mdr2 (Abcb4) knockout mouse, Neutrophil elastase, Neutrophil extracellular trapJournal of autoimmunity
Acute Hepatitis of Unknown Origin in Children: Analysis of 17 Cases Admitted to the Bambino Gesù Children's Hospital in Rome.Di Maio VC, Gentile L, Scutari R, Colagrossi L, Coltella L, Ranno S, Linardos G, Liccardo D, Basso MS, Pietrobattista A, Landi S, Forqué L, Ciofi Degli Atti M, Ricotta L, Onetti Muda A, Maggiore G, Raponi M, Perno CF, Russo C2024-04-19acute hepatitis, adenovirus, pediatricMicroorganisms
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score.Gerussi A, Cappadona C, Bernasconi DP, Cristoferi L, Valsecchi MG, Carbone M, Invernizzi P, Asselta R2024-04-15autoimmunity, liver, precision medicine, risk stratificationLiver international : official journal of the International Association for the Study of the Liver
Metabolic-Associated Steatotic Liver Disease (MASLD): A New Term for a More Appropriate Therapy in Pediatrics?Antonella M, Pietrobattista A, Maggiore G2024-04-10Pediatric reports
Impact of MASLD and MetALD on clinical outcomes: A meta-analysis of preliminary evidence.Ciardullo S, Mantovani A, Morieri ML, Muraca E, Invernizzi P, Perseghin G2024-04-10MASLD, MetALD, cardiovascular disease, mortalityLiver international : official journal of the International Association for the Study of the Liver
Prognosis algorithms for acute decompensation of cirrhosis and ACLF.Valainathan SR, Xie Q, Arroyo V, Rautou PE2024-04-09acute decompensation of cirrhosis, acute‐on‐chronic liver failure, cirrhosis, prognosisLiver international : official journal of the International Association for the Study of the Liver
Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma.Roehrig A, Hirsch TZ, Pire A, Morcrette G, Gupta B, Marcaillou C, Imbeaud S, Chardot C, Gonzales E, Jacquemin E, Sekiguchi M, Takita J, Nagae G, Hiyama E, Guérin F, Fabre M, Aerts I, Taque S, Laithier V, Branchereau S, Guettier C, Brugières L, Fresneau B, Zucman-Rossi J, Letouzé E2024-04-08Nature communications
Apoptotic cell identity induces distinct functional responses to IL-4 in efferocytic macrophages.Liebold I, Al Jawazneh A, Casar C, Lanzloth C, Leyk S, Hamley M, Wong MN, Kylies D, Gräfe SK, Edenhofer I, Aranda-Pardos I, Kriwet M, Haas H, Krause J, Hadjilaou A, Schromm AB, Richardt U, Eggert P, Tappe D, Weidemann SA, Ghosh S, Krebs CF, A-Gonzalez N, Worthmann A, Lohse AW, Huber S, Rothlin CV, Puelles VG, Jacobs T, Gagliani N, Bosurgi L2024-04-05Science (New York, N.Y.)
Hepatomegaly in a patient with a history of acute myeloid leukemia.Moga L, Paradis V, Bruno O, Valla D, Rautou PE2024-04-01constrictive pericarditis, hepatic sinusoidal dilatation, mosaic enhancement, portal hypertension, right heart catheterizationJournal of hepatology
Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis-More evidence needed. Authors' reply.Martini A, Pontisso P2024-04-01Alimentary pharmacology & therapeutics
Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis.Hofer BS, Burghart L, Halilbasic E, Simbrunner B, Petrenko O, Mandorfer M, Stättermayer AF, Trauner M, Reiberger T2024-04-01Baveno VII, advanced chronic liver disease, cholestatic liver disease, disease regression, hepatic recompensationAlimentary pharmacology & therapeutics
New horizons in the diagnosis and management of patients with MASLD.van Erpecum KJ, Dalekos GN2024-04-01Metabolic dysfunction-associated steatohepatitis, Metabolic dysfunction-associated steatotic liver disease, NomenclatureEuropean journal of internal medicine
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU.Riveiro-Barciela M, Carballal S, Díaz-González Á, Mañosa M, Gallego-Plazas J, Cubiella J, Jiménez-Fonseca P, Varela M, Menchén L, Sangro B, Fernández-Montes A, Mesonero F, Rodríguez-Gandía MÁ, Rivera F, Londoño MC2024-04-01Colitis, Diarrea, Diarrhea, Drug-induced liver injury, Efectos adversos inmunomediados, Hepatitis, Hepatotoxicidad, Immune checkpoint inhibitors, Immune-related adverse events, Immunotherapy, Inhibidores de checkpoint inmunológicos, Inmunoterapia, Toxicidad, ToxicityGastroenterologia y hepatologia
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort.Kondili LA, Zanetto A, Quaranta MG, Ferrigno L, Panetta V, Calvaruso V, Zignego AL, Brunetto MR, Raimondo G, Biliotti E, Ieluzzi D, Iannone A, Madonia S, Chemello L, Cavalletto L, Coppola C, Morisco F, Barbaro F, Licata A, Federico A, Cerini F, Persico M, Pompili M, Ciancio A, Piscaglia F, Chessa L, Giacometti A, Invernizzi P, Brancaccio G, Benedetti A, Baiocchi L, Gentile I, Coppola N, Nardone G, Craxì A, Russo FP2024-04-01coagulation, direct‐acting antiviral, long term outcomes, predictive factors, real‐life cohortUnited European gastroenterology journal
Calprotectin serum levels on admission and during follow-up predict severity and outcome of patients with COVID-19: A prospective study.Gatselis NK, Lyberopoulou A, Lygoura V, Giannoulis G, Samakidou A, Vaiou A, Antoniou K, Triantafyllou K, Stefos A, Georgiadou S, Sagris D, Sveroni D, Gabeta S, Ntaios G, Norman GL, Dalekos GN2024-04-01Biomarker, COVID-19, Calprotectin, Outcome, PrognosisEuropean journal of internal medicine
Prednisolone with azathioprine or mycophenolate mofetil as first-line therapy in autoimmune hepatitis: insights from a randomized controlled trial.Snijders RJALM, Stoelinga AEC, van Hoek B, Drenth JPH2024-03-28Journal of hepatology
Endoscopic features of low-phospholipid-associated cholelithiasis syndrome: A retrospective cohort study.Salin G, Corpechot C, Ouazana S, Dong C, Becq A, Lemoinne S, Ben Belkacem K, Leenhardt R, Chaput U, Chazouillères O, Kirchgesner J, Camus M2024-03-23Ercp, Lpac, UDCAClinics and research in hepatology and gastroenterology
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease.Loomba R, Clark G, Teckman J, Ajmera V, Behling C, Brantly M, Brenner D, D'Armiento J, Fried MW, Iyer JS, Mandorfer M, Rockey DC, Tincopa M, Vuppalanchi R, Younossi Z, Krag A, Turner AM, Strnad P2024-03-22Alimentary pharmacology & therapeutics
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure.Semmler G, Alonso López S, Pons M, Lens S, Dajti E, Griemsmann M, Zanetto A, Burghart L, Hametner-Schreil S, Hartl L, Manzano M, Rodriguez-Tajes S, Zanaga P, Schwarz M, Luisa Gutierrez M, Jachs M, Pocurull A, Polo B, Ecker D, Mateos B, Izquierdo S, Real Y, Ahumada A, Josef Maria Bauer D, Benjamin Mauz J, Casanova-Cabral M, Gschwantler M, Paolo Russo F, Azzaroli F, Maasoumy B, Reiberger T, Forns X, Genesca J, Bañares R, Mandorfer M2024-03-21Chronic hepatitis C, Compensated advanced chronic liver disease, Etiological cure, Liver stiffness measurement, SVR, Sustained virological response, Transient elastographyJournal of hepatology
Long-term outcome of combined radiologic and surgical strategy for the management of biliary complications after pediatric liver transplantation.Calinescu AM, Monluc S, Franchi-Abella S, Habes D, Weber G, Almes MF, Waguet J, Jacquemin E, Fouquet V, Miatello J, Hery G, Baujard C, Gonzales E, Branchereau S, Guérin F2024-03-20Biliary complications, Pediatric liver transplantation, Repeated radiologic proceduresBMC research notes
ECFS standards of care on CFTR-related disorders: Identification and care of the disorders.Simmonds NJ, Southern KW, De Wachter E, De Boeck K, Bodewes F, Mainz JG, Middleton PG, Schwarz C, Vloeberghs V, Wilschanski M, Bourrat E, Chalmers JD, Ooi CY, Debray D, Downey DG, Eschenhagen P, Girodon E, Hickman G, Koitschev A, Nazareth D, Nick JA, Peckham D, VanDevanter D, Raynal C, Scheers I, Waller MD, Sermet-Gaudelus I, Castellani C2024-03-19ABPA, Aquagenic palmoplantar keratoderma, Aquagenic wrinkling, Bronchiestasis, CFTR, CFTR-related disorder, Congenital absence of the vas deferens, Cystic fibrosis, Genetics, Intestinal current measurement, Nasal potential difference, Pancreatitis, Rhinosinusitis, Sclerosing cholangitis, Sweat testJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study.Dragoni G, Innocenti T, Amiot A, Castiglione F, Melotti L, Festa S, Savarino EV, Truyens M, Argyriou K, Noviello D, Molnar T, Bouillon V, Bezzio C, Eder P, Fernandes S, Kagramanova A, Armuzzi A, Oliveira R, Viola A, Ribaldone DG, Drygiannakis I, Viganò C, Calella F, Gravina AG, Pugliese D, Chaparro M, Ellul P, Vieujean S, Milla M, Caprioli F2024-03-19The American journal of gastroenterology
Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial.Kyriazopoulou E, Hasin-Brumshtein Y, Midic U, Poulakou G, Milionis H, Metallidis S, Astriti M, Fragkou A, Rapti A, Taddei E, Kalomenidis I, Chrysos G, Angheben A, Kainis I, Alexiou Z, Castelli F, Serino FS, Bakakos P, Nicastri E, Tzavara V, Ioannou S, Dagna L, Dimakou K, Tzatzagou G, Chini M, Bassetti M, Kotsis V, Tsoukalas DG, Selmi C, Konstantinou A, Samarkos M, Doumas M, Masgala A, Pagkratis K, Argyraki A, Akinosoglou K, Symbardi S, Netea MG, Panagopoulos P, Dalekos GN, Liesenfeld O, Sweeney TE, Khatri P, Giamarellos-Bourboulis EJ2024-03-12Anakinra, COVID-19, Endotypes, Viral sepsisCritical care (London, England)
Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy.Ampuero J, Lucena A, Berenguer M, Hernández-Guerra M, Molina E, Gómez-Camarero J, Valdivia C, Gómez E, Casado M, Álvarez-Navascuez C, Jorquera F, García-Buey L, Díaz-González Á, Morillas R, García-Retortillo M, Sousa JM, Pérez-Medrano I, Simón MÁ, Martínez J, Arenas J, Londoño MC, Olveira A, Fernández-Rodríguez C2024-03-06Hepatology (Baltimore, Md.)
HEPARIN-BINDING PROTEIN LEVELS PREDICT UNFAVORABLE OUTCOME IN COVID-19 PNEUMONIA: A POST HOC ANALYSIS OF THE SAVE TRIAL.Kyriazopoulou E, Dalekos GN, Metallidis S, Poulakou G, Papanikolaou IC, Tzavara V, Argyraki K, Alexiou Z, Panagopoulos P, Samarkos M, Chrysos G, Tseliou A, Milionis H, Sympardi S, Vasishta A, Giamarellos-Bourboulis EJ2024-03-01Shock (Augusta, Ga.)
Corrigendum to "Expert management of congenital portosystemic shunts and their complications" [JHEP Reports 6 (2024)].McLin VA, Franchi-Abella S, Brütsch T, Bahadori A, Casotti V, de Ville de Goyet J, Dumery G, Gonzales E, Guérin F, Hascoet S, Heaton N, Kuhlmann B, Lador F, Lambert V, Marra P, Plessier DA, Quaglia A, Rougemont AL, Savale L, Sarma MS, Sitbon O, Superina RA, Uchida H, van Albada M, Johannes van der Doef HP, Vilgrain V, Wacker J, Zwaveling-Soonawala N, Debray D, Wildhaber BE2024-03-01JHEP reports : innovation in hepatology
Failure of cholic acid therapy in a child with a bile acid synthesis defect and harboring plectin mutations.Thébaut A, Aumar M, Gardin A, Almes M, Davit-Spraul A, Jacquemin E2024-03-01Journal of pediatric gastroenterology and nutrition
Porto-sinusoidal vascular disorder in chronic HBV: A significant coexistence not to be overlooked.Olivas P, Perez-Campuzano V, Orts L, Montironi C, Magaz M, Ruiz P, Shalaby S, Ojeda A, Rosich P, Baiges A, Turon F, Lens S, García Pagán JC, Hernández-Gea V2024-03-01Chronic Hepatitis B, Idiopathic portal hypertension, Incomplete septal cirrhosis, Non-cirrhotic Portal Hypertension, Obliterative portal venopathy, Porto-Sinusoidal Vascular Disease, Regenerative nodular hyperplasia, Vascular liver diseasesJHEP reports : innovation in hepatology
Expert opinion on bleeding risk from invasive procedures in cirrhosis.Riescher-Tuczkiewicz A, Caldwell SH, Kamath PS, Villa E, Rautou PE2024-03-01INR, aPTT, anticoagulant, biopsy, coagulation, fibrinogen, haemorrhage, haemostasis, platelet, procedural related bleedingJHEP reports : innovation in hepatology
The evolving phenotype of autoimmune hepatitis across the millennium: The 40-year experience of a referral centre in Italy.Ferronato M, Lalanne C, Quarneti C, Panico ML, Guidi M, Lenzi M, Muratori L2024-03-01acute onset, autoimmune hepatitis, elderly, epidemiology, treatment response, updateLiver international : official journal of the International Association for the Study of the Liver
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry.Slooter CD, van den Brand FF, Lleo A, Colapietro F, Lenzi M, Muratori P, Kerkar N, Dalekos GN, Zachou K, Lucena MI, Robles-Díaz M, Di Zeo-Sánchez DE, Andrade RJ, Montano-Loza AJ, Lytvyak E, Lissenberg-Witte BI, Maisonneuve P, Bouma G, Macedo G, Liberal R, de Boer YS2024-03-01Hepatology (Baltimore, Md.)
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.Hirschfield GM, Bowlus CL, Mayo MJ, Kremer AE, Vierling JM, Kowdley KV, Levy C, Villamil A, Ladrón de Guevara Cetina AL, Janczewska E, Zigmond E, Jeong SH, Yilmaz Y, Kallis Y, Corpechot C, Buggisch P, Invernizzi P, Londoño Hurtado MC, Bergheanu S, Yang K, Choi YJ, Crittenden DB, McWherter CA2024-02-29The New England journal of medicine
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.Kowdley KV, Bowlus CL, Levy C, Akarca US, Alvares-da-Silva MR, Andreone P, Arrese M, Corpechot C, Francque SM, Heneghan MA, Invernizzi P, Jones D, Kruger FC, Lawitz E, Mayo MJ, Shiffman ML, Swain MG, Valera JM, Vargas V, Vierling JM, Villamil A, Addy C, Dietrich J, Germain JM, Mazain S, Rafailovic D, Taddé B, Miller B, Shu J, Zein CO, Schattenberg JM2024-02-29The New England journal of medicine
NMR-based metabolomic signature: An important tool for the diagnosis and study of pathogenesis of autoimmune hepatitis.Dimou A, Zachou K, Kostara C, Azariadis K, Giannoulis G, Lyberopoulou A, Bairaktari E, Dalekos GN2024-02-05Hepatology (Baltimore, Md.)
Pediatric Autoimmune Hepatitis.Nastasio S, Sciveres M, Francalanci P, Maggiore G2024-02-01Pediatric reports
The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation.Martini A, Turato C, Cannito S, Quarta S, Biasiolo A, Ruvoletto M, Novo E, Marafatto F, Guerra P, Tonon M, Clemente N, Bocca C, Piano SS, Guido M, Gregori D, Parola M, Angeli P, Pontisso P2024-02-01SB3-PD, SerpinB3, TGF-β1, fibrosis, portal hypertension, proinflammatory cytokinesAlimentary pharmacology & therapeutics
Autophagy and extracellular vesicles in the liver endothelium: friends or foes?Biquard L, Rautou PE2024-02-01Hepatology international
The ubiquitin-like modifier FAT10 is induced in MASLD and impairs the lipid-regulatory activity of PPARα.Clavreul L, Bernard L, Cotte AK, Hennuyer N, Bourouh C, Devos C, Helleboid A, Haas JT, Verrijken A, Gheeraert C, Derudas B, Guille L, Chevalier J, Eeckhoute J, Vallez E, Dorchies E, Van Gaal L, Lassailly G, Francque S, Staels B, Paumelle R2024-02-01FAT10, Liver, MASH, MASLD, PPARα, UBDMetabolism: clinical and experimental
Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ).Fromme M, Hamesch K, Schneider CV, Mandorfer M, Pons M, Thorhauge KH, Pereira V, Sperl J, Frankova S, Reichert MC, Benini F, Burbaum B, Kleinjans M, Amzou S, Rademacher L, Bewersdorf L, Verbeek J, Nevens F, Genesca J, Miravitlles M, Nuñez A, Schaefer B, Zoller H, Janciauskiene S, Waern J, Oliveira A, Maia L, Simões C, Mahadeva R, Fraughen DD, Trauner M, Krag A, Lammert F, Bals R, Gaisa NT, Aigner E, Griffiths WJ, Denk H, Teumer A, McElvaney NG, Turner AM, Trautwein C, Strnad P2024-02-01Augmentation Therapy, Fibroscan, Liver Fibrosis, Pi∗Z, SERPINA1, α(1)-Antitrypsin DeficiencyClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Expression of E-cadherin by CD8+ T cells promotes their invasion into biliary epithelial cells.Davies SP, Ronca V, Wootton GE, Krajewska NM, Bozward AG, Fiancette R, Patten DA, Yankouskaya K, Reynolds GM, Pat S, Osei-Bordom DC, Richardson N, Grover LM, Weston CJ, Oo YH2024-01-29Nature communications
Osteonecrosis risk after steroids-related treatment of COVID-19 is not negligible: A cross sectional study.Koutalos AA, Koskiniotis A, Rountas C, Konstantinou E, Georgiadou S, Stefos A, Gatselis NK, Dalekos GN, Malizos KN2024-01-27COVID-19, Corticosteroids, Cross-Sectional studies, Femur head necrosis, FerritinEuropean journal of internal medicine
Chronic Liver Diseases: What is Up?Fagoonee S, Invernizzi P2024-01-22Journal of clinical medicine
Long-term outcome for children undergoing open hepatico-jejunostomy for choledochal malformations: a 43-year single-center experience.Stern MV, Boroni G, Parolini F, Torri F, Calza S, Alberti D2024-01-19Choledochal malformation, Long-term follow-up, Quality of life, Roux-en-Y hepaticojejunostomyPediatric surgery international
A novel way to evaluate autoantibody interference in samples with mixed antinuclear antibody patterns in the HEp-2 cell based indirect immunofluorescence assay and comparison of conventional microscopic and computer-aided pattern recognition.Nagy G, Földesi R, Csípő I, Tarr T, Szűcs G, Szántó A, Bubán T, Szekanecz Z, Papp M, Kappelmayer J, Antal-Szalmás P2024-01-15ANA HEp-2 test, Automated pattern recognition, Indirect immunofluorescence, Mixed patterns, Multiple patternsClinica chimica acta; international journal of clinical chemistry
Beat the Clock: Assessment of Night Eating Syndrome and Circadian Rhythm in a Sample of Greek Adults.Blouchou A, Chamou V, Eleftheriades C, Poulimeneas D, Kontouli KM, Gkiouras K, Bargiota A, Gkouskou KK, Rigopoulou E, Bogdanos DP, Goulis DG, Grammatikopoulou MG2024-01-05chronobiology, chrononutrition, chronotherapeutic interventions, circadian misalignment, eating disorder, insufficient sleep, metabolic disturbance, obesity, sleep disruptionNutrients
SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma.Martini A, Prasai K, Zemla TJ, Ahmed FY, Elnagar MB, Giama NH, Guzzardo V, Biasiolo A, Fassan M, Yin J, Pontisso P, Roberts LR2024-01-03SerpinB3/4, SerpinB3/4–IgM, cholangiocarcinoma, prognostic markerCancers
Advancements in pharmacological treatment of NAFLD/MASLD: a focus on metabolic and liver-targeted interventions.Ciardullo S, Muraca E, Vergani M, Invernizzi P, Perseghin G2024-01-01GLP1-RA, MASH, MASLD, NASH, resmetiromGastroenterology report
Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease.Kocheise L, Piseddu I, Vonderlin J, Tjwa ET, Buescher G, Meunier L, Goeggelmann P, Fianchi F, Dumortier J, Barciela MR, Gevers TJG, Beretta-Piccoli BT, Londoño MC, Frankova S, Roesner T, Joerg V, Schmidt C, Glaser F, Sutter JP, Fründt TW, Lohse AW, Huber S, von Felden J, Sebode M, Schulze K2024-01-01PD-1/PD-L1 immune checkpoint inhibitors, autoimmune disease (AID), autoimmune hepatitis (AIH), autoimmune liver diseases (AILD), immune checkpoint inhibitors (ICI), immune related adverse effects (irAEs), primary biliary cholangitis (PBC), primary sclerosing cholangites (PSC)Frontiers in immunology
Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word setting.Corpechot C, Verdoux M, Frank-Soltysiak M, Duclos-Vallée JC, Grimaldi L2024-01-01PBC, PSC, SARS-CoV-2, UDCA, chronic liver diseaseJournal of medical virology
Expert management of congenital portosystemic shunts and their complications.McLin VA, Franchi-Abella S, Brütsch T, Bahadori A, Casotti V, de Ville de Goyet J, Dumery G, Gonzales E, Guérin F, Hascoet S, Heaton N, Kuhlmann B, Lador F, Lambert V, Marra P, Plessier A, Quaglia A, Rougemont AL, Savale L, Sarma MS, Sitbon O, Superina RA, Uchida H, van Albada M, Johannes van der Doef HP, Vilgrain V, Wacker J, Zwaveling N, Debray D, Wildhaber BE2024-01-01adenoma, congenital portosystemic shunt, focal nodular hyperplasia, hepatocellular carcinoma, hyperandrogenism, hyperinsulinism, hypoglycemia, occlusion test, portal pressure, puberty, pulmonary hypertension, β-cateninJHEP reports : innovation in hepatology
Developing a Tool for Differentiation Between Bacterial and Viral Respiratory Infections Using Myxovirus Resistance Protein A and C-Reactive Protein.Iliopoulou K, Koufargyris P, Doulou S, Tasouli E, Katopodis S, Chachali SP, Schinas G, Karachalios C, Astriti M, Katsaounou P, Chrysos G, Seferlis T, Dimopoulou E, Kollia M, Poulakou G, Gerakari S, Papanikolaou IC, Milionis H, Dalekos GN, Tzavara V, Kontopoulou T, Giamarellos-Bourboulis EJ2024-01-01Bacterial infection, CRP, Diagnosis, MxA, Viral infectionInfectious diseases and therapy
Maternal liver-related symptoms during pregnancy in primary sclerosing cholangitis.Nayagam JS, Weismüller TJ, Milkiewicz P, Wronka KM, Bik E, Schramm C, Fuessel K, Zhou T, Chang J, Färkkilä M, Carlsson Y, Lundman A, Cazzagon N, Corrà G, Rigopoulou E, Dalekos GN, Båve AL, Bergquist A, Ben Belkacem K, Marzioni M, Mancinelli M, Verhelst X, Marschall HU, Heneghan MA, Joshi D2024-01-01Bile acids, Cholangiopathy, Intrahepatic cholestasis of pregnancy, Primary sclerosing cholangitis, Pruritus, Ursodeoxycholic acidJHEP reports : innovation in hepatology
Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica) study group.Corti P, Ferrari GM, Faraguna MC, Capitoli G, Longo F, Corradini E, Casini T, Boscarol G, Pinto VM, Ghilardi R, Russo G, Colombatti R, Mariani R, Piperno A2024-01-01haemochromatosis, hyperferritinaemia, iron chelation, juvenile haemochromatosis, phlebotomyBritish journal of haematology
[Splanchnic vein thrombosis].Riescher-Tuczkiewicz A, Elkrief L, Rautou PE2024-01-01Anticoagulants, Budd-Chiari syndrome, Cirrhose, Cirrhosis, Portal vein, Syndrome de Budd Chiari, Thrombose veineuse, Veine porte, Venous thrombosisLa Revue de medecine interne
Obeticholic acid as a second-line treatment for low phospholipid-associated cholelithiasis syndrome.Soret PA, Lemoinne S, Mallet M, Belkacem KB, Chazouillères O, Corpechot C2024-01-01FXR, LPAC, OCA, UDCAAlimentary pharmacology & therapeutics
HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy.Sonneveld MJ, Chiu SM, Park JY, Brakenhoff SM, Kaewdech A, Seto WK, Tanaka Y, Carey I, Papatheodoridi M, Colombatto P, van Bömmel F, Janssen HL, Berg T, Zoulim F, Ahn SH, Dalekos GN, Erler NS, Brunetto M, Wedemeyer H, Cornberg M, Yuen MF, Agarwal K, Boonstra A, Buti M, Piratvisuth T, Papatheodoridis G, Chen CH, Maasoumy B2024-01-01Clinical Relapse, HBV DNA, HBsAg, HBsAg LossGastroenterology
Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study.Ribaldone DG, Parisio L, Variola A, Bossa F, Castiglione F, Marzo M, Piazza N, Aratari A, Savarino EV, Bodini G, Mastronardi M, Micheli F, Mazzuoli S, Ascolani M, Viganò C, Cappello M, Bezzio C, Ciccocioppo R, Scardino G, Sarli E, Pugliese D, Scaldaferri F, Napolitano D, Todeschini A, Geccherle A, Colaci N, Guerra M, Annese M, Testa A, Caiazzo A, Conforti FS, Festa S, Lorenzon G, Marra A, Magiotta A, Baccini F, Amato A, Poshnjari A, Vernero M, Caprioli F, Caviglia GP2024-01-01Biologics, IBD, Switch, VedolizumabDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?Corpechot C, Lemoinne S, Soret PA, Hansen B, Hirschfield G, Gulamhusein A, Montano-Loza AJ, Lytvyak E, Pares A, Olivas I, Eaton JE, Osman KT, Schramm C, Sebode M, Lohse AW, Dalekos G, Gatselis N, Nevens F, Cazzagon N, Zago A, Russo FP, Floreani A, Abbas N, Trivedi P, Thorburn D, Saffioti F, Barkai L, Roccarina D, Calvaruso V, Fichera A, Delamarre A, Sobenko N, Villamil AM, Medina-Morales E, Bonder A, Patwardhan V, Rigamonti C, Carbone M, Invernizzi P, Cristoferi L, van der Meer A, de Veer R, Zigmond E, Yehezkel E, Kremer AE, Deibel A, Bruns T, Große K, Wetten A, Dyson JK, Jones D, Dumortier J, Pageaux GP, de Lédinghen V, Chazouillères O, Carrat F2024-01-01Hepatology (Baltimore, Md.)
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies?Elvevi A, Laffusa A, Elisei F, Morzenti S, Guerra L, Rovere A, Invernizzi P, Massironi S2023-12-27Combined Therapies, Intrahepatic cholangiocarcinoma, Locoregional treatment, Neo-adjuvant therapy, Overall Survival, Prognostic factors, Response rates, Transarterial radioembolizationWorld journal of hepatology
Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA.Hansen BE, Vandriel SM, Vig P, Garner W, Mogul DB, Loomes KM, Piccoli DA, Rand EB, Jankowska I, Czubkowski P, Gliwicz-Miedzińska D, Gonzales EM, Jacquemin E, Bouligand J, D'Antiga L, Nicastro E, Arnell H, Fischler B, Sokal É, Demaret T, Siew S, Stormon M, Karpen SJ, Romero R, Ebel NH, Feinstein JA, Roberts AJ, Evans HM, Sundaram SS, Chaidez A, Hardikar W, Shankar S, Fischer RT, Lacaille F, Debray D, Lin HC, Jensen MK, Jaramillo C, Karthikeyan P, Indolfi G, Verkade HJ, Larson-Nath C, Quiros-Tejeira RE, Valentino PL, Rogalidou M, Dezsőfi A, Squires JE, Schwarz K, Calvo PL, Bernabeu JQ, Zizzo AN, Nebbia G, Bulut P, Santos-Silva E, Fawaz R, Nastasio S, Karnsakul W, Tamara ML, Busoms CM, Kelly DA, Sandahl TD, Jimenez-Rivera C, Banales JM, Mujawar Q, Li LT, She H, Wang JS, Kim KM, Oh SH, Sanchez MC, Cavalieri ML, Lee WS, Hajinicolaou C, Lertudomphonwanit C, Waisbourd-Zinman O, Arikan C, Alam S, Carvalho E, Melere M, Eshun J, Önal Z, Desai DM, Wiecek S, Pinto RB, Wolters VM, Garcia J, Beretta M, Kerkar N, Brecelj J, Rock N, Lurz E, Blondet N, Shah U, Thompson RJ, Kamath BM2023-12-25Hepatology (Baltimore, Md.)
Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis.Ratziu V, Francque S, Behling CA, Cejvanovic V, Cortez-Pinto H, Iyer JS, Krarup N, Le Q, Sejling AS, Tiniakos D, Harrison SA2023-12-19Hepatology (Baltimore, Md.)
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma.Calderaro J, Ghaffari Laleh N, Zeng Q, Maille P, Favre L, Pujals A, Klein C, Bazille C, Heij LR, Uguen A, Luedde T, Di Tommaso L, Beaufrère A, Chatain A, Gastineau D, Nguyen CT, Nguyen-Canh H, Thi KN, Gnemmi V, Graham RP, Charlotte F, Wendum D, Vij M, Allende DS, Aucejo F, Diaz A, Rivière B, Herrero A, Evert K, Calvisi DF, Augustin J, Leow WQ, Leung HHW, Boleslawski E, Rela M, François A, Cha AW, Forner A, Reig M, Allaire M, Scatton O, Chatelain D, Boulagnon-Rombi C, Sturm N, Menahem B, Frouin E, Tougeron D, Tournigand C, Kempf E, Kim H, Ningarhari M, Michalak-Provost S, Gopal P, Brustia R, Vibert E, Schulze K, Rüther DF, Weidemann SA, Rhaiem R, Pawlotsky JM, Zhang X, Luciani A, Mulé S, Laurent A, Amaddeo G, Regnault H, De Martin E, Sempoux C, Navale P, Westerhoff M, Lo RC, Bednarsch J, Gouw A, Guettier C, Lequoy M, Harada K, Sripongpun P, Wetwittayaklang P, Loménie N, Tantipisit J, Kaewdech A, Shen J, Paradis V, Caruso S, Kather JN2023-12-14Nature communications
Prospective Comparison of Attenuation Imaging and Controlled Attenuation Parameter for Liver Steatosis Diagnosis in Patients With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes.Dioguardi Burgio M, Castera L, Oufighou M, Rautou PE, Paradis V, Bedossa P, Sartoris R, Ronot M, Bodard S, Garteiser P, Van Beers B, Valla D, Vilgrain V, Correas JM2023-12-10Fatty Liver, Nonalcoholic, Steatohepatitis, UltrasonographyClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
∆4-3-oxo-5β-reductase deficiency: favorable outcome in 16 patients treated with cholic acid.Gardin A, Ruiz M, Beime J, Cananzi M, Rathert M, Rohmer B, Grabhorn E, Almes M, Logarajah V, Peña-Quintana L, Casswall T, Darmellah-Remil A, Reyes-Domínguez A, Barkaoui E, Hierro L, Baquero-Montoya C, Baumann U, Fischler B, Gonzales E, Davit-Spraul A, Laplanche S, Jacquemin E2023-12-07AKR1D1, Bile acid, Genetic cholestasisOrphanet journal of rare diseases
Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases.Steinmann S, Hartl J, Weidemann S, Füssel K, Kroll C, Sebode M, Lohse AW, Schramm C2023-12-01Autoimmune hepatitis, Autoimmune liver disease, Controlled attenuation parameter, Inflammation, Non-invasive steatosis measurement, Primary biliary cholangitis, Primary sclerosing cholangitis, Steatosis hepatisJHEP reports : innovation in hepatology
Predictors of 6-year event-free survival in Alagille syndrome patients treated with maralixibat, an ileal bile acid transporter inhibitor.Sokol RJ, Gonzales EM, Kamath BM, Baker A, Vig P, Mogul DB, Garner W, Hansen BE, Jacquemin E, Thompson RJ2023-12-01Hepatology (Baltimore, Md.)
Evaluation of Tofacitinib in Primary Sclerosing Cholangitis and Associated Colitis: A Multicenter, Retrospective Study.Schregel I, Ramos GP, Ioannou S, Culver E, Färkkilä M, Schramm C2023-12-01Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors.Sidali S, Borie R, Sicre de Fontbrune F, El Husseini K, Rautou PE, Lainey E, Goria O, Crestani B, Cadranel J, Cottin V, Bunel V, Dumortier J, Jacquemin E, Reboux N, Hirschi S, Bourdin A, Meszaros M, Dharancy S, Hilaire S, Mallet V, Reynaud-Gaubert M, Terriou L, Gottrand F, Abou Chahla W, Khan JE, Carrier P, Saliba F, Rubbia-Brandt L, Aubert JD, Elkrief L, de Lédinghen V, Abergel A, Olivier T, Houssel P, Jouneau S, Wemeau L, Bergeron A, Leblanc T, Ollivier-Hourmand I, Nguyen Khac E, Morisse-Pradier H, Ba I, Boileau C, Roudot-Thoraval F, Vilgrain V, Bureau C, Nunes H, Naccache JM, Durand F, Francoz C, Roulot D, Valla D, Paradis V, Kannengiesser C, Plessier A2023-11-06Hepatology (Baltimore, Md.)
Current limitations of gene therapy for rare pediatric diseases: Lessons learned from clinical experience with AAV vectors.Gardin A, Ronzitti G2023-11-01Adeno-associated virus, Gene therapy, Immune response, Neutralizing antibodiesArchives de pediatrie : organe officiel de la Societe francaise de pediatrie
FibroMeter scores are predictive noninvasive markers of advanced and significant liver fibrosis in patients with chronic viral hepatitis or metabolic dysfunction-associated steatotic liver disease.Arvaniti P, Giannoulis G, Lygoura V, Gatselis NK, Gabeta S, Rigopoulou E, Koukoulis GK, Zachou K, Dalekos GN2023-11-01FibroMeter, FibroMeter vibration-controlled transient elastography, chronic viral hepatitis, liver fibrosis, metabolic dysfunction-associated steatotic liver diseaseAnnals of gastroenterology
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant.Mehta G, Riva A, Ballester MP, Uson E, Pujadas M, Carvalho-Gomes Â, Sahuco I, Bono A, D'Amico F, Viganò R, Diago E, Lanseros BT, Inglese E, Vazquez DM, Sharma R, Tsou HLP, Harris N, Broekhoven A, Kikkert M, Morales SPT, Myeni SK, Riveiro-Barciela M, Palom A, Zeni N, Brocca A, Cussigh A, Cmet S, Escudero-García D, Stocco M, Natola LA, Ieluzzi D, Paon V, Sangiovanni A, Farina E, di Benedetto C, Sánchez-Torrijos Y, Lucena-Varela A, Román E, Sánchez E, Sánchez-Aldehuelo R, López-Cardona J, Canas-Perez I, Eastgate C, Jeyanesan D, Morocho AE, Di Cola S, Lapenna L, Zaccherini G, Bongiovanni D, Zanaga P, Sayaf K, Hossain S, Crespo J, Robles-Díaz M, Madejón A, Degroote H, Fernández J, Korenjak M, Verhelst X, García-Samaniego J, Andrade RJ, Iruzubieta P, Wright G, Caraceni P, Merli M, Patel VC, Gander A, Albillos A, Soriano G, Donato MF, Sacerdoti D, Toniutto P, Buti M, Duvoux C, Grossi PA, Berg T, Polak WG, Puoti M, Bosch-Comas A, Belli L, Burra P, Russo FP, Coenraad M, Calleja JL, Perricone G, Berenguer M, Claria J, Moreau R, Arroyo V, Angeli P, Sánchez C, Ampuero J, Piano S, Chokshi S, Jalan R2023-11-01Hepatology communications
Splanchnic vein thrombosis associated with SARS-CoV-2 infection: A VALDIG case-control study.Deltenre P, Payancé A, Elkrief L, La Mura V, Artru F, Baiges A, Cervoni JP, China L, Colle I, Lemaitre E, Procopet B, Schiller D, Bureau C, Goria O, Ollivier I, Nuzzo A, Rautou PE, Plessier A2023-11-01Portal vein thrombosis, SARS-CoV-2 infection, Splanchnic vein thrombosisJHEP reports : innovation in hepatology
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity.Tedbury PR, Manfredi C, Degenhardt F, Conway J, Horwath MC, McCracken C, Sorscher AJ, Moreau S, Wright C, Edwards C, Brewer J, Guarner J, de Wit E, Williamson BN, Suthar MS, Ong YT, Roback JD, Alter DN, Holter JC, Karlsen TH, Sacchi N, Romero-Gómez M, Invernizzi P, Fernández J, Buti M, Albillos A, Julià A, Valenti L, Asselta R, Banales JM, Bujanda L, de Cid R, Franke A, Sarafianos SG, Hong JS, Sorscher EJ, Ehrhardt A2023-11-01COVID-19, SARS-CoV-2, comorbidity, cystic fibrosis transmembrane conductance regulator, mucus membrane, virus replicationFASEB journal : official publication of the Federation of American Societies for Experimental Biology
The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study.Dajti E, Ravaioli F, Paiola G, Volpi S, Colecchia L, Ferrarese A, Alemanni LV, Cusumano C, Di Biase AR, Marasco G, Vestito A, Festi D, Rautou PE, Cipolli M, Colecchia A2023-11-01CFLD, liver stiffness, liver transplantation, noncirrhotic portal hypertension, porto-sinusoidal vascular disease, spleen stiffnessLiver international : official journal of the International Association for the Study of the Liver
Artificial Intelligence and liver: Opportunities and barriers.Balsano C, Burra P, Duvoux C, Alisi A, Piscaglia F, Gerussi A2023-11-01Artificial Intelligence, Big data, Imaging, Liver disease, Robotic, TransplantationDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Authors' reply to Zou et al.Ciardullo S, Carbone M, Invernizzi P, Perseghin G2023-11-01Liver international : official journal of the International Association for the Study of the Liver
Exploring the landscape of steatotic liver disease in the general US population.Ciardullo S, Carbone M, Invernizzi P, Perseghin G2023-11-01Fibroscan, MAFLD, MASLD, steatotic liver diseaseLiver international : official journal of the International Association for the Study of the Liver
Vaccination practices in pediatric transplantation: A survey among member centers of the European reference network TransplantChild.Donà D, Bravo-Gallego LY, Remacha EF, Cananzi M, Gastaldi A, Canizalez JT, Stephenne X, Lacaille F, Lindemans C, Calore E, Galea N, Benetti E, Nachbaur E, Sandes AR, Teixeira A, Ferreira S, Klaudel-Dreszler M, Ackermann O, Boyer O, Espinosa L, Guereta LG, Sciveres M, Fischler B, Schwerk N, Neland M, Nicastro E, Dello Strologo L, Toporski J, Vainumae I, Rascon J, Urbonas V, Del Rosal T, López-Granados E, Perilongo G, Baker A, Vega PJ2023-11-01children, immunosuppression, transplant, vaccination, vaccine-preventable infectionsPediatric transplantation
Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms.Massironi S, Mulinacci G, Gallo C, Elvevi A, Danese S, Invernizzi P, Vespa E2023-10-18Th2 response, cytokines, eosinophilic esophagitis, immune cells, pathogenesis, soluble inflammatory mediators, tissue remodelingCells
Therapeutic Challenges for Gastric Neuroendocrine Neoplasms: Take It or Leave It?Cavalcoli F, Gallo C, Coltro LA, Rausa E, Cantù P, Invernizzi P, Massironi S2023-10-01chronic atrophic gastritis, endoscopic mucosal resection, endoscopic resection, endoscopic submucosal dissection, gastric neuroendocrine neoplasm, systemic therapiesMedicina (Kaunas, Lithuania)
Outcomes of 38 patients with PFIC3: Impact of genotype and of response to ursodeoxycholic acid therapy.Gonzales E, Gardin A, Almes M, Darmellah-Remil A, Seguin H, Mussini C, Franchi-Abella S, Duché M, Ackermann O, Thébaut A, Habes D, Hermeziu B, Lapalus M, Falguières T, Combal JP, Benichou B, Valero S, Davit-Spraul A, Jacquemin E2023-10-01ABCB4, MDR3, biliary lithiasis, hepatocellular carcinoma, intrahepatic cholestasis of pregnancy, liver transplantationJHEP reports : innovation in hepatology
Endothelial autophagy is not required for liver regeneration after partial hepatectomy in mice with fatty liver.Hammoutene A, Tanguy M, Calmels M, Pravisani R, Albuquerque M, Casteleyn C, Slimani L, Sadoine J, Boulanger CM, Paradis V, Gilgenkrantz H, Rautou PE2023-10-01LSECs, NAFLD, autophagy, hepatectomy, liver regenerationLiver international : official journal of the International Association for the Study of the Liver
Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group.Gatselis NK, Zachou K, Loza AJM, Cançado ELR, Arinaga-Hino T, Muratori P, Efe C, Floreani A, Invernizzi P, Takahashi A, Takaki A, Beretta-Piccoli BT, van Hoek B, Lytvyak E, Guedes LV, Purnak T, Cazzagon N, Lygoura V, Arvaniti P, Rigopoulou EI, Muratori L, Dalekos GN2023-10-01Antimitochondrial antibodies, Autoantibodies, Autoimmune hepatitis, Autoimmune hepatitis/primary biliary cholangitis variant syndrome, Outcome, Primary biliary cholangitisEuropean journal of internal medicine
Hepatocyte-derived biomarkers predict liver-related events at 2 years in Child-Pugh class A alcohol-related cirrhosis.Elkrief L, Ganne-Carrié N, Manceau H, Tanguy M, Valainathan SR, Riescher-Tuczkiewicz A, Biquard L, Barget N, Chaffaut C, Louvet A, Paradis V, Ziol M, Bæk R, Jørgensen MM, Van Niel G, Coly PM, Hammoutène A, Dujardin F, Peoc'h K, Poynard T, Chevret S, Rautou PE2023-10-01FibroTest, alcoholic liver disease, biomarkers, decompensation of cirrhosis, liver cirrhosis, prognosisJournal of hepatology
Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis.Lalloyer F, Mogilenko DA, Verrijken A, Haas JT, Lamazière A, Kouach M, Descat A, Caron S, Vallez E, Derudas B, Gheeraert C, Baugé E, Despres G, Dirinck E, Tailleux A, Dombrowicz D, Van Gaal L, Eeckhoute J, Lefebvre P, Goossens JF, Francque S, Staels B2023-10-01Roux-en-Y gastric bypass, bile acid, cholesterol, liver, transcriptomeJournal of hepatology
Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study.Anstee QM, Lucas KJ, Francque S, Abdelmalek MF, Sanyal AJ, Ratziu V, Gadano AC, Rinella M, Charlton M, Loomba R, Mena E, Schattenberg JM, Noureddin M, Lazas D, Goh GBB, Sarin SK, Yilmaz Y, Martic M, Stringer R, Kochuparampil J, Chen L, Rodriguez-Araujo G, Chng E, Naoumov NV, Brass C, Pedrosa MC2023-10-01Hepatology (Baltimore, Md.)
Diagnostic Approach to Elevated Liver Function Tests during Pregnancy: A Pragmatic Narrative Review.Dajti E, Bruni A, Barbara G, Azzaroli F2023-09-16elastography, intrahepatic cholestasis of pregnancy, liver disease, liver enzymes, pre-eclampsia, pregnancyJournal of personalized medicine
Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis.Terziroli Beretta-Piccoli B, Buescher G, Dalekos G, Zachou K, Geerts A, Semmo N, Kolev M, De Martin E, Janik MK, Madaleno J, Lalosevic Stojkovic M, Dumortier J, Vanwolleghem T, Schregel I, Steinmann S, Lacaille F, Sebode M2023-09-14Journal of autoimmunity
Total and individual PBC-40 scores are reliable for the assessment of health-related quality of life in Greek patients with primary biliary cholangitis.I Rigopoulou E, Bakarozi M, Dimas I, Galanis K, Lygoura V, K Gatselis N, Koulentaki M, N Dalekos G2023-09-01PBC-40, Primary biliary cholangitis, quality of lifeJournal of translational internal medicine
Autoimmune liver diseases and diabetes.Jensen AH, Ytting H, Winther-Sørensen M, Burisch J, Bergquist A, Gluud LL, Wewer Albrechtsen NJ2023-09-01European journal of gastroenterology & hepatology
Liver Histology Before Treatment Withdrawal in Autoimmune Hepatitis: Is It Time to Review the ESPGHAN Recommendations?Maggiore G, Bernard O, Mosca A, Jacquemin E2023-09-01Journal of pediatric gastroenterology and nutrition
Questionnaire PLD-complaint-specific assessment identifies need for therapy in polycystic liver disease: A multi-centric prospective study.Billiet A, Temmerman F, Coudyzer W, Van den Ende N, Colle I, Francque S, De Maeght S, Janssens F, Orlent H, Sprengers D, Delwaide J, Decock S, De Vloo C, Moreno C, van Malenstein H, van der Merwe S, Verbeek J, Nevens F2023-09-01health-related quality of life, liver transplantation, liver volume, polycystic liver disease, somatostatin analoguesUnited European gastroenterology journal
Benefits of using exchangeable copper and the ratio of exchangeable copper in a real-world cohort of patients with Wilson disease.Mariño Z, Molera-Busoms C, Badenas C, Quintero-Bernabeu J, Torra M, Forns X, Artuch R2023-09-01REC, Wilson disease, exchangeable copper, labile copper, non-ceruloplasmin bound copper, serum biomarkersJournal of inherited metabolic disease
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.Andrade RJ, Aithal GP, de Boer YS, Liberal R, Gerbes A, Regev A, Terziroli Beretta-Piccoli B, Schramm C, Kleiner DE, De Martin E, Kullak-Ublick GA, Stirnimann G, Devarbhavi H, Vierling JM, Manns MP, Sebode M, Londoño MC, Avigan M, Robles-Diaz M, García-Cortes M, Atallah E, Heneghan M, Chalasani N, Trivedi PJ, Hayashi PH, Taubert R, Fontana RJ, Weber S, Oo YH, Zen Y, Licata A, Lucena MI, Mieli-Vergani G, Vergani D, Björnsson ES2023-09-01AIH, DI-ALH, DILI, Drug-induced autoimmune-like hepatitis, Liver injury, autoimmune hepatitis, diagnosis, drug-induced liver injury, epidemiology, hepatotoxicity, management, outcomeJournal of hepatology
A proposal from the liver forum for the management of comorbidities in non-alcoholic steatohepatitis therapeutic trials.Pais R, Cariou B, Noureddin M, Francque S, Schattenberg JM, Abdelmalek MF, Lalazar G, Varma S, Dietrich J, Miller V, Sanyal A, Ratziu V2023-09-01NAFLD, NASH, arterial hypertension, diabetes, dyslipidemia, fibrosis, metabolic syndrome, obesity, randomized placebo-controlled trials, run-in periodJournal of hepatology
Exploring the spectrum of incidental gastric polyps in autoimmune gastritis.Massironi S, Elvevi A, Gallo C, Laffusa A, Tortorella A, Invernizzi P2023-09-01Atrophic gastritis, Autoimmune gastritis, Gastric polyp, Gastrin, Neuroendocrine tumorsDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks.Massironi S, Pirola L, Mulinacci G, Ciaccio A, Viganò C, Palermo A, Zilli A, Invernizzi P, Danese S2023-09-01Crohn’s disease, biologic therapy, inflammatory bowel diseases, liver toxicity, small molecules, ulcerative colitisInflammatory bowel diseases
Juvenile Autoimmune Hepatitis: Recent Advances in Diagnosis, Management and Long-Term Outcome.Nastasio S, Mosca A, Alterio T, Sciveres M, Maggiore G2023-08-24active chronic hepatitis liver transplantation, acute liver failure, autoimmune hepatitis, autoimmune liver diseaseDiagnostics (Basel, Switzerland)
Innate Immune Gene Polymorphisms and COVID-19 Prognosis.Bakaros E, Voulgaridi I, Paliatsa V, Gatselis N, Germanidis G, Asvestopoulou E, Alexiou S, Botsfari E, Lygoura V, Tsachouridou O, Mimtsoudis I, Tseroni M, Sarrou S, Mouchtouri VA, Dadouli K, Kalala F, Metallidis S, Dalekos G, Hadjichristodoulou C, Speletas M2023-08-22CARD8, CD14, CD40, COVID-19, IL18, TLR2, TLR4, innate immunity, polymorphism, prognosisViruses
Circulating microRNAs improve bacterial infection diagnosis and overall survival prediction in acute decompensation of liver cirrhosis.Chouik Y, Lebossé F, Plissonnier ML, Lega JC, Pradat P, Antonini T, Subic M, Hartig-Lavie K, Erard D, Villeret F, Guichon C, Payancé A, Radenne S, Rautou PE, Zoulim F, Levrero M2023-08-18Bacteriology, Cell biologyiScience
Focus on Liver Function Abnormalities in Patients With Turner Syndrome: Risk Factors and Evaluation of Fibrosis Risk.Bourcigaux N, Dubost E, Buzzi JC, Donadille B, Corpechot C, Poujol-Robert A, Christin-Maitre S2023-08-18Turner syndrome, hormone replacement therapy, liver enzymes, liver fibrosis, primary ovarian insufficiency, steatosisThe Journal of clinical endocrinology and metabolism
JAG1 and THBS2 Mutations in a Child Presenting With Incomplete Alagille Syndrome.Almes M, Gardin A, Davit-Spraul A, Bouligand J, Habes D, Jacquemin E2023-08-01cholestasis, modifier gene, next generation sequencing, thrombospondin 2JPGN reports
Reply to: "Ductular reaction is a prognostic factor in primary biliary cholangitis".Carpino G, Cardinale V, Carbone M2023-08-01JHEP reports : innovation in hepatology
Intensive care management of acute-on-chronic liver failure.Perricone G, Artzner T, De Martin E, Jalan R, Wendon J, Carbone M2023-08-01Acute decompensation, Acute on chronic liver failure, Cirrhosis, Intensive care management, Liver transplantation, Organ failuresIntensive care medicine
Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study.Sonneveld MJ, Chiu SM, Park JY, Brakenhoff SM, Kaewdech A, Seto WK, Tanaka Y, Carey I, Papatheodoridi M, Colombatto P, van Bömmel F, Berg T, Zoulim F, Ahn SH, Dalekos GN, Erler NS, Brunetto M, Wedemeyer H, Cornberg M, Yuen MF, Agarwal K, Boonstra A, Buti M, Piratvisuth T, Papatheodoridis G, Chen CH, Maasoumy B2023-08-01Entecavir, HBV DNA, HBcrAg, HBsAg, HBsAg loss, TenofovirJHEP reports : innovation in hepatology
Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis.Thompson RJ, Artan R, Baumann U, Calvo PL, Czubkowski P, Dalgic B, D'Antiga L, Di Giorgio A, Durmaz Ö, Gonzalès E, Grammatikopoulos T, Gupte G, Hardikar W, Houwen RHJ, Kamath BM, Karpen SJ, Lacaille F, Lachaux A, Lainka E, Loomes KM, Mack CL, Mattsson JP, McKiernan P, Ni Q, Özen H, Rajwal SR, Roquelaure B, Shteyer E, Sokal E, Sokol RJ, Soufi N, Sturm E, Tessier ME, van der Woerd WL, Verkade HJ, Vittorio JM, Wallefors T, Warholic N, Yu Q, Horn P, Kjems L2023-08-01Bile acids and salts, Clinical trial, Enterohepatic circulation, Liver diseasesJHEP reports : innovation in hepatology
Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease.Zachou K, Azariadis K, Lytvyak E, Snijders RJALM, Takahashi A, Gatselis NK, Robles M, Andrade RJ, Schramm C, Lohse AW, Tanaka A, Drenth JPH, Montano-Loza AJ, Dalekos GN2023-08-01Autoimmune hepatitis, Metabolic dysfunction-associated fatty liver disease, Non-alcoholic fatty liver disease, Non-alcoholic steatohepatitisJHEP reports : innovation in hepatology
Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency.Ruiz M, Lacaille F, Schrader C, Pons M, Socha P, Krag A, Sturm E, Bouchecareilh M, Strnad P2023-08-01Seminars in liver disease
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, Kremer AE, Zigmond E, Andreone P, Gordon SC, Bowlus CL, Lawitz EJ, Aspinall RJ, Pratt DS, Raikhelson K, Gonzalez-Huezo MS, Heneghan MA, Jeong SH, Ladrón de Guevara AL, Mayo MJ, Dalekos GN, Drenth JPH, Janczewska E, Leggett BA, Nevens F, Vargas V, Zuckerman E, Corpechot C, Fassio E, Hinrichsen H, Invernizzi P, Trivedi PJ, Forman L, Jones DEJ, Ryder SD, Swain MG, Steinberg A, Boudes PF, Choi YJ, McWherter CA2023-08-01Hepatology (Baltimore, Md.)
Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression.Jachs M, Panzer M, Hartl L, Schwarz M, Balcar L, Camp JV, Munda P, Mandorfer M, Trauner M, Aberle SW, Zoller H, Reiberger T, Ferenci P2023-08-01Antivirals, Cirrhosis, Hepatitis D, Treatment, Viral hepatitisJHEP reports : innovation in hepatology
Nutritional optimization in medical and surgical treatment of IBD patients.Viganò C, Sampietro GM2023-08-01Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Cholangiopathy in sickle cell disease.Vo Quang E, Ithier G, Jager M, Plessier A2023-08-01Cholangiopathy, Sickle cell diseaseClinics and research in hepatology and gastroenterology
Patient-reported quality of care in primary sclerosing cholangitis.Walmsley M, Tornai D, Cazzagon N, Leburgue A, Mrzljak A, Lenzen H, Carbone M, Madaleno J, Lleo A, Junge N, Schramm C, Bergquist A2023-08-01elastography, guidelines, inflammatory bowel disease, primary sclerosing cholangitis, symptomsLiver international : official journal of the International Association for the Study of the Liver
Prevalence and dynamics of NAFLD-associated fibrosis in people living with HIV in Vienna from first presentation to last follow-up.Schwarz C, Chromy D, Bauer D, Duong N, Schmidbauer VU, Schwarz M, Mandorfer M, Rieger A, Trauner M, Gschwantler M, Reiberger T2023-08-01Epidemiology, Human Immunodeficiency Virus, Metabolic dysfunction associated fatty liver disease, Non-alcoholic Fatty Liver Disease, Protease InhibitorsWiener klinische Wochenschrift
Health-Related Quality of Life in Patients Living with Wilson Disease in Spain: A Cross-Sectional Observational Study.Mariño Z, Berenguer M, Peña-Quintana L, Olveira A, Miralpeix A, Sastre I, Reyes-Domínguez A, Castillo P, García-Solà C, Bono A, Romero M, Pérez-Sádaba FJ, Aceituno S, Anguera A2023-07-21Wilson disease, adherence, emotional status, health-related quality of life, real-world evidenceJournal of clinical medicine
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?Brustia R, Bouattour M, Allaire M, Lequoy M, Hollande C, Regnault H, Blaise L, Ganne-Carrié N, Vilgrain V, Larrey E, Lim C, Scatton O, Mouhadi SE, Ozenne V, Paye F, Balladur P, Dohan A, Massault PP, Pol S, Dioguardi Burgio M, Sepulveda A, Cauchy F, Luciani A, Sommacale D, Leroy V, Calderaro J, Roudot-Thoraval F, Nault JC, Amaddeo G2023-07-172019-nCoV, COVID-19, Hepatocellular carcinoma, Management, cirrhosisAnnals of hepatology
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves.Bezzio C, Vernero M, Costa S, Armuzzi A, Fiorino G, Ardizzone S, Roselli J, Carparelli S, Orlando A, Caprioli FA, Castiglione F, Viganò C, Ribaldone DG, Zingone F, Monterubbianesi R, Imperatore N, Festa S, Daperno M, Scucchi L, Ferronato A, Pastorelli L, Alimenti E, Balestrieri P, Ricci C, Cappello M, Felice C, Coppini F, Alvisi P, Di Luna I, Gerardi V, Variola A, Mazzuoli S, Lenti MV, Saibeni S2023-07-05COVID-19, Inflammatory bowel disease, Outcome, Pandemic, SARS-CoV-2BMC gastroenterology
Radiologic Features of T10 Paravertebral Muscle Sarcopenia: Prognostic Factors in COVID-19.Schinas G, Dimakopoulou V, Dionysopoulos K, Fezoulidi G, Vlychou M, Vassiou K, Gatselis NK, Samakidou A, Giannoulis G, Tzouvelekis A, Marangos M, Gogos C, Dalekos GN, Kalogeropoulou C, Akinosoglou K2023-07-01COVID-19, Chest computed tomography, Cross-sectional anatomy, Muscle mass, Prognostic factors, SAR-CoV-2Journal of clinical medicine research
NEN Gain or NEN Loss: Endoscopic Resection for Rectal Neuroendocrine Neoplasms < 15 mm.Rossi RE, Massironi S2023-07-01Digestive diseases and sciences
Setanaxib, a first-in-class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo-controlled, phase 2 trial.Invernizzi P, Carbone M, Jones D, Levy C, Little N, Wiesel P, Nevens F2023-07-01NADPH oxidase 1/4 inhibitor, cholestasis, fibrosis, primary biliary cholangitis, setanaxibLiver international : official journal of the International Association for the Study of the Liver
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival.Murillo Perez CF, Ioannou S, Hassanally I, Trivedi PJ, Corpechot C, van der Meer AJ, Lammers WJ, Battezzati PM, Lindor KD, Nevens F, Kowdley KV, Bruns T, Cazzagon N, Floreani A, Mason AL, Gulamhusein A, Ponsioen CY, Carbone M, Lleo A, Mayo MJ, Dalekos GN, Gatselis NK, Thorburn D, Verhelst X, Parés A, Londoño MC, Janssen HLA, Invernizzi P, Vuppalanchi R, Hirschfield GM, Hansen BE, Levy C2023-07-01early identification, monitoring, primary biliary cholangitis, prognosis, treatmentLiver international : official journal of the International Association for the Study of the Liver
Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value.Sciascia S, Bizzaro N, Meroni PL, Dimitrios B, Borghi MO, Bossuyt X, Grossi C, Tornai D, Papp M, Shoenfeld Y, Ielo D, Fritzler MJ2023-07-01Antiphospholipid syndrome, Connective tissues disease, Interstitial lung disease, Primary biliary cirrhosis, Rheumatoid arthritis, Sclerosing cholangitisAutoimmunity reviews
Bleeding and Thrombotic Complications in Patients With Cirrhosis: A State-of-the-Art Appraisal.Rautou PE, Caldwell SH, Villa E2023-07-01Bleeding, Coagulation, Hemorrhage, Liver, ThrombusClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Reply to: "3P and 5P models of limited value for the detection of clinically significant portal hypertension in patients with hepatitis delta".Jachs M, Mandorfer M, Reiberger T2023-07-01Journal of hepatology
Etiology and Outcome of Adult and Pediatric Acute Liver Failure in Europe.Lenz D, Hørby Jørgensen M, Kelly D, Cardinale V, Geerts A, Gonçalves Costa I, Fichtner A, Garbade SF, Hegen B, Hilberath J, de Kleine R, Kupčinskas L, McLin V, Niesert M, Prado Gonzalez V, Sturm E, Staufner C, Tjwa E, Willemse J, Zecher BF, Larsen FS, Sebode M, Ytting H2023-07-01Journal of pediatric gastroenterology and nutrition
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.Lapitz A, Azkargorta M, Milkiewicz P, Olaizola P, Zhuravleva E, Grimsrud MM, Schramm C, Arbelaiz A, O'Rourke CJ, La Casta A, Milkiewicz M, Pastor T, Vesterhus M, Jimenez-Agüero R, Dill MT, Lamarca A, Valle JW, Macias RIR, Izquierdo-Sanchez L, Pérez Castaño Y, Caballero-Camino FJ, Riaño I, Krawczyk M, Ibarra C, Bustamante J, Nova-Camacho LM, Falcon-Perez JM, Elortza F, Perugorria MJ, Andersen JB, Bujanda L, Karlsen TH, Folseraas T, Rodrigues PM, Banales JM2023-07-01Cholangiocarcinoma, Extracellular vesicles, Liquid biopsy, Mass spectrometry, Primary sclerosing cholangitis, Protein biomarkers, Single-cell RNA-sequencingJournal of hepatology
Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.Guerrero A, Campo LD, Piscaglia F, Scheiner B, Han G, Violi F, Ferreira CN, Téllez L, Reiberger T, Basili S, Zamora J, Albillos A2023-07-01anticoagulation, cirrhosis, portal vein, thrombosisJournal of hepatology
Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis.de Veer RC, van Hooff MC, Corpechot C, Thorburn D, Invernizzi P, Lammers WJ, Janssen HLA, Battezzati PM, Nevens F, Lindor KD, Floreani A, Ponsioen CY, Mayo MJ, Parés A, Mason AL, Kowdley KV, Trivedi PJ, Hirschfield GM, Goet JC, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Hansen BE, Harms MH, van der Meer AJ2023-07-01The American journal of gastroenterology
Evaluation of immunoserological detection of anti-liver kidney microsomal, anti-soluble liver antigen and anti-mitochondrial antibodies.Campos-Murguia A, Henjes N, Loges S, Wedemeyer H, Jaeckel E, Taubert R, Engel B2023-06-20Scientific reports
Inflammation and malnutrition in inflammatory bowel disease.Massironi S, Viganò C, Palermo A, Pirola L, Mulinacci G, Allocca M, Peyrin-Biroulet L, Danese S2023-06-01The lancet. Gastroenterology & hepatology
COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study.Fazio N, Gervaso L, Halfdanarson TR, Sonbol M, Eiring RA, Pusceddu S, Prinzi N, Lombardi Stocchetti B, Grozinsky-Glasberg S, Gross DJ, Walter T, Robelin P, Lombard-Bohas C, Frassoni S, Bagnardi V, Antonuzzo L, Sparano C, Massironi S, Gelsomino F, Bongiovanni A, Ranallo N, Tafuto S, Rossi M, Cives M, Rasul Kakil I, Hamid H, Chirco A, Squadroni M, La Salvia A, Hernando J, Hofland J, Koumarianou A, Boselli S, Tamayo D, Mazzon C, Rubino M, Spada F2023-06-01COVID-19, SARS-CoV-2, coronavirus, neuroendocrine neoplasms, neuroendocrine tumorsEndocrine-related cancer
Late-onset enteric virus infection associated with hepatitis (EVAH) in transplanted SCID patients.Riller Q, Fourgeaud J, Bruneau J, De Ravin SS, Smith G, Fusaro M, Meriem S, Magerus A, Luka M, Abdessalem G, Lhermitte L, Jamet A, Six E, Magnani A, Castelle M, Lévy R, Lecuit MM, Fournier B, Winter S, Semeraro M, Pinto G, Abid H, Mahlaoui N, Cheikh N, Florkin B, Frange P, Jeziorski E, Suarez F, Sarrot-Reynauld F, Nouar D, Debray D, Lacaille F, Picard C, Pérot P, Regnault B, Da Rocha N, de Cevins C, Delage L, Pérot BP, Vinit A, Carbone F, Brunaud C, Marchais M, Stolzenberg MC, Asnafi V, Molina T, Rieux-Laucat F, Notarangelo LD, Pittaluga S, Jais JP, Moshous D, Blanche S, Malech H, Eloit M, Cavazzana M, Fischer A, Ménager MM, Neven B2023-06-01B-cell function, CD8(+) T cells, SCID, enteric virus, gene therapy, interferon, transplantationThe Journal of allergy and clinical immunology
Cleaning up alpha-1 antitrypsin deficiency related liver disease.Rademacher L, Fromme M, Strnad P2023-05-01Current opinion in gastroenterology
Noninvasive identification of probable fibrotic nonalcoholic steatohepatitis across the spectrum of glucose tolerance in the United States.Ciardullo S, Carbone M, Invernizzi P, Perseghin G2023-05-01FAST, Fibroscan, NAFLD, NASH, NFIDiabetes research and clinical practice
Future Treatment Options and Regimens for Nonalcoholic Fatty Liver Disease.Francque S, Ratziu V2023-05-01Endpoints, Fibrosis regression, NASH resolution, Pharmacological treatmentClinics in liver disease
Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆" [J Hepatol (2020) 505-515].Anstee QM, Darlay R, Cockell S, Meroni M, Govaere O, Tiniakos D, Burt AD, Bedossa P, Palmer J, Liu YL, Aithal GP, Allison M, Yki-Järvinen H, Vacca M, Dufour JF, Invernizzi P, Prati D, Ekstedt M, Kechagias S, Francque S, Petta S, Bugianesi E, Clement K, Ratziu V, Schattenberg JM, Valenti L, Day CP, Cordell HJ, Daly AK2023-05-01Journal of hepatology
Paediatric autoimmune hepatitis: Time to change the textbooks?Lohse AW, Hørby Jørgensen M2023-05-01Journal of hepatology
Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting in childhood.Maggiore G, Bernard O, Mosca A, Ballot E, Johanet C, Jacquemin E2023-05-01autoimmune liver disease, liver transplantation, prothrombin ratio, treatment withdrawalJournal of hepatology
Letter to the editor: discussing the place of TIPS in noncirrhotic patients with chronic extrahepatic portal vein occlusion (EHPVO).Artru F, Rautou PE, Denys A2023-05-01Hepatology (Baltimore, Md.)
Sporadic and MEN1-related gastrinoma and Zollinger-Ellison syndrome: differences in clinical characteristics and survival outcomes.Massironi S, Rossi RE, Laffusa A, Eller-Vainicher C, Cavalcoli F, Zilli A, Ciafardini C, Sciola V, Invernizzi P, Peracchi M2023-05-01Gastrinoma, MEN-1, Multiple endocrine neoplasia type 1, Neuroendocrine neoplasms, Neuroendocrine tumors, Zollinger–Ellison syndromeJournal of endocrinological investigation
Diet and non-alcoholic fatty liver disease, a short narrative review.Kwanten WJ2023-04-01NAFLD, diet, lifestyle, mediterranean diet, recommendations, reviewActa gastro-enterologica Belgica
Salvage therapies of autoimmune hepatitis limit proinflammatory immune cells while sparing regulatory T cells.Derben FC, Ytting H, Hartleben B, Bantel H, Wedemeyer H, Willemoe GL, Jaeckel E, Taubert R2023-04-01Hepatology communications
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study.Dragoni G, Castiglione F, Bezzio C, Pugliese D, Spagnuolo R, Viola A, Cocomazzi F, Aratari A, Savarino EV, Balestrieri P, Onali S, Viganò C, Ribaldone DG, Innocenti T, Testa A, Saibeni S, Privitera G, Milla M, Armuzzi A, Fantini MC, Fiorino G2023-04-01Crohn's disease, Rutgeerts Score, endoscopic recurrence, ileo-colonic resection, immunoprophylaxis, inflammatory bowel disease, postoperative Crohn's disease, postoperative recurrenceUnited European gastroenterology journal
Management of splanchnic vein thrombosis.Elkrief L, Payancé A, Plessier A, d'Alteroche L, Ronot M, Paradis V, Valla D, Rautou PE2023-04-01BCS, Budd-Chiari syndrome, CALR, calreticulin, Cavernoma, DOACs, direct-acting oral anticoagulants, Direct oral anticoagulants, EHPVO, extrahepatic portal vein obstruction, GFR, glomerular filtration rate, JAK2, Janus kinase 2, LMWH, low-molecular-weight heparin, MPN, myeloproliferative neoplasm, MTHFR, methylene-tetrahydrofolate reductase, PNH, paroxysmal nocturnal hemoglobinuria, PVT, portal vein thrombosis, Portal biliopathy, Portal vein recanalisation, SVT, splanchnic vein thrombosis, TIPS, transjugular intrahepatic portosystemic shunt, VKAs, vitamin K antagonists, Vascular liver diseasesJHEP reports : innovation in hepatology
Protective potential of the gallbladder in primary sclerosing cholangitis.Cazzagon N, Gonzalez-Sanchez E, El-Mourabit H, Wendum D, Rainteau D, Humbert L, Corpechot C, Chazouillères O, Arrivé L, Housset C, Lemoinne S2023-04-01ABC, ATP-binding cassette transporter, Abcb4 knockout mice, BA, bile acid, Bile acids, C4, 7α-hydroxy-4-cholesten-3-one, CFTR, cystic fibrosis transmembrane conductance regulator, CK19, cytokeratin 19, Cholecystectomy, FGF19, fibroblast growth factor 19, Gallbladder volume, HPLC-MS/MS, high-performance liquid chromatography coupled to tandem mass spectrometry, IBD, inflammatory bowel disease, MRC, magnetic resonance cholangiography, Magnetic resonance imaging, PSC, primary sclerosing cholangitis, UDCA, ursodeoxycholic acid, ULN, upper limit of normalJHEP reports : innovation in hepatology
The oft-overlooked cardiovascular complications of inflammatory bowel disease.Massironi S, Mulinacci G, Gallo C, Viganò C, Fichera M, Villatore A, Peretto G, Danese S2023-04-01Atherosclerosis, JAK inhibitors, cardiovascular disease, inflammatory bowel disease/complications, myocarditis, prophylaxis, venous thromboembolismExpert review of clinical immunology
Corrigendum to: "An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs" [J Hepatol 75 (2021) 572-581].Cordell HJ, Fryett JJ, Ueno K, Darlay R, Aiba Y, Hitomi Y, Kawashima M, Nishida N, Khor SS, Gervais O, Kawai Y, Nagasaki M, Tokunaga K, Tang R, Shi Y, Li Z, Juran BD, Atkinson EJ, Gerussi A, Carbone M, Asselta R, Cheung A, de Andrade M, Baras A, Horowitz J, Ferreira MAR, Sun D, Jones DE, Flack S, Spicer A, Mulcahy VL, Byan J, Han Y, Sandford RN, Lazaridis KN, Amos CI, Hirschfield GM, Seldin MF, Invernizzi P, Siminovitch KA, Ma X, Nakamura M, Mells GF2023-04-01Journal of hepatology
Reply.Valainathan SR, Ronot M, Vilgrain V, Rautou PE2023-04-01Hepatology (Baltimore, Md.)
Bile detection of squamous cell carcinoma antigen (SCCA) in extrahepatic cholangiocarcinoma.Gringeri E, Biasiolo A, Di Giunta M, Mescoli C, Guzzardo V, Sartori A, Cirillo G, Nieddu E, D'Amico FE, Pontisso P, Cillo U2023-04-01Biomarkers, Cholangiocarcinoma, Liver, Prognosis, SerpinB3/4Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Role of autoantibodies in the clinical management of primary biliary cholangitis.Rigopoulou EI, Bogdanos DP2023-03-28Anti-gp210, Anti-mitochondrial antibodies, Anti-sp100, Primary biliary cholangitis, Primary biliary cholangitis-specific antinuclear antibodies, PrognosisWorld journal of gastroenterology
Molecular and Clinical Links between Drug-Induced Cholestasis and Familial Intrahepatic Cholestasis.Vitale G, Mattiaccio A, Conti A, Berardi S, Vero V, Turco L, Seri M, Morelli MC2023-03-18ABCB1, ABCB11, ABCB4, ABCC2, BSEP protein, MDR1 protein, MDR3 protein, MRP2, drug-induced cholestasis, familial intrahepatic cholestasis, idiosyncratic drug-induced liver injuryInternational journal of molecular sciences
Interaction between Gut Microbiota and Celiac Disease: From Pathogenesis to Treatment.Rossi RE, Dispinzieri G, Elvevi A, Massironi S2023-03-07celiac disease, gut microbiota, immune response, intestinal microbiotaCells
Monkeypox: A real new warning or just a sign of times?Georgiadou SP, Giamarellos-Bourboulis EJ, Dalekos GN2023-03-01Journal of translational internal medicine
Health-related quality of life and symptoms in autoimmune liver diseases.Janik MK, Wunsch E, Milkiewicz P2023-03-01Minerva gastroenterology
Autoimmune liver diseases.Scaravaglio M, Carbone M, Invernizzi P2023-03-01Minerva gastroenterology
Editorial: The next-generation toolkit for exploring biliary diseases.Housset C2023-03-01Current opinion in gastroenterology
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial.Jones D, Carbone M, Invernizzi P, Little N, Nevens F, Swain MG, Wiesel P, Levy C2023-03-01Hepatology communications
Reply to: "2022 international autoimmune hepatitis group non-response criteria in autoimmune hepatitis: Quick vs. slow responders".Snijders RJALM, Gevers TJG, Drenth JPH2023-03-01Journal of hepatology
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis.Cristoferi L, Porta M, Bernasconi DP, Leonardi F, Gerussi A, Mulinacci G, Palermo A, Gallo C, Scaravaglio M, Stucchi E, Maino C, Ippolito D, D'Amato D, Ferreira C, Nardi A, Banerjee R, Valsecchi MG, Antolini L, Corso R, Sironi S, Fagiuoli S, Invernizzi P, Carbone M2023-03-01Artificial intelligence, MRCP, Primary sclerosing cholangitis, Prognostic scoreDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
2022 International autoimmune hepatitis group non-response criteria in autoimmune hepatitis: Quick vs. slow responders.Engel B, Jaeckel E, Taubert R2023-03-01Journal of hepatology
Risk stratification in primary sclerosing cholangitis.Mulinacci G, Cristoferi L, Palermo A, Luca M, Gerussi A, Invernizzi P, Carbone M2023-03-01Minerva gastroenterology
Open challenges in the management of autoimmune hepatitis.Gerussi A, Halliday N, Carbone M, Invernizzi P, Thorburn D2023-03-01Minerva gastroenterology
Diagnosis and management of autoimmune hepatitis.Muratori L, Lohse AW, Lenzi M2023-02-06BMJ (Clinical research ed.)
Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency.Felzen A, van Wessel DBE, Gonzales E, Thompson RJ, Jankowska I, Shneider BL, Sokal E, Grammatikopoulos T, Kadaristiana A, Jacquemin E, Spraul A, Lipiński P, Czubkowski P, Rock N, Shagrani M, Broering D, Nicastro E, Kelly D, Nebbia G, Arnell H, Fischler B, Hulscher JBF, Serranti D, Arikan C, Polat E, Debray D, Lacaille F, Goncalves C, Hierro L, Muñoz Bartolo G, Mozer-Glassberg Y, Azaz A, Brecelj J, Dezsőfi A, Calvo PL, Grabhorn E, Hartleif S, van der Woerd WJ, Kamath BM, Wang JS, Li L, Durmaz Ö, Kerkar N, Jørgensen MH, Fischer R, Jimenez-Rivera C, Alam S, Cananzi M, Laverdure N, Ferreira CT, Guerrero FO, Wang H, Sency V, Kim KM, Chen HL, de Carvalho E, Fabre A, Bernabeu JQ, Zellos A, Alonso EM, Sokol RJ, Suchy FJ, Loomes KM, McKiernan PJ, Rosenthal P, Turmelle Y, Horslen S, Schwarz K, Bezerra JA, Wang K, Hansen BE, Verkade HJ2023-02-01ABCB11, ATP-binding cassette, sub-family B member 11, ALT, alanine aminotransferase, AST, aspartate aminotransferase, BSEP, BSEP, bile salt export pump, ChiLDReN, Childhood Liver Disease Research Network, GGT, gamma-glutamyltransferase, HCC, hepatocellular carcinoma, LTx, liver transplantation, NAPPED, NAtural course and Prognosis of PFIC and Effect of biliary Diversion, NLS, native liver survival, PFIC2, PFIC2, progressive familial intrahepatic cholestasis type 2, PPTM, predicted protein truncating mutation, REDCap, Research Electronic Data Capture, TSB, total serum bilirubin, UDCA, ursodeoxycholic acid, compound heterozygosity, genotype, interruption of the enterohepatic circulation, phenotype, sBAs, serum bile acids, siEHC, surgical interruption of the enterohepatic circulationJHEP reports : innovation in hepatology
Letter: chronic HDV infection-is ignorance bliss? Authors' reply.Jachs M, Reiberger T, Ferenci P2023-02-01Alimentary pharmacology & therapeutics
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial.Akinosoglou K, Kotsaki A, Gounaridi IM, Christaki E, Metallidis S, Adamis G, Fragkou A, Fantoni M, Rapti A, Kalomenidis I, Chrysos G, Boni G, Kainis I, Alexiou Z, Castelli F, Serino FS, Bakakos P, Nicastri E, Tzavara V, Safarika A, Ioannou S, Dagna L, Dimakou K, Tzatzagou G, Chini M, Bassetti M, Kotsis V, Angheben A, Tsoukalas G, Selmi C, Spiropoulou OM, Samarkos M, Doumas M, Damoraki G, Masgala A, Papanikolaou I, Argyraki A, Negri M, Leventogiannis K, Sympardi S, Gatselis NK, Petrakis V, Netea MG, Panagopoulos P, Sakka V, Milionis H, Dalekos GN, Giamarellos-Bourboulis EJ2023-02-01Anakinra, COVID-19, Clinical efficacy, Co-morbidities, Cost, Survival, suPAREClinicalMedicine
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia.Samaras C, Kyriazopoulou E, Poulakou G, Reiner E, Kosmidou M, Karanika I, Petrakis V, Adamis G, Gatselis NK, Fragkou A, Rapti A, Taddei E, Kalomenidis I, Chrysos G, Bertoli G, Kainis I, Alexiou Z, Castelli F, Saverio Serino F, Bakakos P, Nicastri E, Tzavara V, Kostis E, Dagna L, Koukidou S, Tzatzagou G, Chini M, Bassetti M, Trakatelli C, Tsoukalas G, Selmi C, Samarkos M, Pyrpasopoulou A, Masgala A, Antonakis E, Argyraki A, Akinosoglou K, Sympardi S, Panagopoulos P, Milionis H, Metallidis S, Syrigos KN, Angel A, Dalekos GN, Netea MG, Giamarellos-Bourboulis EJ2023-02-01Anakinra, COVID-19, IP-10, Prognosis, Respiratory failureCytokine
Autoimmune serology testing in clinical practice: An updated roadmap for the diagnosis of autoimmune hepatitis.Dalekos GN, Gatselis NK2023-02-01Antinuclear antibodies, Autoimmune hepatitis, Liver kidney microsomal antibodies, Smooth muscle antibodies, Soluble liver antigen antibodiesEuropean journal of internal medicine
Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases†.Nevens F, Trauner M, Manns MP2023-02-01FXR, OCA, PBC, PPAR, PSC, cholestasis, second-line therapyJournal of hepatology
Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder.Lampichler K, Semmler G, Wöran K, Simbrunner B, Jachs M, Hartl L, Bauer DJM, Balcar L, Burghart L, Trauner M, Tamandl D, Ba-Ssalamah A, Mandorfer M, Reiberger T, Scheiner B, Scharitzer M2023-02-01Contrast agent, Liver cirrhosis, Multiparametric magnetic resonance imaging, Portal veinEuropean radiology
Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis.Reiniš J, Petrenko O, Simbrunner B, Hofer BS, Schepis F, Scoppettuolo M, Saltini D, Indulti F, Guasconi T, Albillos A, Téllez L, Villanueva C, Brujats A, Garcia-Pagan JC, Perez-Campuzano V, Hernández-Gea V, Rautou PE, Moga L, Vanwolleghem T, Kwanten WJ, Francque S, Trebicka J, Gu W, Ferstl PG, Gluud LL, Bendtsen F, Møller S, Kubicek S, Mandorfer M, Reiberger T2023-02-01hepatic venous pressure gradient, machine learning, non-invasive testingJournal of hepatology
Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study.Vandriel SM, Li LT, She H, Wang JS, Gilbert MA, Jankowska I, Czubkowski P, Gliwicz-Miedzińska D, Gonzales EM, Jacquemin E, Bouligand J, Spinner NB, Loomes KM, Piccoli DA, D'Antiga L, Nicastro E, Sokal É, Demaret T, Ebel NH, Feinstein JA, Fawaz R, Nastasio S, Lacaille F, Debray D, Arnell H, Fischler B, Siew S, Stormon M, Karpen SJ, Romero R, Kim KM, Baek WY, Hardikar W, Shankar S, Roberts AJ, Evans HM, Jensen MK, Kavan M, Sundaram SS, Chaidez A, Karthikeyan P, Sanchez MC, Cavalieri ML, Verkade HJ, Lee WS, Squires JE, Hajinicolaou C, Lertudomphonwanit C, Fischer RT, Larson-Nath C, Mozer-Glassberg Y, Arikan C, Lin HC, Bernabeu JQ, Alam S, Kelly DA, Carvalho E, Ferreira CT, Indolfi G, Quiros-Tejeira RE, Bulut P, Calvo PL, Önal Z, Valentino PL, Desai DM, Eshun J, Rogalidou M, Dezsőfi A, Wiecek S, Nebbia G, Pinto RB, Wolters VM, Tamara ML, Zizzo AN, Garcia J, Schwarz K, Beretta M, Sandahl TD, Jimenez-Rivera C, Kerkar N, Brecelj J, Mujawar Q, Rock N, Busoms CM, Karnsakul W, Lurz E, Santos-Silva E, Blondet N, Bujanda L, Shah U, Thompson RJ, Hansen BE, Kamath BM2023-02-01Hepatology (Baltimore, Md.)
Analysis of the humoral and cellular response after the third COVID-19 vaccination in patients with autoimmune hepatitis.Hartl J, Rüther DF, Duengelhoef PM, Brehm TT, Steinmann S, Weltzsch JP, Glaser F, Sterneck M, Sebode M, Weiler-Normann C, Lütgehetmann M, Schaub GM, Haag F, Schramm C, Wiesch JSZ, Lohse AW2023-02-01COVID-19 vaccination, autoimmune hepatitis, immunosuppressionLiver international : official journal of the International Association for the Study of the Liver
Fibrosis-Related Gene Profiling in Liver Biopsies of PiZZ α1-Antitrypsin Children with Different Clinical Courses.Kamp JC, Kappe NN, Moro CF, Fuge J, Kuehnel MP, Wrenger S, Welte T, Hoek BV, Jonigk DD, Khedoe PPSJ, Strnad P, Björnstedt M, Stolk J, Janciauskiene S, Nemeth A2023-01-27PiZZ deficiency, Z-AAT polymers, cholestasis, cirrhosis, lipid metabolism, liver, mRNA expression, nCounter Fibrosis Panel, transcriptome profilingInternational journal of molecular sciences
SERPINB3, Adult-Onset Immunodeficiency, and Generalized Pustular Psoriasis.Kantaputra P, Daroontum T, Chuamanochan M, Chaowattanapanit S, Kiratikanon S, Choonhakarn C, Intachai W, Olsen B, Tongsima S, Ngamphiw C, Pontisso P, Cox TC, Ounjai P2023-01-19SERPIN, SERPINB3 mutation, adult-onset immunodeficiency syndrome, anti-interferon-γ autoantibody, generalized pustular psoriasis, hyperactive elastase activity, pustular skin reactionGenes
Incidence of Isolated Biliary Atresia during the COVID Lockdown in Europe: Results from a Collaborative Project by RARE-Liver.Nomden M, Alizai NK, Betalli P, Bruggink JLM, Cananzi M, Christensen VB, D'Antiga L, Davenport M, Fischler B, Hindemith L, Hukkinen M, Johansen LS, de Kleine RH, Madadi-Sanjani O, Ong EGP, Pakarinen MP, Petersen C, Ruiz M, Schunn M, Sturm E, Verkade HJ, Wildhaber BE, Hulscher JBF, On Behalf Of Members Of The Biliary Atresia And Related Disorders Bard Community The Ern Ra-Re-Liver2023-01-18COVID lockdown, European reference network RARE-LIVER, biliary atresia, epidemiology, stringency indexJournal of clinical medicine
Making inroads to precision medicine for the treatment of autoimmune diseases: Harnessing genomic studies to better diagnose and treat complex disorders.Baglaenko Y, Wagner C, Bhoj VG, Brodin P, Gershwin ME, Graham D, Invernizzi P, Kidd KK, Korsunsky I, Levy M, Mammen AL, Nizet V, Ramirez-Valle F, Stites EC, Williams MS, Wilson M, Rose NR, Ladd V, Sirota M2023-01-01Autoimmunity, bioinformatics, data integration, diagnosis, genomicsCambridge prisms. Precision medicine
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease.Kocheise L, Piseddu I, Vonderlin J, Tjwa ET, Buescher G, Meunier L, Goeggelmann P, Fianchi F, Dumortier J, Riveiro Barciela M, Gevers TJG, Terziroli Beretta-Piccoli B, Londoño MC, Frankova S, Roesner T, Joerg V, Schmidt C, Glaser F, Sutter JP, Fründt TW, Lohse AW, Huber S, von Felden J, Sebode M, Schulze K2023-01-01PD-1/PD-L1 immune checkpoint inhibitors, autoimmune disease (AID), autoimmune hepatitis (AIH), autoimmune liver diseases (AILD), immune checkpoint inhibitors (ICI), immune related adverse effects (irAEs), primary biliary cholangitis (PBC), primary sclerosing cholangites (PSC)Frontiers in immunology
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)-A European Society of Organ Transplantation (ESOT) Consensus Statement.Carbone M, Della Penna A, Mazzarelli C, De Martin E, Villard C, Bergquist A, Line PD, Neuberger JM, Al-Shakhshir S, Trivedi PJ, Baumann U, Cristoferi L, Hov J, Fischler B, Hadzic NH, Debray D, D'Antiga L, Selzner N, Belli LS, Nadalin S2023-01-01IBD, PSC, immunosuppression, liver transplantation, retransplantationTransplant international : official journal of the European Society for Organ Transplantation
Premature birth associated with a favorable course in gestational alloimmune liver disease (GALD): A case report.Mulzer LM, Reutter H, Jüngert J, Knisely AS, Schmid M, Hoerning A, Morhart P2023-01-01gestational alloimmune liver disease, liver disease, neonatal acute liver failure, neonatal hemochromatosis, prematurit, prematurityFrontiers in pediatrics
Urea cycle disorders and indications for liver transplantation.García Vega M, Andrade JD, Morais A, Frauca E, Muñoz Bartolo G, Lledín MD, Bergua A, Hierro L2023-01-01hepatology, hyperammonemia, inborn errors of metabolism, liver transplant, urea cycle disordersFrontiers in pediatrics
Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation.Cortesi PA, Viganò R, Conti S, Lenci I, Volpes R, Martini S, Angelico M, Fung J, Buti M, Coilly A, Durand F, Fondevila C, Lebray P, Nevens F, Polak WG, Rizzetto M, Zoulim F, Perricone G, Berenguer M, Mantovani LG, Duvoux C, Belli LS2023-01-01economics, hepatitis B, immunoglobulin (IgG), liver transplant, prophylaxisTransplant international : official journal of the European Society for Organ Transplantation
Histological and serological features of acute liver injury after SARS-CoV-2 vaccination.Codoni G, Kirchner T, Engel B, Villamil AM, Efe C, Stättermayer AF, Weltzsch JP, Sebode M, Bernsmeier C, Lleo A, Gevers TJ, Kupčinskas L, Castiella A, Pinazo J, De Martin E, Bobis I, Sandahl TD, Pedica F, Invernizzi F, Del Poggio P, Bruns T, Kolev M, Semmo N, Bessone F, Giguet B, Poggi G, Ueno M, Jang H, Elpek GÖ, Soylu NK, Cerny A, Wedemeyer H, Vergani D, Mieli-Vergani G, Lucena MI, Andrade RJ, Zen Y, Taubert R, Terziroli Beretta-Piccoli B2023-01-01AIH, autoimmune hepatitis, ALP, alkaline phosphatase, ALT, alanine aminotransferase, AMA, anti-mitochondrial antibody, ANA, anti-nuclear antibody, AST, aspartate aminotransferase, COVID-19, coronavirus disease 2019, DILI, drug-induced liver injury, IAIHG, International Autoimmune Hepatitis Group, IFT, indirect immunofluorescence, LKM, liver kidney microsomal, LT, liver transplantation, PCA, parietal cell antigen, SARS-CoV-2 vaccines, SARS-CoV-2, severe acute respiratory syndrome coronavirus type 2, SLA, soluble liver antigen, SMA, anti-smooth muscle antibody, ULN, upper limit of normal, acute liver injury, autoimmune liver serology, liver histology, pIgG, polyreactive IgGJHEP reports : innovation in hepatology
Maralixibat Treatment Response in Alagille Syndrome is Associated with Improved Health-Related Quality of Life.Kamath BM, Goldstein A, Howard R, Garner W, Vig P, Marden JR, Billmyer E, Anderson A, Kirson N, Jacquemin E, Gonzales E2023-01-01HRQoL, PedsQL, cholestasis, family impact, fatigue, ileal bile acid transporter, liver disease, pediatric, rare disease, serum bile acidsThe Journal of pediatrics
Author Correction: JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm.Al-Rifai R, Vandestienne M, Lavillegrand JR, Mirault T, Cornebise J, Poisson J, Laurans L, Esposito B, James C, Mansier O, Hirsch P, Favale F, Braik R, Knosp C, Vilar J, Rizzo G, Zernecke A, Saliba AE, Tedgui A, Lacroix M, Arrive L, Mallat Z, Taleb S, Diedisheim M, Cochain C, Rautou PE, Ait-Oufella H2022-12-23Nature communications
The Emerging Role of Tumor Microenvironmental Stimuli in Regulating Metabolic Rewiring of Liver Cancer Stem Cells.Correnti M, Binatti E, Gammella E, Invernizzi P, Recalcati S2022-12-20cancer stem cells, heterogeneity, liver cancer, metabolism, plasticity, tumor microenvironmentCancers
No association of serum ferritin levels with advanced liver fibrosis in untreated German patients with autoimmune hepatitis.Engel B, Jaeckel E, Taubert R2022-12-19AIH, Biochemical remission, Incomplete response, Iron, Treatment responseBMC gastroenterology
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study.Yanai H, Kagramanova A, Knyazev O, Sabino J, Haenen S, Mantzaris GJ, Mountaki K, Armuzzi A, Pugliese D, Furfaro F, Fiorino G, Drobne D, Kurent T, Yassin S, Maharshak N, Castiglione F, de Sire R, Nardone OM, Farkas K, Molnar T, Krznaric Z, Brinar M, Chashkova E, Livne Margolin M, Kopylov U, Bezzio C, Bar-Gil Shitrit A, Lukas M, Chaparro M, Truyens M, Nancey S, Lobaton T, Gisbert JP, Saibeni S, Bacsúr P, Bossuyt P, Schulberg J, Hoentjen F, Viganò C, Palermo A, Torres J, Revés J, Karmiris K, Velegraki M, Savarino E, Markopoulos P, Tsironi E, Ellul P, Calviño Suárez C, Weisshof R, Ben-Hur D, Naftali T, Eriksson C, Koutroubakis IE, Foteinogiannopoulou K, Limdi JK, Liu E, Surís G, Calabrese E, Zorzi F, Filip R, Ribaldone DG, Snir Y, Goren I, Banai-Eran H, Broytman Y, Amir Barak H, Avni-Biron I, Ollech JE, Dotan I, Aharoni Golan M2022-12-05Crohn’s disease, biologics, post-operative recurrenceJournal of Crohn's & colitis
Gamma-Glutamyl Transferase in Patients With Primary Biliary Cholangitis.Gerussi A2022-12-01Gastroenterology & hepatology
Rivaroxaban Prophylaxis in Noncirrhotic Portal Vein Thrombosis.Plessier A, Goria O, Cervoni JP, Ollivier I, Bureau C, Poujol-Robert A, Minello A, Houssel-Debry P, Rautou PE, Payancé A, Scoazec G, Bruno O, Corbic M, Durand F, Vilgrain V, Paradis V, Boudaoud L, de Raucourt E, Roy C, Gault N, Valla D2022-12-01NEJM evidence
Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis.Dalekos GN, Arvaniti P, Gatselis NK, Gabeta S, Samakidou A, Giannoulis G, Rigopoulou E, Koukoulis GK, Zachou K2022-12-01AIH, autoimmune hepatitis, ALT, alanine aminotransferase, ANA, antinuclear antibodies, AZA, azathioprine, Autoimmune hepatitis, Azathioprine, CBR, complete biochemical response, HASL, Hellenic Association for the Study of the Liver, HR, hazard ratio, IAIHG, International AIH Group, LSM, liver stiffness measurement, MMF, mycophenolate mofetil, Mycophenolate mofetil, Outcome, SMA, smooth muscle antibodies, Survival, ULN, upper limit of normal, anti-LC1, anti-liver cytosol type 1 antibodies, anti-LKM1, anti-liver/kidney microsomal type 1 antibodies, anti-SLA/LP, antibodies against soluble liver antigen/liver pancreas, mHAI, modified hepatitis activity indexJHEP reports : innovation in hepatology
GWAS and autoimmunity: What have we learned and what next.Gerussi A, Soskic B, Asselta R, Invernizzi P, Gershwin ME2022-12-01Autoimmunity, Fine mapping, GWAS, Genetic variants, Liver, eQTLJournal of autoimmunity
Continuous clinical remission with biologics in ulcerative colitis: the 'AURORA' comparison study.Cassinotti A, Mezzina N, De Silvestri A, Di Paolo D, Lenti MV, Bezzio C, Stradella D, Mauri M, Zadro V, Ricci C, Casini V, Radice E, Massari A, Maconi G, Saibeni S, Caprioli F, Tari R, Fichera M, Cortelezzi CC, Parravicini M, Tinelli C, Testoni PA, Pace F, Segato S, Invernizzi P, Occhipinti P, Manes G, Di Sabatino A, Pastorelli L, Vecchi M, Ardizzone S2022-12-01European journal of gastroenterology & hepatology
Predicting bleeding after liver biopsy using comprehensive clinical and laboratory investigations: A prospective analysis of 302 procedures.Bissonnette J, Riescher-Tuczkiewicz A, Gigante E, Bourdin C, Boudaoud L, Soliman H, Durand F, Ronot M, Valla D, Vilgrain V, de Raucourt E, Rautou PE2022-12-01blood coagulation, diagnostic techniques and procedures, hemorrhage, liver cirrhosis, liver diseasesJournal of thrombosis and haemostasis : JTH
Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma.Calderaro J, Di Tommaso L, Maillé P, Beaufrère A, Nguyen CT, Heij L, Gnemmi V, Graham RP, Charlotte F, Chartier S, Wendum D, Vij M, Allende D, Diaz A, Fuster C, Rivière B, Herrero A, Augustin J, Evert K, Calvisi DF, Leow WQ, Leung HHW, Bednarsch J, Boleslawski E, Rela M, Chan AW, Forner A, Reig M, Pujals A, Favre L, Allaire M, Scatton O, Uguen A, Trépo E, Sanchez LO, Chatelain D, Remmelink M, Boulagnon-Rombi C, Bazille C, Sturm N, Menahem B, Frouin E, Tougeron D, Tournigand C, Kempf E, Kim H, Ningarhari M, Michalak-Provost S, Kather JN, Gouw ASH, Gopal P, Brustia R, Vibert E, Schulze K, Rüther DF, Weidemann SA, Rhaiem R, Nault JC, Laurent A, Amaddeo G, Regnault H, de Martin E, Sempoux C, Navale P, Shinde J, Bacchuwar K, Westerhoff M, Lo RC, Sebbagh M, Guettier C, Lequoy M, Komuta M, Ziol M, Paradis V, Shen J, Caruso S2022-12-01cancer, cholangiocarcinoma, combined hepatocellular-cholangiocarcinoma, hepatocellular carcinoma, liver, nestinJournal of hepatology
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis.Corpechot C, Carrat F, Gaouar F, Chau F, Hirschfield G, Gulamhusein A, Montano-Loza AJ, Lytvyak E, Schramm C, Pares A, Olivas I, Eaton JE, Osman KT, Dalekos G, Gatselis N, Nevens F, Cazzagon N, Zago A, Russo FP, Abbas N, Trivedi P, Thorburn D, Saffioti F, Barkai L, Roccarina D, Calvaruso V, Fichera A, Delamarre A, Medina-Morales E, Bonder A, Patwardhan V, Rigamonti C, Carbone M, Invernizzi P, Cristoferi L, van der Meer A, de Veer R, Zigmond E, Yehezkel E, Kremer AE, Deibel A, Dumortier J, Bruns T, Große K, Pageaux GP, Wetten A, Dyson J, Jones D, Chazouillères O, Hansen B, de Lédinghen V2022-12-01FibroScan, Mortality, PBC, Prognosis, TransplantationJournal of hepatology
Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome.Efe C, Kulkarni AV, Terziroli Beretta-Piccoli B, Magro B, Stättermayer A, Cengiz M, Clayton-Chubb D, Lammert C, Bernsmeier C, Gül Ö, la Tijera FH, Anders M, Lytvyak E, Akın M, Purnak T, Liberal R, Peralta M, Ebik B, Duman S, Demir N, Balaban Y, Urzua Á, Contreras F, Venturelli MG, Bilgiç Y, Medina A, Girala M, Günşar F, Londoño MC, Androutsakos T, Kisch A, Yurci A, Güzelbulut F, Çağın YF, Avcı E, Akyıldız M, Dindar-Demiray EK, Harputluoğlu M, Kumar R, Satapathy SK, Mendizabal M, Silva M, Fagiuoli S, Roberts SK, Soylu NK, Idilman R, Yoshida EM, Montano-Loza AJ, Dalekos GN, Ridruejo E, Schiano TD, Wahlin S2022-12-01Hepatology (Baltimore, Md.)
Detailed stratified GWAS analysis for severe COVID-19 in four European populations.Degenhardt F, Ellinghaus D, Juzenas S, Lerga-Jaso J, Wendorff M, Maya-Miles D, Uellendahl-Werth F, ElAbd H, Rühlemann MC, Arora J, Özer O, Lenning OB, Myhre R, Vadla MS, Wacker EM, Wienbrandt L, Blandino Ortiz A, de Salazar A, Garrido Chercoles A, Palom A, Ruiz A, Garcia-Fernandez AE, Blanco-Grau A, Mantovani A, Zanella A, Holten AR, Mayer A, Bandera A, Cherubini A, Protti A, Aghemo A, Gerussi A, Ramirez A, Braun A, Nebel A, Barreira A, Lleo A, Teles A, Kildal AB, Biondi A, Caballero-Garralda A, Ganna A, Gori A, Glück A, Lind A, Tanck A, Hinney A, Carreras Nolla A, Fracanzani AL, Peschuck A, Cavallero A, Dyrhol-Riise AM, Ruello A, Julià A, Muscatello A, Pesenti A, Voza A, Rando-Segura A, Solier A, Schmidt A, Cortes B, Mateos B, Nafria-Jimenez B, Schaefer B, Jensen B, Bellinghausen C, Maj C, Ferrando C, de la Horra C, Quereda C, Skurk C, Thibeault C, Scollo C, Herr C, Spinner CD, Gassner C, Lange C, Hu C, Paccapelo C, Lehmann C, Angelini C, Cappadona C, Azuure C, Bianco C, Cea C, Sancho C, Hoff DAL, Galimberti D, Prati D, Haschka D, Jiménez D, Pestaña D, Toapanta D, Muñiz-Diaz E, Azzolini E, Sandoval E, Binatti E, Scarpini E, Helbig ET, Casalone E, Urrechaga E, Paraboschi EM, Pontali E, Reverter E, Calderón EJ, Navas E, Solligård E, Contro E, Arana-Arri E, Aziz F, Garcia F, García Sánchez F, Ceriotti F, Martinelli-Boneschi F, Peyvandi F, Kurth F, Blasi F, Malvestiti F, Medrano FJ, Mesonero F, Rodriguez-Frias F, Hanses F, Müller F, Hemmrich-Stanisak G, Bellani G, Grasselli G, Pezzoli G, Costantino G, Albano G, Cardamone G, Bellelli G, Citerio G, Foti G, Lamorte G, Matullo G, Baselli G, Kurihara H, Neb H, My I, Kurth I, Hernández I, Pink I, de Rojas I, Galván-Femenia I, Holter JC, Afset JE, Heyckendorf J, Kässens J, Damås JK, Rybniker J, Altmüller J, Ampuero J, Martín J, Erdmann J, Banales JM, Badia JR, Dopazo J, Schneider J, Bergan J, Barretina J, Walter J, Hernández Quero J, Goikoetxea J, Delgado J, Guerrero JM, Fazaal J, Kraft J, Schröder J, Risnes K, Banasik K, Müller KE, Gaede KI, Garcia-Etxebarria K, Tonby K, Heggelund L, Izquierdo-Sanchez L, Bettini LR, Sumoy L, Sander LE, Lippert LJ, Terranova L, Nkambule L, Knopp L, Gustad LT, Garbarino L, Santoro L, Téllez L, Roade L, Ostadreza M, Intxausti M, Kogevinas M, Riveiro-Barciela M, Berger MM, Schaefer M, Niemi MEK, Gutiérrez-Stampa MA, Carrabba M, Figuera Basso ME, Valsecchi MG, Hernandez-Tejero M, Vehreschild MJGT, Manunta M, Acosta-Herrera M, D'Angiò M, Baldini M, Cazzaniga M, Grimsrud MM, Cornberg M, Nöthen MM, Marquié M, Castoldi M, Cordioli M, Cecconi M, D'Amato M, Augustin M, Tomasi M, Boada M, Dreher M, Seilmaier MJ, Joannidis M, Wittig M, Mazzocco M, Ciccarelli M, Rodríguez-Gandía M, Bocciolone M, Miozzo M, Imaz Ayo N, Blay N, Chueca N, Montano N, Braun N, Ludwig N, Marx N, Martínez N, Cornely OA, Witzke O, Palmieri O, Faverio P, Preatoni P, Bonfanti P, Omodei P, Tentorio P, Castro P, Rodrigues PM, España PP, Hoffmann P, Rosenstiel P, Schommers P, Suwalski P, de Pablo R, Ferrer R, Bals R, Gualtierotti R, Gallego-Durán R, Nieto R, Carpani R, Morilla R, Badalamenti S, Haider S, Ciesek S, May S, Bombace S, Marsal S, Pigazzini S, Klein S, Pelusi S, Wilfling S, Bosari S, Volland S, Brunak S, Raychaudhuri S, Schreiber S, Heilmann-Heimbach S, Aliberti S, Ripke S, Dudman S, Wesse T, Zheng T, Bahmer T, Eggermann T, Illig T, Brenner T, Pumarola T, Feldt T, Folseraas T, Gonzalez Cejudo T, Landmesser U, Protzer U, Hehr U, Rimoldi V, Monzani V, Skogen V, Keitel V, Kopfnagel V, Friaza V, Andrade V, Moreno V, Albrecht W, Peter W, Poller W, Farre X, Yi X, Wang X, Khodamoradi Y, Karadeniz Z, Latiano A, Goerg S, Bacher P, Koehler P, Tran F, Zoller H, Schulte EC, Heidecker B, Ludwig KU, Fernández J, Romero-Gómez M, Albillos A, Invernizzi P, Buti M, Duga S, Bujanda L, Hov JR, Lenz TL, Asselta R, de Cid R, Valenti L, Karlsen TH, Cáceres M, Franke A2022-11-28Human molecular genetics
Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial.Leventogiannis K, Kyriazopoulou E, Antonakos N, Kotsaki A, Tsangaris I, Markopoulou D, Grondman I, Rovina N, Theodorou V, Antoniadou E, Koutsodimitropoulos I, Dalekos G, Vlachogianni G, Akinosoglou K, Koulouras V, Komnos A, Kontopoulou T, Prekates A, Koutsoukou A, van der Meer JWM, Dimopoulos G, Kyprianou M, Netea MG, Giamarellos-Bourboulis EJ2022-11-15ferritin, immunoparalysis, macrophage activation, monocytes, mortality, sepsisCell reports. Medicine
JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm.Al-Rifai R, Vandestienne M, Lavillegrand JR, Mirault T, Cornebise J, Poisson J, Laurans L, Esposito B, James C, Mansier O, Hirsch P, Favale F, Braik R, Knosp C, Vilar J, Rizzo G, Zernecke A, Saliba AE, Tedgui A, Lacroix M, Arrive L, Mallat Z, Taleb S, Diedisheim M, Cochain C, Rautou PE, Ait-Oufella H2022-11-03Nature communications
Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis.Cazzagon N, El Mouhadi S, Vanderbecq Q, Ferreira C, Finnegan S, Lemoinne S, Corpechot C, Chazouillères O, Arrivé L2022-11-013D, 3-dimensional, Cholestasis, ERCP, endoscopic retrograde cholangiopancreatography, HR, hazard ratio, IBD, inflammatory bowel disease, IHBD, intrahepatic bile duct, LSM, liver stiffness measurement, LT, liver transplantation, Liver stiffness, MR, magnetic resonance, MRCP+, MRCP, magnetic resonance cholangiopancreatography, MRI, magnetic resonance imaging, Magnetic resonance imaging, PSC, primary sclerosing cholangitis, Prognosis, VCTE, vibration-controlled transient elastographyJHEP reports : innovation in hepatology
A BCB4 variant is associated with hepatobiliary MR abnormalities in people with low-phospholipid-associated cholelithiasis syndrome.Biyoukar M, Corpechot C, El Mouhadi S, Chambenois E, Vanderbecq Q, Barbu V, Dong C, Lemoinne S, Tordjman M, Jomaah R, Chazouilleres O, Arrivé L2022-11-013D, 3-dimensional, ABCB4, ABCB4, ATP-binding-cassette subfamily B, member 4, Cholelithiasis, GGT, gamma-glutamyl transferase, LPAC, LPAC, low-phospholipid-associated cholelithiasis, MDR3, MDR3, multidrug resistance protein 3, MR, magnetic resonance, MRC, MR cholangiography, MRCP, MRI, magnetic resonance imaging, OR, odds ratio, PACS, picture archive and communication system, UDCA, ursodeoxycholic acid, US, ultrasound, Ursodesoxycholic acidJHEP reports : innovation in hepatology
Editorial: differences in altered duodenal T-cell immunology in alcoholic liver damage versus NAFLD.Francque SMA2022-11-01Alimentary pharmacology & therapeutics
Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis.Corpechot C2022-11-01Baveno criteria, Elastography, PBC, Prognosis, Serum fibrosis markers, VCTEClinics in liver disease
Genetics of Primary Biliary Cholangitis.Gerussi A, Asselta R, Invernizzi P2022-11-01Autoimmunity, Complex trait, GWAS, HLA, LiverClinics in liver disease
Role of ductular reaction and ductular-canalicular junctions in identifying severe primary biliary cholangitis.Overi D, Carpino G, Cristoferi L, Onori P, Kennedy L, Francis H, Zucchini N, Rigamonti C, Viganò M, Floreani A, D'Amato D, Gerussi A, Venere R, Alpini G, Glaser S, Alvaro D, Invernizzi P, Gaudio E, Cardinale V, Carbone M2022-11-01AE2, anion exchanger 2, ALP, alkaline phosphatase, ALPt0, ALP at diagnosis, ALPt12, ALP at 12 months after UDCA therapy, ALT, alanine aminotransferase, ALTt0, ALT at diagnosis, AMA, antimitochondrial antibody, ANA, antinuclear antibody, AST, aspartate aminotransferase, ASTt0, AST at diagnosis, BAC, bile acid control, BIL, bilirubin, BILt0, BIL at diagnosis, CA, cholangitis activity, CK19, cytokeratin 19, CK7, cytokeratin 7, Cholangiopathy, Cholestasis, DCJ, ductular–canalicular junction, DCJ/d, DCJ per ductule, DCJ/pt, DCJ per portal tract, DR, ductular reaction, EpCAM, epithelial cell adhesion molecule, GGT, gamma-glutamyl transferase, HA, hepatitis activity, HSC, hepatic stellate cell, Histology, IH, intermediate hepatocyte, Liver biopsy, MF, myofibroblast, Muc-1, mucin 1, PBC, primary biliary cholangitis, PCNA, proliferating cell nuclear antigen, RT-qPCR, real-time quantitative PCR, Regeneration, SCTR, secretin receptor, SQ, semiquantitative, UDCA, ursodeoxycholic acid, ULN, upper limit of normal, URS, UDCA response score, Ursodeoxycholic acid, WT, wild type, αSMA, α-smooth muscle actinJHEP reports : innovation in hepatology
Survey uncovering variations in the management of primary sclerosing cholangitis across Europe.Eliasson J, Lo B, Schramm C, Chazouilleres O, Folseraas T, Beuers U, Ytting H2022-11-01Primary sclerosing cholangitis, cholangiocarcinoma, gallbladder polyp, inflammatory bowel disease, surveillanceJHEP reports : innovation in hepatology
Hepatic venous pressure gradient in sinusoidal obstruction syndrome: diagnostic value and link with histological lesions.Gressens SB, Cazals-Hatem D, Lloyd V, Plessier A, Payancé A, Lebrec D, Durand F, Socie G, Valla D, Paradis V, Michonneau D, Rautou PE2022-11-01HSCT, hematopoietic stem cell transplantation, HVPG, hepatic venous pressure gradient, NPV, negative predictive value, PPV, positive predictive value, SOS, sinusoidal obstruction syndrome, ascites, jaundice, liver biopsy, portal hypertensionJHEP reports : innovation in hepatology
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid.de Veer RC, Harms MH, Corpechot C, Thorburn D, Invernizzi P, Janssen HLA, Battezzati PM, Nevens F, Lindor KD, Floreani A, Ponsioen CY, Mayo MJ, Parés A, Mason AL, Kowdley KV, Trivedi PJ, Hirschfield GM, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Lammers WJ, Hansen BE, van Buuren HR, van der Meer AJ2022-11-01GLOBE score, primary biliary cholangitis, second-line treatment, treatment responseAlimentary pharmacology & therapeutics
Reply to: "Correspondence on 'Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group'": Defining endpoints that guide treatment in autoimmune hepatitis.Snijders RJALM, Gevers TJG, Heneghan MA, Drenth JPH2022-11-01Journal of hepatology
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid.De Vincentis A, D'Amato D, Cristoferi L, Gerussi A, Malinverno F, Lleo A, Colapietro F, Marra F, Galli A, Fiorini C, Coco B, Brunetto M, Niro GA, Cotugno R, Saitta C, Cozzolongo R, Losito F, Giannini EG, Labanca S, Marzioni M, Marconi G, Morgando A, Pellicano R, Vanni E, Cazzagon N, Floreani A, Chessa L, Morelli O, Muratori L, Pellicelli A, Pompili M, Ponziani F, Tortora A, Rosina F, Russello M, Cannavò M, Simone L, Storato S, Viganò M, Abenavoli L, D'Antò M, De Gasperi E, Distefano M, Scifo G, Zolfino T, Calvaruso V, Cuccorese G, Palitti VP, Sacco R, Bertino G, Frazzetto E, Alvaro D, Mulinacci G, Palermo A, Scaravaglio M, Terracciani F, Galati G, Ronca V, Zuin M, Claar E, Izzi A, Picardi A, Invernizzi P, Vespasiani-Gentilucci U, Carbone M2022-11-01decision curve analysis, efficacy, liver decompensation, safety, total bilirubinLiver international : official journal of the International Association for the Study of the Liver
Portal fibroblasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis.Lei L, Bruneau A, El Mourabit H, Guégan J, Folseraas T, Lemoinne S, Karlsen TH, Hoareau B, Morichon R, Gonzalez-Sanchez E, Goumard C, Ratziu V, Charbord P, Gautheron J, Tacke F, Jaffredo T, Cadoret A, Housset C2022-11-01Hepatology (Baltimore, Md.)
Increased concentrations of conjugated bile acids are associated with osteoporosis in PSC patients.Stürznickel J, Behler-Janbeck F, Baranowsky A, Schmidt T, Schwinge D, John C, Lohse AW, Schramm C, Heeren J, Schinke T, Amling M2022-10-03Scientific reports
Prognosis of Children Undergoing Liver Transplantation: A 30-Year European Study.Baumann U, Karam V, Adam R, Fondevila C, Dhawan A, Sokal E, Jacquemin E, Kelly DA, Grabhorn E, Pawlowska J, D'Antiga L, Jara Vega P, Debray D, Polak WG, de Ville de Goyet J, Verkade HJ2022-10-01Pediatrics
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis.Efe C, Taşçılar K, Gerussi A, Bolis F, Lammert C, Ebik B, Stättermayer AF, Cengiz M, Gökçe DT, Cristoferi L, Peralta M, Massoumi H, Montes P, Cerda E, Rigamonti C, Yapalı S, Adali G, Çalışkan AR, Balaban Y, Eren F, Eşkazan T, Barutçu S, Lytvyak E, Zazueta GM, Kayhan MA, Heurgue-Berlot A, De Martin E, Yavuz A, Bıyık M, Narro GC, Duman S, Hernandez N, Gatselis NK, Aguirre J, Idilman R, Silva M, Mendizabal M, Atay K, Güzelbulut F, Dhanasekaran R, Montano-Loza AJ, Dalekos GN, Ridruejo E, Invernizzi P, Wahlin S2022-10-01Autoimmunity, Breakthrough infection, Immunosuppression, Liver failure, VaccineJournal of autoimmunity
Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease.Kong Y, Lv T, Li M, Zhao L, Meng T, Wu S, Wei W, Zhang Q, Chen S, You H, Lens S, Yoshiji H, Francque S, Tsochatzis E, Sarin SK, Mandorfer M, Jia J2022-10-01Advanced chronic liver disease, Antiviral therapy, Meta-analysis, Systematic reviewHepatology international
Acute Hepatitis of Unknown Etiology Among Young Children: Research Agenda by the ESPGHAN Hepatology Committee.Indolfi G, Czubkowski P, Fitzpatrick E, Gonzales E, Gupte G, Mancell S, Mozer-Glassberg Y, Nicastro E, Norman J, Stephenne X, Zellos A, Samyn M2022-10-01Journal of pediatric gastroenterology and nutrition
Efficacy and Safety of Endoscopic Primary Prophylaxis of Bleeding in Children With High-Risk Gastroesophageal Varices.Ackermann O, Darmellah-Remil A, Bernard O, Boytchev I, Staiti G, Gonzalès E, Jacquemin E, Duché M2022-10-01Journal of pediatric gastroenterology and nutrition
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis.Gerussi A, Verda D, Cappadona C, Cristoferi L, Bernasconi DP, Bottaro S, Carbone M, Muselli M, Invernizzi P, Asselta R, On Behalf Of The Italian Pbc Genetics Study Group2022-09-26autoimmunity, explainable artificial intelligence, genome-wide association study, genomics, liver, machine learning, precision medicine, primary biliary cholangitis, risk stratificationJournal of personalized medicine
Recent advances in the diagnosis and management of autoimmune hepatitis.Dalekos GN, Samakidou A, Lyberopoulou A, Banakou E, Gatselis NK2022-09-26Polish archives of internal medicine
In Vitro Rescue of the Bile Acid Transport Function of ABCB11 Variants by CFTR Potentiators.Mareux E, Lapalus M, Ben Saad A, Zelli R, Lakli M, Riahi Y, Almes M, Banet M, Callebaut I, Decout JL, Falguières T, Jacquemin E, Gonzales E2022-09-15ABC transporter, BSEP, VX-770, cholestasis, pediatrics, potentiatorInternational journal of molecular sciences
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence?Lacetera R, Roggero L, Vercelloni P, Uzzo M, Carbone M, Invernizzi P, L'Imperio V, Pieruzzi F, Sinico RA2022-09-01AA amyloidosis, Nephrotic syndrome, Primary sclerosing cholangitisCase reports in nephrology and dialysis
Acute non-A, non-B, non-C hepatitis differences and similarities between hepatitis E virus infection and autoimmune hepatitis, with phylogenetic analysis of hepatitis E virus in humans and wild boars.Zachou K, Azariadis K, Sofia M, Lyberopoulou A, Arvaniti P, Gatselis N, Spyrou V, Billinis C, Dalekos GN2022-09-01Hepatitis E virus, acute autoimmune hepatitis, genotyping, wild boarsAnnals of gastroenterology
Impact of thiopurines and tumour necrosis factor antagonists on primary sclerosing cholangitis outcomes in patients with inflammatory bowel disease.Biron A, Beaugerie L, Chazouillères O, Kirchgesner J2022-09-01anti-TNF, biliary tract cancer, inflammatory bowel disease, primary sclerosing cholangitis, thiopurinesAlimentary pharmacology & therapeutics
Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.Thompson RJ, Arnell H, Artan R, Baumann U, Calvo PL, Czubkowski P, Dalgic B, D'Antiga L, Durmaz Ö, Fischler B, Gonzalès E, Grammatikopoulos T, Gupte G, Hardikar W, Houwen RHJ, Kamath BM, Karpen SJ, Kjems L, Lacaille F, Lachaux A, Lainka E, Mack CL, Mattsson JP, McKiernan P, Özen H, Rajwal SR, Roquelaure B, Shagrani M, Shteyer E, Soufi N, Sturm E, Tessier ME, Verkade HJ, Horn P2022-09-01The lancet. Gastroenterology & hepatology
[Hepatic granuloma-A diagnostic challenge].Horst LJ, Weidemann S, Lohse AW, Sebode M2022-09-01Hepatic sarcoidosis, Liver biopsy, Liver parenchymal damage, Liver values, Primary biliary cholangitisZeitschrift fur Rheumatologie
Standardizing the histological assessment of late posttransplantation biopsies from pediatric liver allograft recipients.Hübscher SG, Feng S, Gouw ASH, Haga H, Kang HJ, Kelly DA, Komuta M, Lesniak A, Popp BA, Verkade HJ, Yu E, Demetris AJ2022-09-01Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Reply.Valainathan SR, Rautou PE2022-09-01Hepatology (Baltimore, Md.)
Primary biliary cholangitis: perception and expectation of illness.Floreani A, Scaffidi M, Coco B, Giannini EG, Labanca S, Bonaiuto E, De Martin S, Invernizzi P, Carbone M, Alvaro D, Bragazzi MC, Calvaruso V, Cossiga V, Cazzagon N2022-09-01Illness perception, PBC, Quality of life, QuestionnaireDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Complement C3 inhibition in severe COVID-19 using compstatin AMY-101.Skendros P, Germanidis G, Mastellos DC, Antoniadou C, Gavriilidis E, Kalopitas G, Samakidou A, Liontos A, Chrysanthopoulou A, Ntinopoulou M, Kogias D, Karanika I, Smyrlis A, Cepaityte D, Fotiadou I, Zioga N, Mitroulis I, Gatselis NK, Papagoras C, Metallidis S, Milionis H, Dalekos GN, Willems L, Persson B, Manivel VA, Nilsson B, Connolly ES, Iacobelli S, Papadopoulos V, Calado RT, Huber-Lang M, Risitano AM, Yancopoulou D, Ritis K, Lambris JD2022-08-19Science advances
Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency.Strnad P, Mandorfer M, Choudhury G, Griffiths W, Trautwein C, Loomba R, Schluep T, Chang T, Yi M, Given BD, Hamilton JC, San Martin J, Teckman JH2022-08-11The New England journal of medicine
Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction.Artru F, Vietti-Violi N, Sempoux C, Vieira Barbosa J, Becce F, Sah N, Marot A, Deltenre P, Moschouri E, Fraga M, Hocquelet A, Duran R, Moradpour D, Rautou PE, Denys A2022-08-01CNC-EHPVO, chronic noncirrhotic extrahepatic portal vein obstruction, Chronic non-cirrhotic extrahepatic portal vein obstruction (CNC-EHPVO), DICOM, digital imaging and communications in medicine, EHPVO, extrahepatic portal vein obstruction, Gastrointestinal bleeding, HE, hepatic encephalopathy, L3, lumbar 3, L3SMI, skeletal muscle index at L3, L4, lumbar 4, NFH, non-fractioned heparin, PVR, portal vein recanalisation, Portal cholangiopathy, Portal hypertension, Portal vein recanalisation, SMI, skeletal muscle index, SMV, superior mesenteric vein, SV, splenic vein, Sarcopenia, TIPS, transjugular intrahepatic portosystemic shunt, TPMA, total psoas muscle area, US, ultrasoundJHEP reports : innovation in hepatology
HERACLIS-TAF: a multi-centre prospective cohort study on 2-year safety and efficacy of tenofovir alafenamide in patients with chronic hepatitis B with renal and/or bone disorders or risks.Papatheodoridis GV, Mimidis K, Manolakopoulos S, Gatselis N, Goulis J, Kapatais A, Manesis E, Vasiliadis T, Triantos C, Samonakis D, Sevastianos V, Karatapanis S, Elefsiniotis I, Deutsch M, Mylopoulou T, Papatheodoridi M, Kranidioti H, Agorastou P, Karaoulani T, Kyriazidou A, Zisimopoulos K, Dalekos GN2022-08-01Alimentary pharmacology & therapeutics
Children with autoimmune liver disease have limited access to age-appropriate drug formulations, results from a European survey.Jørgensen MH, Cananzi M, Buescher G, Samyn M, De Bruyne R2022-08-01Liver, autoimmune liver disease, children, drug formulations, hepatitis, medications, paediatric, pharmacologyJournal of hepatology
Impact of the new definition of metabolic dysfunction-associated fatty liver disease on detection of significant liver fibrosis in US adolescents.Ciardullo S, Carbone M, Invernizzi P, Perseghin G2022-08-01Hepatology communications
Contrast-enhanced CT and liver surface nodularity for the diagnosis of porto-sinusoidal vascular disorder: A case-control study.Valainathan SR, Sartoris R, Elkrief L, Magaz M, Betancourt F, Pellegrino S, Nivolli A, Dioguardi Burgio M, Flattet Y, Terraz S, Drilhon N, Lazareth M, Herrou J, Bruno O, Payance A, Plessier A, Durand F, Ronot M, Valla DC, Paradis V, Garcia-Pagan JC, Vilgrain V, Rautou PE2022-08-01Hepatology (Baltimore, Md.)
International registry of congenital porto-systemic shunts: a multi-centre, retrospective and prospective registry of neonates, children and adults with congenital porto-systemic shunts.Korff S, Mostaguir K, Beghetti M, D'Antiga L, Debray D, Franchi-Abella S, Gonzales E, Guerin F, Hachulla AL, Lambert V, Makrythanasis P, Roduit N, Savale L, Senat MV, Spaltenstein J, van Steenbeek F, Wildhaber BE, Zwahlen M, McLin VA2022-07-19Congenital, Liver, Portosystemic, Rare disease, Registry, ShuntOrphanet journal of rare diseases
Tolerance and autoimmunity in the liver.Schramm C, Oo YH, Lohse AW2022-07-01Seminars in immunopathology
Imaging-guided interventions modulating portal venous flow: Evidence and controversies.Cannella R, Tselikas L, Douane F, Cauchy F, Rautou PE, Duran R, Ronot M2022-07-01ALPPS, associating liver partition and portal vein ligation for staged hepatectomy, BSG, British Society of Gastroenterology, EASL, European Association for the Study of the Liver, FLR, future liver remnant, HE, hepatic encephalopathy, NCBA, N-butyl cyanoacrylate, PH, portal hypertension, PVE, portal vein embolisation, PVR, portal vein recanalisation, Portal vein interventions, RCT, randomised controlled trial, TACE, trans-arterial chemoembolization, TIPS, transjugular intrahepatic portosystemic shunt, image guided, portal hypertension, portal vein embolization, portal vein recanalization, transjugular intrahepatic portosystemic shuntJHEP reports : innovation in hepatology
Review article: vascular effects of PPARs in the context of NASH.Guixé-Muntet S, Biquard L, Szabo G, Dufour JF, Tacke F, Francque S, Rautou PE, Gracia-Sancho J2022-07-01Alimentary pharmacology & therapeutics
Histological spectrum of autoimmune hepatitis-reply to Fujiwara K. et al.Sebode M, Lohse AW, Hübscher SG, Tiniakos D2022-07-01Liver international : official journal of the International Association for the Study of the Liver
Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" study.Jachs M, Schwarz C, Panzer M, Binter T, Aberle SW, Hartl L, Dax K, Aigner E, Stättermayer AF, Munda P, Graziadei I, Holzmann H, Trauner M, Zoller H, Gschwantler M, Mandorfer M, Reiberger T, Ferenci P2022-07-01Alimentary pharmacology & therapeutics
Autoimmune hepatitis and COVID-19: No increased risk for AIH after vaccination but reduced care.Rüther DF, Weltzsch JP, Schramm C, Sebode M, Lohse AW2022-07-01Autoimmune hepatitis, COVID-19 vaccination, OrphanetJournal of hepatology
Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation.Montano-Loza AJ, Ronca V, Ebadi M, Hansen BE, Hirschfield G, Elwir S, Alsaed M, Milkiewicz P, Janik MK, Marschall HU, Burza MA, Efe C, Calışkan AR, Harputluoglu M, Kabaçam G, Terrabuio D, de Quadros Onofrio F, Selzner N, Bonder A, Parés A, Llovet L, Akyıldız M, Arikan C, Manns MP, Taubert R, Weber AL, Schiano TD, Haydel B, Czubkowski P, Socha P, Ołdak N, Akamatsu N, Tanaka A, Levy C, Martin EF, Goel A, Sedki M, Jankowska I, Ikegami T, Rodriguez M, Sterneck M, Weiler-Normann C, Schramm C, Donato MF, Lohse A, Andrade RJ, Patwardhan VR, van Hoek B, Biewenga M, Kremer AE, Ueda Y, Deneau M, Pedersen M, Mayo MJ, Floreani A, Burra P, Secchi MF, Beretta-Piccoli BT, Sciveres M, Maggiore G, Jafri SM, Debray D, Girard M, Lacaille F, Lytvyak E, Mason AL, Heneghan M, Oo YH2022-07-01autoimmune liver disease, graft survival, liver transplantation, recurrent disease, survivalJournal of hepatology
Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases.Baiges A, Cerda E, Amicone C, Téllez L, Alvarado-Tapias E, Puente A, Fortea JI, Llop E, Rocha F, Orts L, Ros-Fargas O, Vizcarra P, Zekrini K, Lounes OA, Touati G, Jiménez-Esquivel N, Serrano MJ, Falgà A, Magaz M, Olivas P, Betancourt F, Perez-Campuzano V, Turon F, Payancé A, Goria O, Rautou PE, Hernández-Gea V, Villanueva C, Albillos A, Plessier A, García-Pagán JC2022-07-01Budd Chiari Syndrome, COVID-19, Portosinusoidal Vascular Disease, SARS-CoV-2, Splanchnic Vein Thrombosis, Vascular Liver DiseasesClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
The Increasing Incidence of Neuroendocrine Neoplasms Worldwide: Current Knowledge and Open Issues.Rossi RE, Massironi S2022-06-30Journal of clinical medicine
The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities.Binatti E, Gerussi A, Barisani D, Invernizzi P2022-06-14Kupffer cells, drug delivery, fibrosis, inflammation, liver fibrosis, macrophages, targeted therapiesInternational journal of molecular sciences
Hepcidin as a Sensitive and Treatment-Responsive Acute-Phase Marker in Patients with Bacteremia: A Pilot Study.Koukoulas K, Lygoura V, Kartalidis P, Gatselis NK, Petinaki E, Dalekos GN, Simos G2022-06-06CRP, acute phase marker, bacteremia, ferritin, hepcidinDiagnostics (Basel, Switzerland)
Modern therapeutic approaches to liver-related disorders.Gardin A, Remih K, Gonzales E, Andersson ER, Strnad P2022-06-01gene addition, gene editing, gene silencing, gene therapy, liver disease, monogenic defectsJournal of hepatology
Breakthroughs in therapies for NASH and remaining challenges.Ratziu V, Francque S, Sanyal A2022-06-01artificial intelligence, cirrhosis, diabetes, digital pathology, fibrosis, hepatocellular carcinoma, non-invasive diagnosis, obesity, randomized controlled trials, steatohepatitis, trial end-pointsJournal of hepatology
Systematic review-pancreatic involvement in inflammatory bowel disease.Massironi S, Fanetti I, Viganò C, Pirola L, Fichera M, Cristoferi L, Capurso G, Invernizzi P, Danese S2022-06-01Alimentary pharmacology & therapeutics
Altered DNA methylation pattern characterizes the peripheral immune cells of patients with autoimmune hepatitis.Zachou K, Arvaniti P, Lyberopoulou A, Sevdali E, Speletas M, Ioannou M, Koukoulis GK, Renaudineau Y, Dalekos GN2022-06-01DNA methylation, DNA-methyltransferases, autoimmune hepatitis, epigenetics, epigenome-wide association studiesLiver international : official journal of the International Association for the Study of the Liver
Targeted-Capture Next-Generation Sequencing in Diagnosis Approach of Pediatric Cholestasis.Almes M, Spraul A, Ruiz M, Girard M, Roquelaure B, Laborde N, Gottrand F, Turquet A, Lamireau T, Dabadie A, Bonneton M, Thebaut A, Rohmer B, Lacaille F, Broué P, Fabre A, Mention-Mulliez K, Bouligand J, Jacquemin E, Gonzales E2022-05-07Alagille syndrome, NGS, PFIC, children, genetic cholestasis, neonatal sclerosing cholangitis, transient neonatal cholestasisDiagnostics (Basel, Switzerland)
Severe acute hepatitis and acute liver failure of unknown origin in children: a questionnaire-based study within 34 paediatric liver centres in 22 European countries and Israel, April 2022.de Kleine RH, Lexmond WS, Buescher G, Sturm E, Kelly D, Lohse AW, Lenz D, Hørby Jørgensen M2022-05-01acute liver failure, hepatitis, liver transplantation, paediatric, virusEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Hepatitis C virus infection and diabetes: A complex bidirectional relationship.Ciardullo S, Mantovani A, Ciaccio A, Carbone M, Invernizzi P, Perseghin G2022-05-01Cirrhosis, DAA, Diabetes, HCVDiabetes research and clinical practice
X marks the spot in autoimmunity.Gerussi A, Caime C, Binatti E, Cappadona C, Cristoferi L, Asselta R, Gershwin ME, Invernizzi P2022-05-01Autoimmune diseases, X-chromosome inactivation, autoimmunity, escape from X-chromosome inactivation, mammalian evolution, sex bias, sex chromosomesExpert review of clinical immunology
Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology.Lohse AW, Sebode M, Bhathal PS, Clouston AD, Dienes HP, Jain D, Gouw ASH, Guindi M, Kakar S, Kleiner DE, Krech T, Lackner C, Longerich T, Saxena R, Terracciano L, Washington K, Weidemann S, Hübscher SG, Tiniakos D2022-05-01autoimmune hepatitis, histology, lobular hepatitis, portal hepatitisLiver international : official journal of the International Association for the Study of the Liver
Spontaneous evolution patterns of focal congenital hepatic hemangiomas: a case series of 25 patients.Rutten C, Ladarre D, Ackermann O, Gonzales E, Guettier C, Franchi-Abella S2022-05-01Children, Congenital hepatic hemangioma, Hemangioma, Infants, Liver, UltrasonographyPediatric radiology
A Model for Early Endoscopic Detection of High-Risk Gastroesophageal Varices in Children With Biliary Atresia.Ackermann O, de Boissieu P, Bernard O, Gonzales E, Jacquemin E, Duché M2022-05-01Journal of pediatric gastroenterology and nutrition
The Role of Epigenetics in Primary Biliary Cholangitis.Gerussi A, Paraboschi EM, Cappadona C, Caime C, Binatti E, Cristoferi L, Asselta R, Invernizzi P2022-04-28autoimmunity, chromosome X, non-coding RNA, sex bias, somatic mosaicismInternational journal of molecular sciences
Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma.Hobeika C, Guyard C, Sartoris R, Maino C, Rautou PE, Dokmak S, Bouattour M, Durand F, Weiss E, Vilgrain V, Beaufrère A, Sepulveda A, Farges O, Paradis V, Luciani A, Lim C, Sommacale D, Scatton O, Laurent A, Nault JC, Soubrane O, Ronot M, Cauchy F2022-04-19The British journal of surgery
Soluble IL-2R Levels at Baseline Predict the Development of Severe Respiratory Failure and Mortality in COVID-19 Patients.Gatselis NK, Lygoura V, Lyberopoulou A, Giannoulis G, Samakidou A, Vaiou A, Vatidis G, Antoniou K, Stefos A, Georgiadou S, Sagris D, Sveroni D, Stergioula D, Gabeta S, Ntaios G, Dalekos GN2022-04-10biomarker, coronavirus disease-19, soluble interleukin-2 receptorViruses
SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease.Duengelhoef P, Hartl J, Rüther D, Steinmann S, Brehm TT, Weltzsch JP, Glaser F, Schaub GM, Sterneck M, Sebode M, Weiler-Normann C, Addo MM, Lütgehetmann M, Haag F, Schramm C, Schulze Zur Wiesch J, Lohse AW2022-04-01SARS-CoV-2 vaccination, autoimmune hepatitis, chronic liver disease, immunosuppression, primary biliary cholangitis, primary sclerosing cholangitisUnited European gastroenterology journal
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group.Pape S, Snijders RJALM, Gevers TJG, Chazouilleres O, Dalekos GN, Hirschfield GM, Lenzi M, Trauner M, Manns MP, Vierling JM, Montano-Loza AJ, Lohse AW, Schramm C, Drenth JPH, Heneghan MA2022-04-01autoimmune hepatitis, complete biochemical response, endpoints, insufficient response, intolerance, non-response, remissionJournal of hepatology
Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complications.Plessier A, Esposito-Farèse M, Baiges A, Shukla A, Garcia Pagan JC, De Raucourt E, Ollivier-Hourmand I, Cervoni JP, De Ledinghen V, Tazi Z, Nousbaum JB, Bun R, Bureau C, Silvain C, Tournilhac O, Gerfaud-Valentin M, Durand F, Goria O, Tellez L, Albillos A, Gioia S, Riggio O, De Gottardi A, Payance A, Rautou PE, Terriou L, Charbonnier A, Elkrief L, de la Tour RP, Valla DC, Gault N, de Fontbrune FS2022-04-01American journal of hematology
Alpha-1 antitrypsin deficiency: A re-surfacing adult liver disorder.Fromme M, Schneider CV, Trautwein C, Brunetti-Pierri N, Strnad P2022-04-01Fibroscan, Pi∗S, Pi∗Z, SERPINA1, liver cirrhosis, liver fibrosisJournal of hepatology
Characterization and Pharmacological Validation of a Preclinical Model of NASH in Göttingen Minipigs.Duvivier V, Creusot S, Broux O, Helbert A, Lesage L, Moreau K, Lesueur N, Gerard L, Lemaitre K, Provost N, Hubert EL, Baltauss T, Brzustowski A, De Preville N, Geronimi J, Adoux L, Letourneur F, Hammoutene A, Valla D, Paradis V, Delerive P2022-03-01CDAHFD, choline-deficient amino acid-defined high fat diet, FDR, false discovery rate, FFC, fatfructose cholesterol diet, NAFLD, nonalcoholic fatty liver disease, NAS, NAFLD activity score, NASH, NASH, nonalcoholic steatohepatitis, PNPLA3, patatin-like phospholipase domain-containing 3, minipig, translational valueJournal of clinical and experimental hepatology
Proceedings of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition Monothematic Conference, 2020: "Acute Liver Failure in Children": Treatment and Directions for Future Research.Zellos A, Debray D, Indolfi G, Czubkowski P, Samyn M, Hadzic N, Gupte G, Fischler B, Smets F, Clément de Cléty S, Grenda R, Mozer Y, Mancell S, Jahnel J, Auzinger G, Worth A, Lisman T, Staufner C, Baumann U, Dhawan A, Alonso E, Squires RH, Verkade HJ2022-03-01Journal of pediatric gastroenterology and nutrition
Proceedings of ESPGHAN Monothematic Conference 2020: "Acute Liver Failure in Children": Diagnosis and Initial Management.Zellos A, Debray D, Indolfi G, Czubkowski P, Samyn M, Hadzic N, Gupte G, Fischler B, Smets F, de Cléty SC, Grenda R, Mozer Y, Mancell S, Jahnel J, Auzinger G, Worth A, Lisman T, Staufner C, Baumann U, Dhawan A, Alonso E, Squires RH, Verkade HJ2022-03-01Journal of pediatric gastroenterology and nutrition
Corrigendum to "ATP7B variant spectrum in a French pediatric Wilson disease cohort" [Eur. J. Med. Genet. 64 (10) (October 2021) 104305].Couchonnal E, Bouchard S, Sandahl TD, Pagan C, Lion-François L, Guillaud O, Habes D, Debray D, Lamireau T, Broué P, Fabre A, Vanlemmens C, Sobesky R, Gottrand F, Bridoux-Henno L, Belmalih A, Poujois A, Collet C, Francou B, Brunet AS, Lachaux A, Misrahi M, Bost M2022-03-01European journal of medical genetics
Machine learning in primary biliary cholangitis: A novel approach for risk stratification.Gerussi A, Verda D, Bernasconi DP, Carbone M, Komori A, Abe M, Inao M, Namisaki T, Mochida S, Yoshiji H, Hirschfield G, Lindor K, Pares A, Corpechot C, Cazzagon N, Floreani A, Marzioni M, Alvaro D, Vespasiani-Gentilucci U, Cristoferi L, Valsecchi MG, Muselli M, Hansen BE, Tanaka A, Invernizzi P2022-03-01artificial intelligence, autoimmune liver disease, cluster analysis, prognosisLiver international : official journal of the International Association for the Study of the Liver
Comparison of Transient Elastography, ShearWave Elastography, Magnetic Resonance Elastography and FibroTest as routine diagnostic markers for assessing liver fibrosis in children with Cystic Fibrosis.Dana J, Girard M, Franchi-Abella S, Berteloot L, Benoit-Cherifi M, Imbert-Bismut F, Sermet-Gaudelus I, Debray D2022-03-01Children, Cystic fibrosis liver disease, Elastography, Liver stiffnessClinics and research in hepatology and gastroenterology
Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature.Gemelli M, Carbone M, Abbate MI, Mancin M, Zucchini N, Colonese F, Invernizzi P, Bidoli P, Cortinovis D2022-03-01immune-related adverse events, immune-related hepatitis, immunotherapy, lung cancer, pembrolizumab, vanishing bile duct syndromeImmunotherapy
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis.Efe C, Lammert C, Taşçılar K, Dhanasekaran R, Ebik B, Higuera-de la Tijera F, Calışkan AR, Peralta M, Gerussi A, Massoumi H, Catana AM, Purnak T, Rigamonti C, Aldana AJG, Khakoo N, Nazal L, Frager S, Demir N, Irak K, Melekoğlu-Ellik Z, Kacmaz H, Balaban Y, Atay K, Eren F, Alvares-da-Silva MR, Cristoferi L, Urzua Á, Eşkazan T, Magro B, Snijders R, Barutçu S, Lytvyak E, Zazueta GM, Demirezer-Bolat A, Aydın M, Heurgue-Berlot A, De Martin E, Ekin N, Yıldırım S, Yavuz A, Bıyık M, Narro GC, Kıyıcı M, Akyıldız M, Kahramanoğlu-Aksoy E, Vincent M, Carr RM, Günşar F, Reyes EC, Harputluoğlu M, Aloman C, Gatselis NK, Üstündağ Y, Brahm J, Vargas NCE, Güzelbulut F, Garcia SR, Aguirre J, Anders M, Ratusnu N, Hatemi I, Mendizabal M, Floreani A, Fagiuoli S, Silva M, Idilman R, Satapathy SK, Silveira M, Drenth JPH, Dalekos GN, N Assis D, Björnsson E, Boyer JL, Yoshida EM, Invernizzi P, Levy C, Montano-Loza AJ, Schiano TD, Ridruejo E, Wahlin S2022-03-01SARS-CoV-2, autoimmunity, azathioprine, budesonide, liver transplantation, mercaptopurineLiver international : official journal of the International Association for the Study of the Liver
Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: A case control study from the prospective COVID-ICU database.Giabicani M, Le Menestrel A, Roux O, Rautou PE, Weiss E2022-03-01Journal of hepatology
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules.Stravalaci M, Pagani I, Paraboschi EM, Pedotti M, Doni A, Scavello F, Mapelli SN, Sironi M, Perucchini C, Varani L, Matkovic M, Cavalli A, Cesana D, Gallina P, Pedemonte N, Capurro V, Clementi N, Mancini N, Invernizzi P, Bayarri-Olmos R, Garred P, Rappuoli R, Duga S, Bottazzi B, Uguccioni M, Asselta R, Vicenzi E, Mantovani A, Garlanda C2022-02-01Nature immunology
Vasoconstrictor antagonism improves functional and structural vascular alterations and liver damage in rats with early NAFLD.van der Graaff D, Chotkoe S, De Winter B, De Man J, Casteleyn C, Timmermans JP, Pintelon I, Vonghia L, Kwanten WJ, Francque S2022-02-01ALT, alanine aminotransferase, ARB, angiotensin receptor blocker, AST, aspartate aminotransferase, ATII, angiotensin II, COX, cyclooxygenase, ET, endothelin, HFHFD, high-fat high-fructose diet, IHVR, intrahepatic vascular resistance, Jak2, Janus-kinase-2, MCD, methionine-choline deficient diet, Mx, methoxamine, NAFLD, non-alcoholic fatty liver disease, NASH, non-alcoholic steatohepatitis, NO, nitric oxide, PP, portal pressure, PR, pulse rate, SEM, scanning electron microscopy, TBW, total body weight, TEM, transmission electron microscopy, TXAS, thromboxane synthase, TxA2, thromboxane A2, ZFR, Zucker fatty rats, angiotensin II, endothelin-1, non-alcoholic fatty liver disease, portal hypertension, thromboxane A2, transhepatic pressure gradientJHEP reports : innovation in hepatology
Advances in genetic, epigenetic and environmental aspects of rare liver diseases.Andersson ER, Lohse AW2022-02-01European journal of medical genetics
Corrigendum to 'An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs' [J Hepatol 2021;75(3):572-581].Cordell HJ, Fryett JJ, Ueno K, Darlay R, Aiba Y, Hitomi Y, Kawashima M, Nishida N, Khor SS, Gervais O, Kawai Y, Nagasaki M, Tokunaga K, Tang R, Shi Y, Li Z, Juran BD, Atkinson EJ, Gerussi A, Carbone M, Asselta R, Cheung A, de Andrade M, Baras A, Horowitz J, Ferreira MAR, Sun D, Jones DE, Flack S, Spicer A, Mulcahy VL, Byun J, Han Y, Sandford RN, Lazaridis KN, Amos CI, Hirschfield GM, Seldin MF, Invernizzi P, Siminovitch KA, Ma X, Nakamura M, Mells GF2022-02-01Journal of hepatology
Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis.Burghart L, Halilbasic E, Schwabl P, Simbrunner B, Stättermayer AF, Petrenko O, Scheiner B, Bauer D, Pinter M, Boztug K, Mandorfer M, Trauner M, Reiberger T2022-02-01CSPH, Decompensation, Elastography, PBC, Portal hypertensionJournal of gastroenterology
Galaxy Is a Suitable Bioinformatics Platform for the Molecular Diagnosis of Human Genetic Disorders Using High-Throughput Sequencing Data Analysis: Five Years of Experience in a Clinical Laboratory.Chappell K, Francou B, Habib C, Huby T, Leoni M, Cottin A, Nadal F, Adnet E, Paoli E, Oliveira C, Verstuyft C, Davit-Spraul A, Gaignard P, Lebigot E, Duclos-Vallee JC, Young J, Kamenicky P, Adams D, Echaniz-Laguna A, Gonzales E, Bouvattier C, Linglart A, Picard V, Bergoin E, Jacquemin E, Guiochon-Mantel A, Proust A, Bouligand J2022-02-01bioinformatics, clinical genomics and molecular biology, next-generation sequencing data analysisClinical chemistry
The mode of dexamethasone decoration influences avidin-nucleic-acid-nano-assembly organ biodistribution and in vivo drug persistence.Ongaro A, Violatto MB, Casarin E, Pellerani I, Marchini G, Ribaudo G, Salmona M, Carbone M, Passoni A, Gnodi E, Schiavon E, Mattarei A, Barisani D, Invernizzi P, Bigini P, Morpurgo M2022-02-01ANANAS, Autoimmune liver disease, Dexamethasone, Liver disease, Liver targeting, NanomedicineNanomedicine : nanotechnology, biology, and medicine
SARS-CoV-2 in Pediatric Liver Transplant Recipients: The European Experience.Buescher G, Sebode M, Marjot T, Webb GJ, Moon AM, Barnes E, Barritt AS, Cananzi M, Lohse AW, Jørgensen MH, McLin V2022-02-01Journal of pediatric gastroenterology and nutrition
Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency.Fromme M, Schneider CV, Pereira V, Hamesch K, Pons M, Reichert MC, Benini F, Ellis P, H Thorhauge K, Mandorfer M, Burbaum B, Woditsch V, Chorostowska-Wynimko J, Verbeek J, Nevens F, Genesca J, Miravitlles M, Nuñez A, Schaefer B, Zoller H, Janciauskiene S, Abreu N, Jasmins L, Gaspar R, Liberal R, Macedo G, Mahadeva R, Gomes C, Schneider KM, Trauner M, Krag A, Gooptu B, Thorburn D, Marshall A, Hurst JR, Lomas DA, Lammert F, Gaisa NT, Clark V, Griffiths W, Trautwein C, Turner AM, McElvaney NG, Strnad P2022-02-01cancer, fibrosis, liver, liver cirrhosisGut
Impact of muscle mass on the prognosis of liver transplantation for infants with biliary atresia.Lledín MD, Parrón-Pajares M, Morais A, Hernández-Oliveros F, Botella-Carretero JI, Hierro L2022-01-01biliary atresia, infants, liver transplant, muscle mass, pediatrics, sarcopeniaFrontiers in pediatrics
Artificial intelligence for precision medicine in autoimmune liver disease.Gerussi A, Scaravaglio M, Cristoferi L, Verda D, Milani C, De Bernardi E, Ippolito D, Asselta R, Invernizzi P, Kather JN, Carbone M2022-01-01autoimmunity, deep learning, digital pathology, genomics, machine learning, population genetics, radiomics, whole-slide digital image analysisFrontiers in immunology
Case report: Huppke-Brendel syndrome in an adult, mistaken for and treated as Wilson disease for 25 years.Kirk FT, Munk DE, Ek J, Birk Møller L, Bendixen Thorup M, Hvid Danielsen E, Vilstrup H, Ott P, Damgaard Sandahl T2022-01-01Huppke-Brendel syndrome, SLC33A1, Wilson disease, case report, copper, neurology, rare diseaseFrontiers in neurology
New insights on the role of human leukocyte antigen complex in primary biliary cholangitis.Mulinacci G, Palermo A, Gerussi A, Asselta R, Gershwin ME, Invernizzi P2022-01-01HLA haplotypes, genetics, human leukocyte antigens complex, immunotolerance, primary biliary cholangitisFrontiers in immunology
Clinical and Endoscopic Outcomes in Coronavirus Disease-2019 Patients With Gastrointestinal Bleeding.Ashktorab H, Russo T, Oskrochi G, Latella G, Massironi S, Luca M, Chirumamilla LG, Laiyemo AO, Brim H2022-01-01ACE2, angiotensin-converting enzyme 2, COVID-19, coronavirus disease–2019, Coronavirus Disease-19, EGD, esophagogastroduodenoscopy, Endoscopy, GI, gastrointestinal, GIB, gastrointestinal bleeding, Gastrointestinal Bleeding, Hematemesis, ICU, intensive care unit, Melena, UGIB, upper GIBGastro hep advances
An update on novel pharmacological agents for primary sclerosing cholangitis.Gallo C, Howardson BO, Cristoferi L, Carbone M, Gershwin ME, Invernizzi P2022-01-01Primary sclerosing cholangitis, anti-inflammatory agents, antibiotics, bile acids, fecal microbiota transplantation, gut–liver axisExpert opinion on therapeutic targets
The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality.Karlsen TH, Sheron N, Zelber-Sagi S, Carrieri P, Dusheiko G, Bugianesi E, Pryke R, Hutchinson SJ, Sangro B, Martin NK, Cecchini M, Dirac MA, Belloni A, Serra-Burriel M, Ponsioen CY, Sheena B, Lerouge A, Devaux M, Scott N, Hellard M, Verkade HJ, Sturm E, Marchesini G, Yki-Järvinen H, Byrne CD, Targher G, Tur-Sinai A, Barrett D, Ninburg M, Reic T, Taylor A, Rhodes T, Treloar C, Petersen C, Schramm C, Flisiak R, Simonova MY, Pares A, Johnson P, Cucchetti A, Graupera I, Lionis C, Pose E, Fabrellas N, Ma AT, Mendive JM, Mazzaferro V, Rutter H, Cortez-Pinto H, Kelly D, Burton R, Lazarus JV, Ginès P, Buti M, Newsome PN, Burra P, Manns MP2022-01-01Lancet (London, England)
Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease.De Broucker C, Plessier A, Ollivier-Hourmand I, Dharancy S, Bureau C, Cervoni JP, Sogni P, Goria O, Corcos O, Sartoris R, Ronot M, Vilgrain V, de Raucourt E, Zekrini K, Davy H, Durand F, Payancé A, Fidouh-Houhou N, Yazdanpanah Y, Valla D, Rautou PE2022-01-01CMV, cavernoma, cytomegalovirus, factor II gene mutation, immunocompetent, infection, prothrombin, recanalization, thrombophilia, thrombosis, vascular liver diseaseJournal of hepatology
Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study.Mazza S, Piazza O Sed N, Conforti FS, Fascì A, Rimondi A, Marinoni B, Casini V, Ricci C, Munari F, Pirola L, Invernizzi P, Girelli C, Lupinacci G, Pastorelli L, Cavallaro F, Ferraris L, Colucci A, Amato A, Eugenio Tontini G, Vecchi M, Fiorino G, Caprioli F2022-01-01Clinical and translational science
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma.Correnti M, Cappon A, Pastore M, Piombanti B, Lori G, Oliveira DVPN, Munoz-Garrido P, Lewinska M, Andersen JB, Coulouarn C, Sulpice L, Peraldo Neia C, Cavalloni G, Quarta S, Biasiolo A, Fassan M, Ramazzotti M, Parri M, Recalcati S, di Tommaso L, Campani C, Invernizzi P, Torzilli G, Marra F, Pontisso P, Raggi C2022-01-01SerpinB3, cancer stem cells, cholangiocarcinoma, invasionLiver international : official journal of the International Association for the Study of the Liver
Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis.Taubert R, Engel B, Diestelhorst J, Hupa-Breier KL, Behrendt P, Baerlecken NT, Sühs KW, Janik MK, Zachou K, Sebode M, Schramm C, Londoño MC, Habes S, Oo YH, Lalanne C, Pape S, Schubert M, Hust M, Dübel S, Thevis M, Jonigk D, Beimdiek J, Buettner FFR, Drenth JPH, Muratori L, Adams DH, Dyson JK, Renand A, Graupera I, Lohse AW, Dalekos GN, Milkiewicz P, Stangel M, Maasoumy B, Witte T, Wedemeyer H, Manns MP, Jaeckel E2022-01-01Hepatology (Baltimore, Md.)
Non-invasive diagnosis and follow-up of primary biliary cholangitis.Corpechot C, Heurgue A, Tanne F, Potier P, Hanslik B, Decraecker M, de Lédinghen V, Ganne-Carrié N, Bureau C, Bourlière M2022-01-01PBCClinics and research in hepatology and gastroenterology
Non-invasive diagnosis and follow-up of vascular liver diseases.Rautou PE, Elkrief L, Decraecker M, Ollivier-Hourmand I, Plessier A, Ronot M, Vilgrain V, Bourlière M, Ganne-Carrié N, de Lédinghen V, Bureau C2022-01-01Clinics and research in hepatology and gastroenterology
Non-invasive diagnosis and follow-up of autoimmune hepatitis.Lemoinne S, Heurgue A, Bouzbib C, Hanslik B, Gournay J, Nguyen-Khac E, Bureau C, de Lédinghen V, Ganne-Carrié N, Bourlière M2022-01-01Clinics and research in hepatology and gastroenterology
Impact of vascular liver disease on the menstrual cycle and metabolic status in premenopausal women.Stempak-Droissart T, Rousset-Jablonski C, Spritzer PM, Lalhou N, Larger E, Pichard C, Plessier A, Gompel A2022-01-01Budd-Chiari syndrome, Contraception, Hyperandrogenism, IgF-1, Portal hypertension, Portal vein thrombosisClinics and research in hepatology and gastroenterology
MARC1 p.A165T variant is associated with decreased markers of liver injury and enhanced antioxidant capacity in autoimmune hepatitis.Janik MK, Smyk W, Kruk B, Szczepankiewicz B, Górnicka B, Lebiedzińska-Arciszewska M, Potes Y, Simões ICM, Weber SN, Lammert F, Więckowski MR, Milkiewicz P, Krawczyk M2021-12-23Scientific reports
Development of extracellular vesicle-based medicinal products: A position paper of the group "Extracellular Vesicle translatiOn to clinicaL perspectiVEs - EVOLVE France".Silva AKA, Morille M, Piffoux M, Arumugam S, Mauduit P, Larghero J, Bianchi A, Aubertin K, Blanc-Brude O, Noël D, Velot E, Ravel C, Elie-Caille C, Sebbagh A, Boulanger C, Wilhelm C, Rahmi G, Raymond-Letron I, Cherukula K, Montier T, Martinaud C, Bach JM, Favre-Bulle O, Spadavecchia J, Jorgensen C, Menasché P, Aussel C, Chopineau J, Mosser M, Ullah M, Sailliet N, Luciani N, Mathieu N, Rautou PE, Brouard S, Boireau W, Jauliac S, Dedier M, Trouvin JH, Gazeau F, Trouillas M, Peltzer J, Monsel A, Banzet S2021-12-01Biological medicinal products, Cell-free therapy, Clinical-grade EV, Exosomes, Medicinal products, Microvesicles, Regulatory requirements, SecretomeAdvanced drug delivery reviews
[Severe secondary sclerosing cholangitis as manifestation of a very rare underlying disease].Zecher BF, Zenouzi R, Lang M, Karagiannis P, Clauditz T, Fischer L, Sterneck M, Schramm C, Lohse AW, Sebode M2021-12-01Cholangiography, endoscopic retrograde, Cholangitis, sclerosing, secondary, Histiocytosis, Langerhans cell, Liver transplantation, Unclear cholestasisDer Internist
Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process.Ponsioen CY, Assis DN, Boberg KM, Bowlus CL, Deneau M, Thorburn D, Aabakken L, Färkkilä M, Petersen B, Rupp C, Hübscher SG2021-12-01Gastroenterology
Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor-Stroma Paracrine Signaling.Lobe C, Vallette M, Arbelaiz A, Gonzalez-Sanchez E, Izquierdo L, Pellat A, Guedj N, Louis C, Paradis V, Banales JM, Coulouarn C, Housset C, Vaquero J, Fouassier L2021-12-01Hepatology (Baltimore, Md.)
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool.Murillo Perez CF, Gulamhusein A, Carbone M, Trivedi PJ, van der Meer AJ, Corpechot C, Battezzati PM, Lammers WJ, Cazzagon N, Floreani A, Parés A, Nevens F, Lleo A, Mayo MJ, Kowdley KV, Ponsioen CY, Dalekos GN, Gatselis NK, Thorburn D, Mason AL, Janssen H, Verhelst X, Bruns T, Lindor KD, Chazouillères O, Invernizzi P, Hansen BE, Hirschfield GM2021-12-01European journal of gastroenterology & hepatology
Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis: a prospective longitudinal study.Nery F, Carneiro P, Correia S, Macedo C, Gandara J, Lopes V, Valadares D, Ferreira S, Oliveira J, Teixeira Gomes M, Miranda HP, Rautou PE, Valla D2021-12-01European journal of gastroenterology & hepatology
In vitro functional rescue by ivacaftor of an ABCB11 variant involved in PFIC2 and intrahepatic cholestasis of pregnancy.Mareux E, Lapalus M, Ben-Saad A, Callebaut I, Falguières T, Gonzales E, Jacquemin E2021-11-18ABC transporters superfamily, BSEP, Cholestasis, Paediatrics, Potentiator, VX-770Orphanet journal of rare diseases
MEDTEC Students against Coronavirus: Investigating the Role of Hemostatic Genes in the Predisposition to COVID-19 Severity.Cappadona C, Paraboschi EM, Ziliotto N, Bottaro S, Rimoldi V, Gerussi A, Azimonti A, Brenna D, Brunati A, Cameroni C, Campanaro G, Carloni F, Cavadini G, Ciravegna M, Composto A, Converso G, Corbella P, D'Eugenio D, Dal Rì G, Di Giorgio SM, Grondelli MC, Guerrera L, Laffoucriere G, Lando B, Lopedote L, Maizza B, Marconi E, Mariola C, Matronola GM, Menga LM, Montorsi G, Papatolo A, Patti R, Profeta L, Rebasti V, Smidili A, Tarchi SM, Tartaglia FC, Tettamanzi G, Tinelli E, Stuani R, Bolchini C, Pattini L, Invernizzi P, Degenhardt F, Franke A, Duga S, Asselta R2021-11-09COVID-19, MTHFR, SARS-CoV-2, association analysis, hemostatic genes, meta-analysis, polygenic risk scoreJournal of personalized medicine
One liver, two samples and two diagnoses-An example of how multiple samples by laparoscopically guided liver biopsy can be decisive.Beisel C, Weidemann SA, Sebode M2021-11-01autoimmune hepatitis, laparoscopically guided liver biopsy, non-alcoholic fatty liver diseaseLiver international : official journal of the International Association for the Study of the Liver
Corrigendum to "ATP7B variant spectrum in a French pediatric Wilson disease cohort" [Eur. J. Med. Genet. 64(10) (2021) 104305].Couchonnal E, Bouchard S, Sandahl TD, Pagan C, Lion-François L, Guillaud O, Habes D, Debray D, Lamireau T, Broué P, Fabre A, Vanlemmens C, Sobesky R, Gottrand F, Bridoux-Henno L, Belmalih A, Poujois A, Brunet AS, Lachaux A, Bost M2021-11-01European journal of medical genetics
Mobile app requirements for patients with rare liver diseases: A single center survey for the ERN RARE-LIVER‬‬‬.Rüther DF, Sebode M, Lohse AW, Wernicke S, Böttinger E, Casar C, Braun F, Schramm C2021-11-01Autoimmune hepatitis, European reference networks, Mobile applications, Patient reported outcome measures, Primary biliary cholangitis, Primary sclerosing cholangitisClinics and research in hepatology and gastroenterology
Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients.Schmidbauer C, Chromy D, Schmidbauer VU, Schwarz M, Jachs M, Bauer DJM, Binter T, Apata M, Nguyen DT, Mandorfer M, Simbrunner B, Rieger A, Mayer F, Breuer M, Strassl R, Schmidt R, Holzmann H, Trauner M, Gschwantler M, Reiberger T2021-11-01HBV, HDV, HIV, epidemiologyLiver international : official journal of the International Association for the Study of the Liver
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study.Arab JP, Díaz LA, Baeza N, Idalsoaga F, Fuentes-López E, Arnold J, Ramírez CA, Morales-Arraez D, Ventura-Cots M, Alvarado-Tapias E, Zhang W, Clark V, Simonetto D, Ahn JC, Buryska S, Mehta TI, Stefanescu H, Horhat A, Bumbu A, Dunn W, Attar B, Agrawal R, Haque ZS, Majeed M, Cabezas J, García-Carrera I, Parker R, Cuyàs B, Poca M, Soriano G, Sarin SK, Maiwall R, Jalal PK, Abdulsada S, Higuera-de la Tijera MF, Kulkarni AV, Rao PN, Guerra Salazar P, Skladaný L, Bystrianska N, Prado V, Clemente-Sanchez A, Rincón D, Haider T, Chacko KR, Cairo F, de Sousa Coelho M, Romero GA, Pollarsky FD, Restrepo JC, Castro-Sanchez S, Toro LG, Yaquich P, Mendizabal M, Garrido ML, Narvaez A, Bessone F, Marcelo JS, Piombino D, Dirchwolf M, Arancibia JP, Altamirano J, Kim W, Araujo RC, Duarte-Rojo A, Vargas V, Rautou PE, Issoufaly T, Zamarripa F, Torre A, Lucey MR, Mathurin P, Louvet A, García-Tsao G, González JA, Verna E, Brown RS, Roblero JP, Abraldes JG, Arrese M, Shah VH, Kamath PS, Singal AK, Bataller R2021-11-01MELD, Maddrey discriminant function, alcohol, alcohol-associated liver disease, alcoholic hepatitis, alcoholic liver disease, cirrhosis, corticosteroids, steroidsJournal of hepatology
Transient elastography in chronic liver disease: Beware of the cut-offs!Cristoferi L, Nardi A, Carbone M2021-11-01dual cut-off, liver fibrosis, non-invasive liver fibrosis markers, transient elastographyJournal of hepatology
REPLY.Elkrief L, Lazareth M, Rautou PE2021-11-01Hepatology (Baltimore, Md.)
Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study.Gonzales E, Hardikar W, Stormon M, Baker A, Hierro L, Gliwicz D, Lacaille F, Lachaux A, Sturm E, Setchell KDR, Kennedy C, Dorenbaum A, Steinmetz J, Desai NK, Wardle AJ, Garner W, Vig P, Jaecklin T, Sokal EM, Jacquemin E2021-10-30Lancet (London, England)
Liver-first strategy for a combined lung and liver transplant in patients with cystic fibrosis.Aburahma K, Salman J, Engel B, Vondran FWR, Greer M, Boethig D, Siemeni T, Avsar M, Schwerk N, Müller C, Taubert R, Hoeper MM, Welte T, Wedemeyer HH, Richter N, Warnecke G, Tudorache I, Haverich A, Kuehn C, Grannas G, Ius F2021-10-22Chronic lung allograft dysfunction, Graft survival, Liver transplantation, Lung transplantationEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Current pharmacological treatment of hepatocellular carcinoma.Muñoz-Martínez S, Iserte G, Sanduzzi-Zamparelli M, Llarch N, Reig M2021-10-01Current opinion in pharmacology
ATP7B variant spectrum in a French pediatric Wilson disease cohort.Couchonnal E, Bouchard S, Sandahl TD, Pagan C, Lion-François L, Guillaud O, Habes D, Debray D, Lamireau T, Broué P, Fabre A, Vanlemmens C, Sobesky R, Gottrand F, Bridoux-Henno L, Belmalih A, Poujois A, Brunet AS, Lachaux A, Bost M2021-10-01ATP7B, Phenotype-genotype correlation, Wilson's disease, p.His1069GlnEuropean journal of medical genetics
Reply to: "Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered".Mallet V2021-10-01COVID-19, Chemical and Drug Induced Liver Injury, Cholangiopathy, Cholangitis, Cholestasis, Intrahepatic, KetamineJournal of hepatology
Drug-induced liver injury at a tertiary care centre in Germany: Model for end-stage liver disease is the best predictor of outcome.Reike-Kunze M, Zenouzi R, Hartel J, Krech T, Weidemann S, Sterneck M, Weiler-Normann C, Lohse AW, Schramm C, Sebode M2021-10-01MELD, acute liver failure, drug-induced liver injury, liver transplantation, outcomeLiver international : official journal of the International Association for the Study of the Liver
Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease.Lackner C, Stauber RE, Davies S, Denk H, Dienes HP, Gnemmi V, Guido M, Miquel R, Paradis V, Schirmacher P, Terracciano L, Berghold A, Pregartner G, Binder L, Douschan P, Rainer F, Sygulla S, Jager M, Rautou PE, Bumbu A, Horhat A, Rusu I, Stefanescu H, Detlefsen S, Krag A, Thiele M, Cortez-Pinto H, Moreno C, Gouw ASH, Tiniakos DG2021-10-01Alcohol-related liver disease, cholestasis, grading, prognosis, stagingJournal of hepatology
Pediatric Wilson's Disease: Phenotypic, Genetic Characterization and Outcome of 182 Children in France.Couchonnal E, Lion-François L, Guillaud O, Habes D, Debray D, Lamireau T, Broué P, Fabre A, Vanlemmens C, Sobesky R, Gottrand F, Bridoux-Henno L, Dumortier J, Belmalih A, Poujois A, Jacquemin E, Brunet AS, Bost M, Lachaux A2021-10-01Journal of pediatric gastroenterology and nutrition
REPLY.Elkrief L, Lazareth M, Rautou PE2021-10-01Hepatology (Baltimore, Md.)
Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer.Hirsch TZ, Pilet J, Morcrette G, Roehrig A, Monteiro BJE, Molina L, Bayard Q, Trépo E, Meunier L, Caruso S, Renault V, Deleuze JF, Fresneau B, Chardot C, Gonzales E, Jacquemin E, Guerin F, Fabre M, Aerts I, Taque S, Laithier V, Branchereau S, Guettier C, Brugières L, Rebouissou S, Letouzé E, Zucman-Rossi J2021-10-01Cancer discovery
The genetic architecture of primary biliary cholangitis.Gerussi A, Carbone M, Corpechot C, Schramm C, Asselta R, Invernizzi P2021-09-01Autoimmunity, Complex traits, GWAS, HLA, Missing heritabilityEuropean journal of medical genetics
Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study.Baumann U, Sturm E, Lacaille F, Gonzalès E, Arnell H, Fischler B, Jørgensen MH, Thompson RJ, Mattsson JP, Ekelund M, Lindström E, Gillberg PG, Torfgård K, Soni PN2021-09-01Alagille syndrome, Apical sodium-dependent bile acid transporter, Biliary atresia, Cholestasis, intrahepatic, Ileal bile acid transporter, PediatricsClinics and research in hepatology and gastroenterology
Prevalence of COVID-19 in patients with autoimmune liver disease in Europe: A patient-oriented online survey.Zecher BF, Buescher G, Willemse J, Walmsley M, Taylor A, Leburgue A, Schramm C, Lohse AW, Sebode M2021-09-01(AILD), COVID-19, Europe, SARS-CoV-2, advanced liver disease, autoimmuneliver disease, chronic liver disease, incidence, online survey, prevalenceUnited European gastroenterology journal
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs.Cordell HJ, Fryett JJ, Ueno K, Darlay R, Aiba Y, Hitomi Y, Kawashima M, Nishida N, Khor SS, Gervais O, Kawai Y, Nagasaki M, Tokunaga K, Tang R, Shi Y, Li Z, Juran BD, Atkinson EJ, Gerussi A, Carbone M, Asselta R, Cheung A, de Andrade M, Baras A, Horowitz J, Ferreira MAR, Sun D, Jones DE, Flack S, Spicer A, Mulcahy VL, Byan J, Han Y, Sandford RN, Lazaridis KN, Amos CI, Hirschfield GM, Seldin MF, Invernizzi P, Siminovitch KA, Ma X, Nakamura M, Mells GF2021-09-01ALSPAC, ERN RARE-LIVER, Genomic co-localization, Network-based in silico drug efficacy screening, UK-PBCJournal of hepatology
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach.Cristoferi L, Calvaruso V, Overi D, Viganò M, Rigamonti C, Degasperi E, Cardinale V, Labanca S, Zucchini N, Fichera A, Di Marco V, Leutner M, Venere R, Picciotto A, Lucà M, Mulinacci G, Palermo A, Gerussi A, D'Amato D, Elisabeth O'Donnell S, Cerini F, De Benedittis C, Malinverno F, Ronca V, Mancuso C, Cazzagon N, Ciaccio A, Barisani D, Marzioni M, Floreani A, Alvaro D, Gaudio E, Invernizzi P, Carpino G, Nardi A, Carbone M2021-09-01Hepatology (Baltimore, Md.)
Cost of illness of Primary Biliary Cholangitis - a population-based study.Gerussi A, Restelli U, Croce D, Bonfanti M, Invernizzi P, Carbone M2021-09-01Cholangiopathies, Cost-of-illness, Liver, Population-based studies, Rare diseasesDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis.Laschtowitz A, Zachou K, Lygoura V, Pape S, Derben F, Jaeckel E, Oller-Moreno S, Weidemann S, Krech T, Piecha F, Schön G, Liebhoff AM, Al Tarrah M, Heneghan M, Drenth JPH, Dalekos G, Taubert R, Lohse AW, Schramm C2021-08-01AIH, autoimmune hepatitis, ALD, alcoholic liver disease, ALP, alkaline phosphatase, ALT, alanine aminotransferase, AST, aspartate aminotransferase, Autoimmune hepatitis, Biochemical remission, Cirrhosis, EASL, European Association for the Study of the Liver, Histological activity, ICC, intraclass correlation coefficient, INR, international normalised ratio, LLN, lower limit of normal, Liver biopsy, MELD, model for end-stage liver disease, NAFLD, non-alcoholic fatty liver disease, TE, transient elastography, TIPS, transjugular intrahepatic portosystemic shunt, ULN, upper limit of normal, gamma-GT, gamma glutamyl transferase, mHAI, mHAI, modified Hepatitis Activity IndexJHEP reports : innovation in hepatology
Alpha1-antitrypsin deficiency: New therapies on the horizon.Remih K, Amzou S, Strnad P2021-08-01Current opinion in pharmacology
Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency.Karatas E, Raymond AA, Leon C, Dupuy JW, Di-Tommaso S, Senant N, Collardeau-Frachon S, Ruiz M, Lachaux A, Saltel F, Bouchecareilh M2021-08-01AAT, alpha 1-antitrypsin, AATD, alpha 1-antitrypsin deficiency, Alpha 1-antitrypsin deficiency, CF, cystic fibrosis, CFTR, cystic fibrosis transmembrane conductance regulator, Cysteamine, ER, endoplasmic reticulum, FFPE, formalin-fixed paraffin-embedded, FKBP10, FK506-binding protein (FKBP) isoform 10, HCC, hepatocellular carcinoma, IHC, immunohistochemistry, IP, immunoprecipitation, Liver damage, NHK, null Hong Kong variant of AAT, P4HB, prolyl 4-hydroxylase subunit beta/PDIA1, PDI, protein disulfide isomerase, PDIA3, protein disulfide isomerase family A member 3/ERP57, PDIA4, PDIA4, protein disulfide isomerase family A member 4/ERP70/ERP72, PDIi, PDI inhibitors, Protein disulfide isomerase, ROS, reactive oxygen species, SURF4, proteins Surfeit 4, Scr, scramble, TRX, thioredoxin, TXNDC5, thioredoxin domain containing 5/PDIA15, Treatment, WT, wild-type, Z-AAT, alpha 1-antitrypsin Z variant, ZZ, homozygosis for the Z mutant allele, siRNA, small RNA interference, ΔF508-CFTR, most common mutation of CFTR, which deletes phenylalanine508JHEP reports : innovation in hepatology
Role of extracellular vesicles in liver diseases and their therapeutic potential.Kostallari E, Valainathan S, Biquard L, Shah VH, Rautou PE2021-08-01Cirrhosis, Exosomes, Fibrosis, Microvesicles, Portal hypertension, SteatosisAdvanced drug delivery reviews
SARS-CoV-2 infection in alpha1-antitrypsin deficiency.Schneider CV, Strnad P2021-08-01AAT, AATD, SARS-CoV2Respiratory medicine
Towards personalised medicine in autoimmune hepatitis: Measurement of thiopurine metabolites results in higher biochemical response rates.Candels LS, Rahim MN, Shah S, Heneghan MA2021-08-01autoimmune hepatitis, azathioprine, outcomes, thioguanine, thiopurine metabolitesJournal of hepatology
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis.Gerussi A, Bernasconi DP, O'Donnell SE, Lammers WJ, Van Buuren H, Hirschfield G, Janssen H, Corpechot C, Reig A, Pares A, Battezzati PM, Zuin MG, Cazzagon N, Floreani A, Nevens F, Gatselis N, Dalekos G, Mayo MJ, Thorburn D, Bruns T, Mason AL, Verhelst X, Kowdley K, van der Meer A, Niro GA, Beretta-Piccoli BT, Marzioni M, Belli LS, Marra F, Valsecchi MG, Lindor KD, Invernizzi P, Hansen BE, Carbone M2021-08-01Autoimmune Liver Disease, Biomarkers, Prediction, UDCAClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Diagnostic and prognostic scoring systems for autoimmune hepatitis: a review.Ducazu O, Degroote H, Geerts A, Hoorens A, Schouten J, Van Vlierberghe H, Verhelst X2021-07-01autoimmune hepatitis, diagnosis, prognosis, scoring systemActa gastro-enterologica Belgica
Thrombotic risk in gastroenteropancreatic neuroendocrine tumor patients: a single-center experience.Massironi S, Cavalcoli F, Artoni A, Sciola V, Zilli A, Ciafardini C, Rossi RE2021-07-01Gastroenteropancreatic neuroendocrine neoplasms, gastrointestinal tumors, paraneoplastic syndromes, thromboembolic complication, thromboembolismAnnals of gastroenterology
Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension.Elkrief L, Lazareth M, Chevret S, Paradis V, Magaz M, Blaise L, Rubbia-Brandt L, Moga L, Durand F, Payancé A, Plessier A, Chaffaut C, Valla D, Malphettes M, Diaz A, Nault JC, Nahon P, Audureau E, Ratziu V, Castera L, Garcia Pagan JC, Ganne-Carrie N, Rautou PE2021-07-01Hepatology (Baltimore, Md.)
RAB10 Interacts with ABCB4 and Regulates Its Intracellular Traffic.Ben Saad A, Vauthier V, Lapalus M, Mareux E, Bennana E, Durand-Schneider AM, Bruneau A, Delaunay JL, Gonzales E, Housset C, Aït-Slimane T, Guillonneau F, Jacquemin E, Falguières T2021-06-30MDR3, RAB GTPase, bile secretion, intracellular traffic, phosphatidylcholineInternational journal of molecular sciences
Genetic aspects of adult and pediatric autoimmune hepatitis: A concise review.Engel B, Laschtowitz A, Janik MK, Junge N, Baumann U, Milkiewicz P, Taubert R, Sebode M2021-06-01Autoimmune hepatitis, Human leukocyte antigen, Regulatory T-cellsEuropean journal of medical genetics
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study.Efe C, Dhanasekaran R, Lammert C, Ebik B, Higuera-de la Tijera F, Aloman C, Rıza Calışkan A, Peralta M, Gerussi A, Massoumi H, Catana AM, Torgutalp M, Purnak T, Rigamonti C, Gomez Aldana AJ, Khakoo N, Kacmaz H, Nazal L, Frager S, Demir N, Irak K, Ellik ZM, Balaban Y, Atay K, Eren F, Cristoferi L, Batıbay E, Urzua Á, Snijders R, Kıyıcı M, Akyıldız M, Ekin N, Carr RM, Harputluoğlu M, Hatemi I, Mendizabal M, Silva M, Idilman R, Silveira M, Drenth JPH, Assis DN, Björnsson E, Boyer JL, Invernizzi P, Levy C, Schiano TD, Ridruejo E, Wahlin S2021-06-01Hepatology (Baltimore, Md.)
Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants.Ben Saad A, Vauthier V, Tóth Á, Janaszkiewicz A, Durand-Schneider AM, Bruneau A, Delaunay JL, Lapalus M, Mareux E, Garcin I, Gonzales E, Housset C, Aït-Slimane T, Jacquemin E, Di Meo F, Falguières T2021-06-01ABC transporters, bile secretion, cell models, cholestatic liver diseases, molecular docking, targeted pharmacotherapyLiver international : official journal of the International Association for the Study of the Liver
SARS-CoV-2 infection in patients with autoimmune hepatitis.Marjot T, Buescher G, Sebode M, Barnes E, Barritt AS, Armstrong MJ, Baldelli L, Kennedy J, Mercer C, Ozga AK, Casar C, Schramm C, Moon AM, Webb GJ, Lohse AW2021-06-01COVID-19, SARS-CoV-2, autoimmune hepatitis, coronavirus, immunosuppression, liver diseaseJournal of hepatology
Safety and efficacy of in vitro fertilisation in patients with chronic liver disease and liver transplantation recipients.Rahim MN, Theocharidou E, Yen Lau KG, Ahmed R, Marattukalam F, Long L, Cannon MD, Heneghan MA2021-06-01Cirrhosis, Foetal outcomes, In vitro fertilisation, Liver transplantation, Maternal outcomes, PregnancyJournal of hepatology
Role of miR-506 in ulcerative colitis associated with primary sclerosing cholangitis.Kempinska-Podhorodecka A, Adamowicz M, Ostrycharz E, Chmielarz M, Wójcicki M, Milkiewicz P, Milkiewicz M2021-05-12Scientific reports
Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH.Reig M, Forner A, Ávila MA, Ayuso C, Mínguez B, Varela M, Bilbao I, Bilbao JI, Burrel M, Bustamante J, Ferrer J, Gómez MÁ, Llovet JM, De la Mata M, Matilla A, Pardo F, Pastrana MA, Rodríguez-Perálvarez M, Tabernero J, Urbano J, Vera R, Sangro B, Bruix J2021-05-07Carcinoma hepatocelular, Cirrhosis, Cirrosis, Diagnosis, Diagnóstico, Hepatocellular carcinoma, Prevención, Prevention, Prognosis, Pronóstico, Tratamiento, TreatmentMedicina clinica
Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"☆ (J Hepatol [2020] 505-515).Anstee QM, Darlay R, Cockell S, Meroni M, Govaere O, Tiniakos D, Burt AD, Bedossa P, Palmer J, Liu YL, Aithal GP, Allison M, Yki-Järvinen H, Vacca M, Dufour JF, Invernizzi P, Prati D, Ekstedt M, Kechagias S, Francque S, Petta S, Bugianesi E, Clement K, Ratziu V, Schattenberg JM, Valenti L, Day CP, Cordell HJ, Daly AK2021-05-01Journal of hepatology
Intravenous ketamine and progressive cholangiopathy in COVID-19 patients.2021-05-01COVID-19, Chemical and Drug Induced Liver Injury, Cholangiopathy, Cholangitis, Cholestasis, Intrahepatic, KetamineJournal of hepatology
Patients with NAFLD do not have severe portal hypertension in the absence of cirrhosis.Moga L, Laroyenne A, Larrue H, Bureau C, Rautou PE2021-05-01Portal hypertension, cirrhosis, hepatic venous pressure gradient, liver fibrosis, non-alcoholic fatty liver disease, steatosisJournal of hepatology
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet).Panzuto F, Maccauro M, Campana D, Faggiano A, Massironi S, Pusceddu S, Spada F, Ferone D, Modica R, Grana CM, Ferolla P, Rinzivillo M, Badalamenti G, Zatelli MC, Gelsomino F, De Carlo E, Bartolomei M, Brizzi MP, Cingarlini S, Versari A, Fanciulli G, Arvat E, Merola E, Cives M, Tafuto S, Baldari S, Falconi M2021-05-01COVID-19, Management, Multidisciplinary team, Neuroendocrine tumors, Pandemic, Peptide receptors radionuclide therapy, SARS-CoV2Journal of endocrinological investigation
Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All.Palermo A, Gerussi A, Mulinacci G, Invernizzi P, Carbone M2021-05-01Digestive diseases and sciences
Ursodeoxycholic acid therapy throughout pregnancy in women affected with chronic cholestasis of childhood: No evidence for teratogenicity.Lykavieris P, Bernard O, Jacquemin E2021-05-01Alagille syndrome, Biliary atresia, Gestation, Liver transplantation, Teratogenicity, UDCAClinics and research in hepatology and gastroenterology
Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models.Gerussi A, Natalini A, Antonangeli F, Mancuso C, Agostinetto E, Barisani D, Di Rosa F, Andrade R, Invernizzi P2021-04-27autoimmune hepatitis, autoimmunity, drug-induced liver injury, genetics, inflammationInternational journal of molecular sciences
[Microvesicles derived from JAK2V617F erythrocytes induce arterial spasms in myeloproliferative neoplasm].Poisson J, Tanguy M, Rautou PE2021-04-01Medecine sciences : M/S
[European Reference Network for Rare Hepatological Diseases (ERN RARE-LIVER)].Schulz L, Sebode M, Schramm C, Lohse AW2021-04-01Clinical patient management system, Patient organizations, Rare diseases, Remote consultation, Standardization of careDer Internist
Real-world experience with obeticholic acid in patients with primary biliary cholangitis.D'Amato D, De Vincentis A, Malinverno F, Viganò M, Alvaro D, Pompili M, Picciotto A, Palitti VP, Russello M, Storato S, Pigozzi MG, Calvaruso V, De Gasperi E, Lleo A, Castellaneta A, Pellicelli A, Cazzagon N, Floreani A, Muratori L, Fagiuoli S, Niro GA, Feletti V, Cozzolongo R, Terreni N, Marzioni M, Pellicano R, Pozzoni P, Baiocchi L, Chessa L, Rosina F, Bertino G, Vinci M, Morgando A, Vanni E, Scifo G, Sacco R, D'Antò M, Bellia V, Boldizzoni R, Casella S, Omazzi B, Poggi G, Cristoferi L, Gerussi A, Ronca V, Venere R, Ponziani F, Cannavò M, Mussetto A, Fontana R, Losito F, Frazzetto E, Distefano M, Colapietro F, Labanca S, Marconi G, Grassi G, Galati G, O'Donnell SE, Mancuso C, Mulinacci G, Palermo A, Claar E, Izzi A, Picardi A, Invernizzi P, Carbone M, Vespasiani-Gentilucci U2021-04-01AIH, autoimmune hepatitis, ALP, alkaline phosphatase, ALT, alanine transferase, AMA, antimitochondrial antibodies, ANA, antinuclear antibodies, AST, aspartate transferase, Autoimmunity, CRFs, case record forms, Cholestasis, Cirrhosis, EDC, electronic data capture, GGT, gamma-glutamyl transferase, OC, Overall cohort, OCA, obeticholic acid, Overlap PBC-AIH, PBC, primary biliary cholangitis, QC, quality control, RCT, randomised controlled trial, RR, risk ratio, TCC, Treatment Completer Cohort, TIPS, transjugular intrahepatic portosystemic shunt, UDCA, ursodeoxycholic acid, ULN, upper limit of normal, aRR, adjusted risk ratioJHEP reports : innovation in hepatology
Low-phospholipid-associated cholelithiasis syndrome: Prevalence, clinical features, and comorbidities.Dong C, Condat B, Picon-Coste M, Chrétien Y, Potier P, Noblinski B, Arrivé L, Hauuy MP, Barbu V, Maftouh A, Gaouar F, Ben Belkacem K, Housset C, Poupon R, Zanditenas D, Chazouillères O, Corpechot C2021-04-01ABCB4, ABCB4, ATP-binding cassette subfamily B member 4, CBD, common bile duct, Cancer, Cholestasis, ERCP, endoscopic retrograde cholangiopancreatography, FDR, false discovery rate, GGT, gamma-glutamyltransferase, ICP, intrahepatic cholestasis of pregnancy, LPAC, LPAC, low-phospholipid-associated cholelithiasis, MRCP, magnetic resonance cholangiopancreatography, Metabolic syndrome, Pregnancy, UDCA, ursodeoxycholic acidJHEP reports : innovation in hepatology
Reply.Schneider CV, Hamesch K, Strnad P2021-04-01Gastroenterology
Shear Wave Elastography and Shear Wave Dispersion Imaging in the Assessment of Liver Disease in Alpha1-Antitrypsin Deficiency.Schulz M, Kleinjans M, Strnad P, Demir M, Holtmann TM, Tacke F, Wree A2021-03-31alpha1-antitrypsin deficiency (AATD), shear wave dispersion (SWD), shear wave elastography (SWE)Diagnostics (Basel, Switzerland)
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know.Cristoferi L, Gerussi A, Invernizzi P2021-03-01Liver international : official journal of the International Association for the Study of the Liver
Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis.Bossen L, Vesterhus M, Hov JR, Färkkilä M, Rosenberg WM, Møller HJ, Boberg KM, Karlsen TH, Grønbæk H2021-03-01Clinical and translational gastroenterology
ABCB4-alteration screening in adult-onset cholestasis.Carbone M, Cardinale V2021-03-01Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Reply to: "Both tacrolimus and mycophenylate mophetil should be considered second-line therapy for autoimmune hepatitis".Lohse AW, Sebode M, Vesterhus M2021-03-01Journal of hepatology
Direct oral anticoagulants and advanced liver disease: A systematic review and meta-analysis.Menichelli D, Ronca V, Di Rocco A, Pignatelli P, Marco Podda G2021-03-01DOACs, bleeding, child pugh, cirrhosis, oesophageal varicesEuropean journal of clinical investigation
Molecular Regulation of Canalicular ABC Transporters.Ben Saad A, Bruneau A, Mareux E, Lapalus M, Delaunay JL, Gonzales E, Jacquemin E, Aït-Slimane T, Falguières T2021-02-20ABCB1, ABCB11, ABCB4, ABCC2, ABCG5/G8, bile secretion, molecular partnersInternational journal of molecular sciences
Measurement of liver and spleen stiffness as complementary methods for assessment of liver fibrosis in autoimmune hepatitis.Janik MK, Kruk B, Szczepankiewicz B, Kostrzewa K, Raszeja-Wyszomirska J, Górnicka B, Lammert F, Milkiewicz P, Krawczyk M2021-02-01autoimmune hepatitis, liver fibrosis, liver stiffness, shear wave elastography, spleen stifness, transient elastographyLiver international : official journal of the International Association for the Study of the Liver
Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing.Galaski J, Weiler-Normann C, Schakat M, Zachou K, Muratori P, Lampalzer S, Haag F, Schramm C, Lenzi M, Dalekos GN, Lohse AW2021-02-01Antinuclear antibodies, Autoantibodies, ELISA, F-actin, Immunofluorescence, Smooth muscle antibodiesJournal of hepatology
Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease?Mulinacci G, Palermo A, Cristoferi L, Invernizzi P, Carbone M2021-01-01Inflammatory bowel disease, Primary sclerosing cholangitis, Takayasu arteritis, VasculitisJournal of translational autoimmunity
Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib.Pomej K, Balcar L, Scheiner B, Semmler G, Meischl T, Mandorfer M, Reiberger T, Müller C, Trauner M, Pinter M2021-01-01antibiotics, hepatocellular carcinoma, sorafenib, targeted therapyJournal of hepatocellular carcinoma
Regulatory T-Cell Therapy in Liver Transplantation and Chronic Liver Disease.Hann A, Oo YH, Perera MTPR2021-01-01Treg, cell therapy, cirrhosis, immunity, liver, rejection, transplantFrontiers in immunology
COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital.Pomej K, Scheiner B, Hartl L, Balcar L, Meischl T, Mandorfer M, Reiberger T, Müller C, Trauner M, Pinter M2021-01-01PloS one
Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension.Ørntoft NW, Blé M, Baiges A, Ferrusquia J, Hernández-Gea V, Turon F, Magaz M, Møller S, Møller HJ, Garcia-Pagan JC, Gronbaek H2021-01-01biomarker, cirrhosis, macrophages, non-cirrhotic portal hypertension, portal hypertensionFrontiers in physiology
Case Report: Hypomorphic Function and Somatic Reversion in DOCK8 Deficiency in One Patient With Two Novel Variants and Sclerosing Cholangitis.Saettini F, Fazio G, Moratto D, Galbiati M, Zucchini N, Ippolito D, Dinelli ME, Imberti L, Mauri M, Melzi ML, Bonanomi S, Gerussi A, Pinelli M, Barisani C, Bugarin C, Chiarini M, Giacomelli M, Piazza R, Cazzaniga G, Invernizzi P, Giliani SC, Badolato R, Biondi A2021-01-01DOCK 8, EBV - Epstein-Barr Virus, lymphopenia, primary immumunodeficiencies, sclerosing cholangitis, somatic reversion, thrombocytopeniaFrontiers in immunology
Ex situ Normothermic Split Liver Machine Perfusion: Protocol for Robust Comparative Controls in Liver Function Assessment Suitable for Evaluation of Novel Therapeutic Interventions in the Pre-clinical Setting.Attard JA, Osei-Bordom DC, Boteon Y, Wallace L, Ronca V, Reynolds G, Perera MTPR, Oo YH, Mergental H, Mirza DF, Afford SC2021-01-01liver function, machine perfusion, normothermic, organ preservation, split liver techniqueFrontiers in surgery
Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison.Montali L, Gragnano A, Miglioretti M, Frigerio A, Vecchio L, Gerussi A, Cristoferi L, Ronca V, D'Amato D, O'Donnell SE, Mancuso C, Lucà M, Yagi M, Reig A, Jopson L, Pilar S, Jones D, Pares A, Mells G, Tanaka A, Carbone M, Invernizzi P2021-01-01Autoimmunity, Cholestasis, Fatigue, LiverJournal of translational autoimmunity
Gastrointestinal Manifestations, Clinical Characteristics and Outcomes of COVID-19 in Adult and Pediatric Patients.Russo T, Pizuorno A, Oskrochi G, Latella G, Massironi S, Schettino M, Aghemo A, Pugliese N, Brim H, Ashktorab H2021-01-01Adults, Coronavirus Disease-19, Gastrointestinal Manifestation, Italy, Pandemic, PediatricsSOJ microbiology & infectious diseases
Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases.Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC2021-01-01Hepatology (Baltimore, Md.)
Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.Wang L, Guo X, Xu X, De Stefano V, Plessier A, Noronha Ferreira C, Qi X2021-01-01Anticoagulants, Liver cirrhosis, Meta-analysis, Survival, Venous thrombosisAdvances in therapy
Reply to: "A spotlight on natural killer cells in primary biliary cholangitis".Carbone M, Ronca V, Invernizzi P2021-01-01Autoimmunity, Biliary cirrhosis, Biliary fibrosis, Cholestasis, PBCJournal of hepatology
CK-18 cell death markers improve the prediction of histological remission in autoimmune hepatitis during biochemical remission.Derben FC, Engel B, Zachou K, Hartl J, Hartleben B, Bantel H, Schramm C, Dalekos GN, Manns MP, Jaeckel E, Taubert R2021-01-01M30, M65, cytokeratin-18, therapyLiver international : official journal of the International Association for the Study of the Liver
Benefits of molecular profiling with next-generation sequencing for the diagnosis and prognosis of myeloproliferative neoplasms in splanchnic vein thrombosis.Kiladjian JJ, Debureaux PE, Plessier A, Soret-Dulphy J, Valla D, Cassinat B, Rautou PE2021-01-01Journal of hepatology
DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma.Nevi L, Di Matteo S, Carpino G, Zizzari IG, Samira S, Ambrosino V, Costantini D, Overi D, Giancotti A, Monti M, Bosco D, De Peppo V, Oddi A, De Rose AM, Melandro F, Bragazzi MC, Faccioli J, Massironi S, Grazi GL, Panici PB, Berloco PB, Giuliante F, Cardinale V, Invernizzi P, Caretti G, Gaudio E, Alvaro D2021-01-01Hepatology (Baltimore, Md.)
Health status of patients with autoimmune hepatitis is not affected by the SARS-CoV-2 outbreak in Flanders, Belgium.Verhelst X, Somers N, Geerts A, Degroote H, Van Vlierberghe H2021-01-01Journal of hepatology
Management of cholangiocarcinoma in the third millennium: time to be guided!Carbone M, Baiocchi L2020-12-01Cholangiocarcinoma, PSC, cancer, diagnosis, staging, treatmentDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Up to 50% of portal vein thrombosis remains undiagnosed until liver transplantation.Bert J, Geerts A, Vanlander A, Abreu de Carvalho L, Degroote H, Berrevoet F, Rogiers X, van Vlierberghe H, Verhelst X2020-12-01anticoagulants, portal vein, risk factors, survival analysis, thrombosisClinical transplantation
Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group.Lohse AW, Sebode M, Jørgensen MH, Ytting H, Karlsen TH, Kelly D, Manns MP, Vesterhus M2020-12-016-Mercaptopurine, Autoimmune hepatitis, Azathioprine, Mycophenolate mofetilJournal of hepatology
Extracellular vesicles as biomarkers in liver diseases: A clinician's point of view.Thietart S, Rautou PE2020-12-01Alcohol, Cancer, Cirrhosis, Exosome, Liver, Microparticle, Microvesicle, VesicleJournal of hepatology
Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation.Goubran M, Aderibigbe A, Jacquemin E, Guettier C, Girgis S, Bain V, Mason AL2020-11-30ABCB4, Case report, MDR3, Progressive familial intrahepatic cholestasisBMC medical genetics
Long-term outcome in PSC patients receiving azathioprine: Does immunosuppression have a positive effect on survival?Creutzfeldt AM, Piecha F, Schattenberg JM, Schramm C, Lohse AW2020-11-01Journal of hepatology
Primary biliary cholangitis management: controversies, perspectives and daily practice implications from an expert panel.Alvaro D, Carpino G, Craxi A, Floreani A, Moschetta A, Invernizzi P2020-11-01fibrates, liver biopsy, management, obeticholic acid, primary biliary cholangitis, risk stratificationLiver international : official journal of the International Association for the Study of the Liver
High rates of 30-day mortality in patients with cirrhosis and COVID-19.Iavarone M, D'Ambrosio R, Soria A, Triolo M, Pugliese N, Del Poggio P, Perricone G, Massironi S, Spinetti A, Buscarini E, Viganò M, Carriero C, Fagiuoli S, Aghemo A, Belli LS, Lucà M, Pedaci M, Rimondi A, Rumi MG, Invernizzi P, Bonfanti P, Lampertico P2020-11-01HBV, HCV, Hepatitis, Hepatocellular carcinoma, Liver transplantation, SARS-CoV-2Journal of hepatology
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy.Viganò C, Massironi S, Pirola L, Cristoferi L, Fichera M, Bravo M, Mauri M, Redaelli AE, Dinelli ME, Invernizzi P2020-10-23COVID-19, Crohn’s disease, SARS-CoV-2, inflammatory bowel disease, ulcerative colitisInflammatory bowel diseases
Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib.Pomej K, Scheiner B, Park D, Bauer D, Balcar L, Meischl T, Mandorfer M, Reiberger T, Müller C, Trauner M, Pinter M2020-10-13bleeding complications, cardiovascular risk, hepatocellular carcinoma, metabolic risk factors, sorafenib, thromboembolic events, vascular complicationsCancers
[Not Available].Zecher B, Sebode M, Lohse AW2020-10-01Zeitschrift fur Gastroenterologie
Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma.Souhami A, Sartoris R, Rautou PE, Cauchy F, Bouattour M, Durand F, Giannelli V, Gigante E, Castera L, Valla D, Soubrane O, Vilgrain V, Ronot M2020-10-01AUROC, area under the receiver operating characteristic, CSPH, clinically significant portal hypertension, HCC, hepatocellular carcinoma, HPV, hepatic venous pressure, HVPG, hepatic venous pressure gradient, LSM, liver stiffness measurements, LSN, liver surface nodularity, LSPS, LSM-spleen-size-to-platelet ratio score, NRI, Net Classification Index Improvement, PHT, portal hypertension, TE, transient elastographyJHEP reports : innovation in hepatology
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets.Carbone M, Milani C, Gerussi A, Ronca V, Cristoferi L, Invernizzi P2020-10-01Autoimmunity, Biliary cirrhosis, Biliary fibrosis, Cholestasis, PBCJournal of hepatology
Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction.Elkrief L, Houssel-Debry P, Ackermann O, Franchi-Abella S, Branchereau S, Valla D, Hillaire S, Dutheil D, Plessier A, Hernandez-Gea V, Bureau C2020-09-01Cavernoma cholangiopathy, Portal cavernoma, VaricealClinics and research in hepatology and gastroenterology
Autoantibodies to intracellular "rods and rings" structures in two patients with autoimmune hepatitis treated with azathioprine.Galaski J, Koop AC, Lütgehetmann M, Lohse AW, Weiler-Normann C2020-09-01Autoimmune hepatitis, autoantibodies, azathioprine, immunofluorescence, rods and ringsAutoimmunity
Risk factors for vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.Soret J, Debray D, Fontbrune FS, Kiladjian JJ, Saadoun D, Latour RP, Valla D, Hernandez-Gea V, Hillaire S, Dutheil D, Plessier A, Bureau C, De Raucourt E2020-09-01Behçet's disease, Thrombosis, Vascular liver diseaseClinics and research in hepatology and gastroenterology
Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy.Massironi S, Viganò C, Dioscoridi L, Filippi E, Pagliarulo M, Manfredi G, Conti CB, Signorelli C, Redaelli AE, Bonato G, Iiritano E, Frego R, Zucchini N, Ungari M, Pedaci M, Bono F, Di Bella C, Buscarini E, Mutignani M, Penagini R, Dinelli ME, Invernizzi P2020-09-01Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Ischemic cholangiopathy: An update.Goria O, Archambeaud I, Lemaitre C, Dutheil D, Plessier A, Rautou PE, Hernandez-Gea V, Valla D2020-09-01Hepatic artery thrombosis, Intensive care, Ischemic cholangiopathy, Liver transplantationClinics and research in hepatology and gastroenterology
Recent (non-cirrhotic) extrahepatic portal vein obstruction.Heurgué A, Habes D, Brugel M, Franchi-Abella S, Condat B, Valla D, Hillaire S, Debray D, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C, Payancé A2020-09-01Cavernoma, Extra hepatic portal vein obstruction, Hypertension, ThrombosisClinics and research in hepatology and gastroenterology
Drug induced liver injury and vascular liver disease.Larrey D, Meunier L, Valla D, Hillaire S, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C2020-09-01Clinics and research in hepatology and gastroenterology
No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease.Biquard L, Valla D, Rautou PE2020-09-01Journal of hepatology
"Vascular liver diseases: Position paper(s) from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and the European Reference Network on Hepatological Diseases (ERN RARE-LIVER)".Plessier A, Bureau C2020-09-01Clinics and research in hepatology and gastroenterology
Social and medical support initiatives in vascular liver diseases in France, from child to adult.Aurélie P, Gasperment M, Debray D, Le Beux E, Brault C, Ollivier-Hourmand I, Dutheil D, Leclercq A, Devictor J, Hernández-Gea V, Pierre Emmanuel R, Goria O2020-09-01Advanced practice nurse, Coordinating nurse, Patient association, Psychological support, Social support, Therapeutic patient education, Transition, Vascular liver diseaseClinics and research in hepatology and gastroenterology
Porto-sinusoidal vascular disease. Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.Giudicelli H, Rautou PE, Paradis V, Bedossa P, Goria O, Lambert V, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C, Valla D2020-09-01Hepatoportal sclerosis, Incomplete septal fibrosis, Nodular regenerative hyperplasia, Non-cirrhotic portal fibrosis, Obliterative portal venopathy, Portal hypertension, Porto-sinusoidal vascular diseaseClinics and research in hepatology and gastroenterology
Extrahepatic portal vein obstruction (EHPVO) in cirrhosis.Abergel A, Gasperment M, Nery FG, Buchard B, Lebreton A, Hordonneau C, Duron C, Valla D, Sophie H, Ledain-Rautou E, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C, Francoz C2020-09-01Cirrhosis, Extra hepatic portal vein obstructionClinics and research in hepatology and gastroenterology
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆.Anstee QM, Darlay R, Cockell S, Meroni M, Govaere O, Tiniakos D, Burt AD, Bedossa P, Palmer J, Liu YL, Aithal GP, Allison M, Yki-Järvinen H, Vacca M, Dufour JF, Invernizzi P, Prati D, Ekstedt M, Kechagias S, Francque S, Petta S, Bugianesi E, Clement K, Ratziu V, Schattenberg JM, Valenti L, Day CP, Cordell HJ, Daly AK2020-09-01Fibrosis, GCKR, GWAS, HSD17B13, NAFLD, NASH, PNPLA3, SNP, TM6SF2Journal of hepatology
Congenital portosystemic shunts: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.Guérin F, Franchi Abella S, McLin V, Ackermann O, Girard M, Cervoni JP, Savale L, Hernandez-Gea V, Valla D, Hillaire S, Dutheil D, Bureau C, Gonzales E, Plessier A2020-09-01Congenital, Portocaval, PostosystemicClinics and research in hepatology and gastroenterology
Management of anticoagulation in adult patients with chronic parenchymal or vascular liver disease: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.Ollivier-Hourmand I, Nguyen N, De Gottardi A, Valla D, Hillaire S, Dutheil D, Bureau C, Hernandez-Gea V, De Raucourt E, Plessier A2020-09-01Anticoagulation, Chronic parenchymal, Vascular liver diseaseClinics and research in hepatology and gastroenterology
Pregnancy and vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.Payancé A, Ceccaldi PF, De Raucourt E, Valla D, Hillaire S, Dutheil D, Hernandez-Gea V, Bureau C, Plessier A2020-09-01Pregnancy, Vascular liver diseaseClinics and research in hepatology and gastroenterology
Hereditary hemorrhagic telangiectasia and liver involvement: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.Silvain C, Thévenot T, Colle I, Vilgrain V, Dupuis-Girod S, Buscarini E, Valla D, Hillaire S, Dutheil D, Sitbon O, Bureau C, Plessier A2020-09-01Hereditary hemorrhagic telangiectasia, Liver, Portal hypertension, Rendu-Osler-Weber diseaseClinics and research in hepatology and gastroenterology
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis.Corpechot C, Chazouillères O, Belnou P, Montano-Loza AJ, Mason A, Ebadi M, Eurich D, Chopra S, Jacob D, Schramm C, Sterneck M, Bruns T, Reuken P, Rauchfuss F, Roccarina D, Thorburn D, Gerussi A, Trivedi P, Hirschfield G, McDowell P, Nevens F, Boillot O, Bosch A, Giostra E, Conti F, Poupon R, Parés A, Reig A, Donato MF, Malinverno F, Floreani A, Russo FP, Cazzagon N, Verhelst X, Goet J, Harms M, van Buuren H, Hansen B, Carrat F, Dumortier J2020-09-01Cyclosporine, PBC, Recurrence, Survival, Tacrolimus, Transplantation, UDCAJournal of hepatology
Sinusoidal obstruction syndrome.de Lédinghen V, Villate A, Robin M, Decraecker M, Valla D, Hillaire S, Hernandez-Gea V, Dutheil D, Bureau C, Plessier A2020-09-01Hematopoietic stem cells transplant, Hepatic Veno-occlusive disease, Sinusoidal obstruction syndromeClinics and research in hepatology and gastroenterology
Budd-Chiari syndrome.Coilly A, Potier P, Broué P, Kounis I, Valla D, Hillaire S, Lambert V, Dutheil D, Hernández-Gea V, Plessier A, Vilgrain V, Bureau C2020-09-01Anticoagulation, Ascite, Budd-Chiari syndrome, Hepatomegaly, Obstruction, ThrombosisClinics and research in hepatology and gastroenterology
Why and when to diagnose Behcet's disease in patients with Budd Chiari Syndrome?Desbois AC, Plessier A2020-09-01Clinics and research in hepatology and gastroenterology
Non-invasive screening for subclinical liver graft injury in adults via donor-specific anti-HLA antibodies.Höfer A, Jonigk D, Hartleben B, Verboom M, Hallensleben M, Manns MP, Jaeckel E, Taubert R2020-08-28Scientific reports
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses.Debureaux PE, Cassinat B, Soret-Dulphy J, Mora B, Verger E, Maslah N, Plessier A, Rautou PE, Ollivier-Hourman I, De Ledinghen V, Goria O, Bureau C, Siracusa C, Valla D, Giraudier S, Passamonti F, Kiladjian JJ2020-08-11Blood advances
[Role of autophagy in liver sinusoidal endothelial cells in nonalcoholic steatohepatitis].Hammoutene A, Rautou PE2020-08-01Medecine sciences : M/S
Therapeutic plasma exchange in acute on chronic liver failure.Stahl K, Busch M, Fuge J, Schneider A, Manns MP, Seeliger B, Schmidt JJ, Wiesner O, Schmidt BMW, Taubert R, Vondran FWR, Hoeper MM, David S2020-08-01decompensation of liver cirrhosis, liver transplantation, plasmapheresisJournal of clinical apheresis
Functional rescue of an ABCB11 mutant by ivacaftor: A new targeted pharmacotherapy approach in bile salt export pump deficiency.Mareux E, Lapalus M, Amzal R, Almes M, Aït-Slimane T, Delaunay JL, Adnot P, Collado-Hilly M, Davit-Spraul A, Falguières T, Callebaut I, Gonzales E, Jacquemin E2020-08-01ABC transporters superfamily, PFIC2, VX-770, cholestatic liver diseases, paediatrics, potentiatorLiver international : official journal of the International Association for the Study of the Liver
Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.Schneider CV, Hamesch K, Gross A, Mandorfer M, Moeller LS, Pereira V, Pons M, Kuca P, Reichert MC, Benini F, Burbaum B, Voss J, Gutberlet M, Woditsch V, Lindhauer C, Fromme M, Kümpers J, Bewersdorf L, Schaefer B, Eslam M, Bals R, Janciauskiene S, Carvão J, Neureiter D, Zhou B, Wöran K, Bantel H, Geier A, Dirrichs T, Stickel F, Teumer A, Verbeek J, Nevens F, Govaere O, Krawczyk M, Roskams T, Haybaeck J, Lurje G, Chorostowska-Wynimko J, Genesca J, Reiberger T, Lammert F, Krag A, George J, Anstee QM, Trauner M, Datz C, Gaisa NT, Denk H, Trautwein C, Aigner E, Strnad P2020-08-01ALT, FibroScan, GGT, SERPINA1Gastroenterology
Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis.Ronca V, Mancuso C, Milani C, Carbone M, Oo YH, Invernizzi P2020-08-01TLR, autoimmunity, biliary epithelial cells, primary biliary cholangitisJournal of leukocyte biology
Management of patients with autoimmune liver disease during COVID-19 pandemic.Lleo A, Invernizzi P, Lohse AW, Aghemo A, Carbone M2020-08-01Journal of hepatology
Non-Invasive Assessment and Management of Liver Involvement in Adults With Alpha-1 Antitrypsin Deficiency.Hamesch K, Strnad P2020-07-01AATD, SERPINA1, alpha-1 antitrypsin deficiency, elastography, genetic liver disease, liver fibrosis, liver stiffness, rare liver diseaseChronic obstructive pulmonary diseases (Miami, Fla.)
Editorial: gut microbiota profile in patients with autoimmune hepatitis-a clue for adjunctive probiotic therapy? Authors' reply.Liwinski T, Schramm C2020-07-01Alimentary pharmacology & therapeutics
Genotype correlates with the natural history of severe bile salt export pump deficiency.van Wessel DBE, Thompson RJ, Gonzales E, Jankowska I, Sokal E, Grammatikopoulos T, Kadaristiana A, Jacquemin E, Spraul A, Lipiński P, Czubkowski P, Rock N, Shagrani M, Broering D, Algoufi T, Mazhar N, Nicastro E, Kelly DA, Nebbia G, Arnell H, Björn Fischler, Hulscher JBF, Serranti D, Arikan C, Polat E, Debray D, Lacaille F, Goncalves C, Hierro L, Muñoz Bartolo G, Mozer-Glassberg Y, Azaz A, Brecelj J, Dezsőfi A, Calvo PL, Grabhorn E, Sturm E, van der Woerd WJ, Kamath BM, Wang JS, Li L, Durmaz Ö, Onal Z, Bunt TMG, Hansen BE, Verkade HJ2020-07-01ABCB11, Natural history, PFIC2, Severe BSEP deficiency, Surgical biliary diversionJournal of hepatology
Metamizole: An underrated agent causing severe idiosyncratic drug-induced liver injury.Sebode M, Reike-Kunze M, Weidemann S, Zenouzi R, Hartl J, Peiseler M, Liwinski T, Schulz L, Weiler-Normann C, Sterneck M, Lohse AW, Schramm C2020-07-01acute liver failure, drug-induced liver injury, elevated liver enzymes, metamizole, side effectsBritish journal of clinical pharmacology
Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists.Abenavoli L, Procopio AC, Fagoonee S, Pellicano R, Carbone M, Luzza F, Invernizzi P2020-06-10chenodeoxycholic acid, liver, obeticholic acid, scaffold, ursodeoxycholicacidDiseases (Basel, Switzerland)
Glycerol Phenylbutyrate Therapy in Progressive Familial Intrahepatic Cholestasis Type 2.Almes M, Jobert A, Lapalus M, Mareux E, Gonzales E, Jacquemin E2020-06-01Journal of pediatric gastroenterology and nutrition
A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis.Liwinski T, Casar C, Ruehlemann MC, Bang C, Sebode M, Hohenester S, Denk G, Lieb W, Lohse AW, Franke A, Schramm C2020-06-01Alimentary pharmacology & therapeutics
Let's not forget our COVID-19-free cirrhotic patients!Viganò M, Carbone M2020-06-01Liver international : official journal of the International Association for the Study of the Liver
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis.Bossen L, Rebora P, Bernuzzi F, Jepsen P, Gerussi A, Andreone P, Galli A, Terziroli B, Alvaro D, Labbadia G, Aloise C, Baiocchi L, Giannini E, Abenavoli L, Toniutto P, Marra F, Marzioni M, Niro G, Floreani A, Møller HJ, Valsecchi MG, Carbone M, Grønbaek H, Invernizzi P2020-06-01macrophage activation markers, non-invasive markers, primary biliary cholangitis, prognostic markersLiver international : official journal of the International Association for the Study of the Liver
New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney disease.Barten TRM, Bernts LHP, Drenth JPH, Gevers TJG2020-06-01Autosomal dominant polycystic kidney disease, autosomal dominant polycystic liver disease, estrogen, hepatic cystogenesis, liver cyst, mTOR, metformin, polycystic liver disease, somatostatin, tolvaptanExpert opinion on therapeutic targets
Switching vs. add-on strategy in PBC treatment: Lessons from UDCA and bezafibrate experience.Corpechot C, Rousseau A, Chazouillères O2020-06-01Journal of hepatology
2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta-analysis.Thiele M, Hugger MB, Kim Y, Rautou PE, Elkrief L, Jansen C, Verlinden W, Allegretti G, Israelsen M, Stefanescu H, Piscaglia F, García-Pagán JC, Franque S, Berzigotti A, Castera L, Jeong WK, Trebicka J, Krag A2020-06-01Aixplorer, Decompensated liver disease, compensated advanced chronic liver disease, liver vein catheterization, supersonic shear imagineLiver international : official journal of the International Association for the Study of the Liver
Population-based study of autoimmune hepatitis and primary biliary cholangitis in Germany: rising prevalences based on ICD codes, yet deficits in medical treatment.Sebode M, Kloppenburg A, Aigner A, Lohse AW, Schramm C, Linder R2020-05-01Zeitschrift fur Gastroenterologie
Primary Sclerosing Cholangitis: Burden of Disease and Mortality Using Data from the National Rare Diseases Registry in Italy.Carbone M, Kodra Y, Rocchetti A, Manno V, Minelli G, Gerussi A, Ronca V, Malinverno F, Cristoferi L, Floreani A, Invernizzi P, Conti S, Taruscio D2020-04-29autoimmune liver disease, cholestatic liver disease, epidemiology, primary sclerosing cholangitis, rare diseases, registryInternational journal of environmental research and public health
A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis.Hammoutene A, Biquard L, Lasselin J, Kheloufi M, Tanguy M, Vion AC, Mérian J, Colnot N, Loyer X, Tedgui A, Codogno P, Lotersztajn S, Paradis V, Boulanger CM, Rautou PE2020-03-01Alcohol, Autophagy, Diabetes, Fibrosis, Inflammation, LSECs, Metabolic syndrome, NASHJournal of hepatology
The future of autoimmune liver diseases - Understanding pathogenesis and improving morbidity and mortality.Engel B, Taubert R, Jaeckel E, Manns MP2020-02-01autoimmune hepatitis, cholangiocarcinoma, primary biliary cholangitis, primary sclerosing cholangitis, regulatory T cellsLiver international : official journal of the International Association for the Study of the Liver
Autoimmune Hepatitis: Tolerogenic Immunological State During Pregnancy and Immune Escape in Post-partum.Bozward AG, Wootton GE, Podstawka O, Oo YH2020-01-01autoimmune hepatitis, memory T cells, placenta, pregnancy, regulatory T cells, toleranceFrontiers in immunology
New Therapeutic Targets in Autoimmune Cholangiopathies.Gerussi A, Lucà M, Cristoferi L, Ronca V, Mancuso C, Milani C, D'Amato D, O'Donnell SE, Carbone M, Invernizzi P2020-01-01FXR agonists, fibrates, gut-liver axis, liver, microbiome, primary biliary cholangitis, primary sclerosing cholangitisFrontiers in medicine
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies.Gerussi A, D'Amato D, Cristoferi L, O'Donnell SE, Carbone M, Invernizzi P2020-01-01Bile acids, FXR agonists, Fibrates, Gut–liver axis, Microbiome, Precision medicine, Primary biliary cholangitis, Primary sclerosing cholangitisAnnals of hepatology
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group.Than NN, Hodson J, Schmidt-Martin D, Taubert R, Wawman RE, Botter M, Gautam N, Bock K, Jones R, Appanna GD, Godkin A, Montano-Loza AJ, Lammert F, Schramm C, Manns MP, Swain M, Burak KW, Adams DH, Hirschfield GM, Oo YH2019-12-01Autoimmune hepatitis, B cell depletion therapy, Difficult-to-manage, Prednisolone, RituximabJHEP reports : innovation in hepatology
Assessment of liver phenotype in adults with severe alpha-1 antitrypsin deficiency (Pi*ZZ genotype).Kümpers J, Fromme M, Schneider CV, Trautwein C, Denk H, Hamesch K, Strnad P2019-12-01Journal of hepatology
The challenges of primary biliary cholangitis: What is new and what needs to be done.Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D, Vierling JM, Adams D, Alpini G, Banales JM, Beuers U, Björnsson E, Bowlus C, Carbone M, Chazouillères O, Dalekos G, De Gottardi A, Harada K, Hirschfield G, Invernizzi P, Jones D, Krawitt E, Lanzavecchia A, Lian ZX, Ma X, Manns M, Mavilio D, Quigley EM, Sallusto F, Shimoda S, Strazzabosco M, Swain M, Tanaka A, Trauner M, Tsuneyama K, Zigmond E, Gershwin ME2019-12-01Bile acids, Biliary epithelial cells, Biomarkers, Histology, Personalized medicine, Primary biliary cholangitisJournal of autoimmunity
Mild Iron Overload as Seen in Individuals Homozygous for the Alpha-1 Antitrypsin Pi*Z Variant Does Not Promote Liver Fibrogenesis in HFE Knockout Mice.Guldiken N, Hamesch K, Schuller SM, Aly M, Lindhauer C, Schneider CV, Fromme M, Trautwein C, Strnad P2019-11-09HFE, SERPINA1, genetic liver disease, iron metabolism, liver fibrosis, rare liver disease, α1-antitrypsin deficiencyCells
Clinical management of autoimmune hepatitis.Pape S, Schramm C, Gevers TJ2019-11-01Autoimmune hepatitis, European Association for Study of the Liver, clinical management, induction therapy, prednisolone, prednisoneUnited European gastroenterology journal
Sex differences in clinical presentation and prognosis in patients with primary biliary cholangitis.Abdulkarim M, Zenouzi R, Sebode M, Schulz L, Quaas A, Lohse AW, Schramm C, Weiler-Normann C2019-11-01Autoimmune liver disease, male, primary biliary cholangitis, prognosis, sex differencesScandinavian journal of gastroenterology
Depression in patients with autoimmune hepatitis: the need for detailed psychiatric assessment.Janik MK, Wunsch E, Moskwa M, Raszeja-Wyszomirska J, Krawczyk M, Milkiewicz P2019-09-30Polish archives of internal medicine
DEFI-ALFA: The French key to the alpha1 mystery?Fromme M, Oliverius M, Strnad P2019-06-01Liver international : official journal of the International Association for the Study of the Liver
Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis.Strnad P, Buch S, Hamesch K, Fischer J, Rosendahl J, Schmelz R, Brueckner S, Brosch M, Heimes CV, Woditsch V, Scholten D, Nischalke HD, Janciauskiene S, Mandorfer M, Trauner M, Way MJ, McQuillin A, Reichert MC, Krawczyk M, Casper M, Lammert F, Braun F, von Schönfels W, Hinz S, Burmeister G, Hellerbrand C, Teufel A, Feldman A, Schattenberg JM, Bantel H, Pathil A, Demir M, Kluwe J, Boettler T, Ridinger M, Wodarz N, Soyka M, Rietschel M, Kiefer F, Weber T, Marhenke S, Vogel A, Hinrichsen H, Canbay A, Schlattjan M, Sosnowsky K, Sarrazin C, von Felden J, Geier A, Deltenre P, Sipos B, Schafmayer C, Nothnagel M, Aigner E, Datz C, Stickel F, Morgan MY, Hampe J, Berg T, Trautwein C2019-06-01NASH, SERPINA1, alcoholic liver disease, alpha1-antitrypsin deficiency, fibrosisGut
Inflammatory Phenotype of Intrahepatic Sulfatide-Reactive Type II NKT Cells in Humans With Autoimmune Hepatitis.Sebode M, Wigger J, Filpe P, Fischer L, Weidemann S, Krech T, Weiler-Normann C, Peiseler M, Hartl J, Tolosa E, Herkel J, Schramm C, Lohse AW, Arrenberg P2019-01-01CD1d, alpha-galactosylceramide, lipid antigen, tumor necrosis factor-alpha, unconventional T cellsFrontiers in immunology
Comparison of non-invasive assessment of liver fibrosis in patients with alpha1-antitrypsin deficiency using magnetic resonance elastography (MRE), acoustic radiation force impulse (ARFI) Quantification, and 2D-shear wave elastography (2D-SWE).Reiter R, Wetzel M, Hamesch K, Strnad P, Asbach P, Haas M, Siegmund B, Trautwein C, Hamm B, Klatt D, Braun J, Sack I, Tzschätzsch H2018-01-01PloS one
TitleAuthorsDateKeywordsIssue name
Last update: May 18th, 2024 on 01:30